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In this study, establishment of HL-CZ (a promonocytic cell line) as a new 
platform for study of antibody dependent enhancement (ADE) of dengue virus 
infection in vitro was achieved. Characteristics of HL-CZ that enable it to support 
ADE were also investigated.   
We performed microarray gene expression profiling to compare HL-CZ cells 
infected with dengue virus under antibody dependent enhancement (ADE) conditions 
versus HL-CZ cells infected to an equivalent degree but under non-enhancing 
conditions.  We observed differential expression of several genes belonging to the 
DEAD-box family of RNA helicases (DDX).  These observations were confirmed at a 
protein level by immunoblotting for these proteins in cell lysates obtained from 
infected cells.  Subsequent experiments employing siRNA-mediated knock-down of 
protein expression suggested that DDX31 and DDX47 may be crucial in supporting 
infection of dengue virus under ADE conditions. 
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1.1 Dengue virus 
1.1.1 Classification of dengue virus 
Dengue virus (DENV) is a flavivirus belonging to the family Flaviviridae; 
other members belonging to the same family are: Yellow Fever Virus (YFV), 
Japanese Encephalitis Virus (JEV), Hepatitis C Virus (HCV), West Nile Virus 
(WNV), Tick-Bourne Encephalitis Virus (TBEV) and other several encephalitis-
causing viruses [Calisher et al. 1989; Blok et al. 1992]. Due to genomic sequence 
variation of 30-35%, DENV are categorised into four serotypes known as: DENV 1, 2, 
3 and 4. Infection with one serotype does not confer protective immunity to the other 
three serotypes, therefore secondary or sequential infections are possible. 
1.1.2 Virus structure 
DENV is a positive-stranded RNA virus. The virion particles are ~50nm in 
size with an electron dense core containing the nucleocapsid (~30nm) [Murphy et al. 
1980]. DENV contain 3 structural proteins: capsid protein (C), membrane protein (M), 
and envelope protein (E). The virions consist of a single-stranded RNA genome 
encapsulated by multiple copies of the C proteins (11kDa) [Chambers et al. 1990, Ma 
et al. 2004, Jones et al. 2003, Chang et al. 2001]. The genomic RNA encapsulated by 
C protein is approximately 10.8kb long. It encodes for the 3 structural genes (C, prM 
and E), followed by 7 non-structural genes (NS 1, 2A, 2B, 3, 4A, 4B and 5) [Cleaves 
et al. 1979, Lindenbach et al. 2003]. This structure of genomic RNA and C proteins 
forms the nucleocapid. The nucleocapsid is in turn encapsulated by a host-derived 
lipid bilayer. The host-derived lipid bilayer contains 180 copies of the viral M and E 
glycoproteins [Kuhn et al. 2002].  
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M proteins (8kDa) are derived from proteolytic cleavage of prM (~21kDa). 
prM is the precursor of M protein that consist of the M protein and a pr fragment. pr 
fragments are believed to function as a chaperone to stabilize E protein during viral 
secretion from the host endoplasmic reticulum [Konishi et al. 1993]. The main 
function of prM is to stabilize E protein and prevent acid-catalyzed inactivation of E 
protein to its fusogenic form [Guirakhoo et al. 1992, Heinz et al. 1994, Allison et al. 
1995]. E protein (53kDa) consists of 3 distinct domains (EDI, II and III) [Nybakken et 
al. 2005]. EDI which forms a β-barrel is a central structure for EDII and III as shown 
in Figure 1.1. EDII contains a putative fusion peptide that is involved in the insertion 
into target cell membrane [Rey et al. 1995, Roehrig et al. 1998, Allison et al. 2001]. 
EDIII is structurally immunoglobulin-like. EDIII also contain receptor binding motifs 
[Crill et al. 2001]. Besides being able to block flaviviruses attachment to receptors 




Figure 1.1: Illustration of dengue E protein homodimer structure; EDI represented in red, EDII 





1.1.3 Virus life cycle in host cell 
 Depending on the type of host cell, DENV is known to use a myriad of 
different cell surface receptors to mediate infection. In mosquito cells, DENV may 
utilize heat-shock protein 70 (Hsp70), R80, R67 or an unidentified 45kDa surface 
glycoprotein for its entry into host cell. In mammalian cells, DENV uses a different 
set of receptors for binding and entry. Heparan sulphate [Chen et al. 1997, Germi et al. 
2002, Hilgard et al. 2000], Hsp90 and 70 [Reyes-Del et al. 2005], CD14 [Chen et al. 
1999], GRP78/BiP [Jindadamrongwech et al. 2004], and a 37/67-kDa high-affinity 
laminin receptor [Thepparit et al. 2004] have been associated with mediation of 
DENV binding and entry into mammalian host cell. In human myeloid cells, DENV is 
known to exploit certain C-type lectin receptors for infection [Fernandez-Garcia et al. 
2009]. DC-specific intracellular adhesion molecule 3-grabbing nonintegrin (DC-SIGN) 
[Lozach et al. 2005, Navarro-Sanchez et al. 2003, Tassaneetrithe et al. 2003] , 
mannose receptor (MR) [Miller et al. 2008]  and C-type lectin domain family 5, 
member A (CLEC5) [Chen et al. 2008] have been identified as receptors on human 
myeloid cells for DENV attachment. 
 It is well documented that flaviviruses exploit clathrin-mediated endocytosis 
for cell entry, DENV is no exception [Acosta et al. 2008, Van der Schaar et al. 2008, 
Krishnan et al. 2007, Chu et al. 2004, Nawa et al. 1984]. After endocytosis, DENV 
are internalized into early endosomes which are Rab-5 positive. Membrane fusion of 
the DENV and the endosome take place during Rab-7 positive late endosomes stage 
[Van der Schaar et al. 2008]. Membrane fusion is likely to be dependent on the acidic 
pH of the endosome. It is also likely to vary depending on the DENV strain, as 
different strains have differing membrane fusion properties [Van der Schaar et al. 
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2008, Krishnan et al. 2007]. Fusion of endosomal membrane and DENV membrane 
results in the release of viral nucleocapsid into the cytoplasm.  
 
Once the viral RNA genome is released into the cytoplasm, the positive-sense 
RNA is translated into a polyprotein by ribosomes associated with the rough 
endoplasmic reticulum [Cylde et al. 2006]. Signal sequences within the polyprotein 
translocate NS1, E and part of the prM domain into ER lumen; whereas C, NS3 and 
NS5 remain in the cytoplasmic region. Remaining NS2A/B and NS4A/B are localized 
as transmembrane proteins as shown in Figure 1.2 [Perera et al. 2008]. The 
polyprotein is processed co- and post-translationally by viral and host proteases 
before viral genome replication occurs in the cytoplasm [Bressanelli et al. 2004, 
Modis et al. 2004]. Viral assembly is initiated near the surface of the ER where viral 
proteins and replicated viral RNA genome buds into the lumen of the ER forming new 
subviral/non-infectious immature DENV [Kuhn et al. 2002, Zhang et al. 2003]. The 
resultant particles are transported to the trans-Golgi network. In the trans-Golgi 
network, the virus particle will be post-translationally modified to reach maturity 




Figure 1.2: Topology of dengue viral polyprotein in ER membrane. Viral protease cleaves the 





 It is intriguing to note that certain steps of the viral assembly can be 
incomplete or skipped during the virus life cycle, resulting in the release of subviral 
particles. Capsidless subviral particles was documented in studies by Allison et al 
[Allison et al. 1995, Russell et al. 1980], such particles implies that encapsulation of 
the nucleocapsid may not be a critical step in virus life cycle [Fonseca et al. 1994, 
Hunt et al. 2001, Konishi et al. 2002]. Immature progeny virions were also commonly 
observed in vitro [Allison et al. 2003]. This is often due to incomplete cleavage of the 
prM by furin. Furin is an enzyme found in the trans-Golgi network and it is 








Figure 1.3: Intracellular life cycle of DENV. Diagram illustrates that DENV utilises cellular 
endocytosis for entry, followed by cellular translational mechanisms in the ER for viral protein 
synthesis. RNA replication takes place in the cytoplasm with the aid of host polymerases and NS 
proteins from the virus. DENV is packaged into the ER and exocytosed from the cell via the 




1.1.4 Pathogenesis of disease  
DENV can cause a range of mild to severe illness. The most common disease 
caused by DENV is known as dengue fever (DF). DF manifest as an undifferentiated 
febrile disease with maculopapular rash in children. Fever, headache, retro-orbital 
pain, myalgia, malaise, anorexia, abdominal discomfort, lymphoadenopathy and 
leucopenia are commonly observed symptoms among infected individuals [Watt et al. 
2003]. The fever usually persists for 5 to 7 days [Fonseca et al. 2002]. Fatalities due 
to DF are low with proper management of symptoms.  
Mortality rate for a more severe form of the disease, known as dengue 
hemorrhagic fever (DHF), is fairly high as compared to DF [Halstead et al. 1970a]. 
DHF is pathophysiologically due to increased vascular permeability leading to plasma 
leakage. It is characterized by 1) fever, 2) hemorrhagic episodes determined by 
positive tourniquet test, petechiae/ecchymoses/purpura, or mucosa/gastrointestinal 
tract/ injection sites bleeding, 3) thrombocytopenia with 100000/mm
3
 or less in 
platelet count, 4) and evidence of plasma leakage [WHO 2010].  
DHF usually last for 7 to 10 days and is more severe than DF. Mortality rate 
can be lowered to less than 1% if there is proper management of the circulatory fluid 
volume [Rothman 1999]. In severe DHF, after a few days of fever, the patient may 
suddenly experience a drop in body temperature followed by signs of systemic 
circulatory failure. The condition of the patient will spiral into a critical state of shock; 
death will follow within 12 to 24 hours if medical intervention is not available to 
recover the fluid loss [Halstead et al. 1970b]. Such cases are known as dengue shock 
syndrome (DSS). DSS is the most severe form of DHF, DSS is categorised as 
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GRADE III and IV DHF according to DHF classification by World Health 
Organization (WHO) (Refer Table 1.1). 
 
Table 1.1.1: Classification of DHF according to symptoms by WHO in 1997 




Grade I Fever and non-specific constitutional symptoms, and 
positive tourniquet test and/or easy bruising. 
 
Grade II Spontaneous bleeding coupled with Grade I 
manifestation. 
 
Grade III (DSS) Early signs of circulatory failure, incipient shock. 
 
Grade IV (DSS) Profound shock with undetectable pulse and blood 
pressure. 
 
 The classification of dengue is further simplified into uncomplicated and 
severe dengue in 2009 as WHO found that the old classification is too restrictive. 
DHF/DSS will be considered as severe dengue. 
Table 1.1.2: New and simplified classification of dengue proposed by WHO in 2009 [Adapted 





1.1.5 Dengue Epidemiology 
Dengue is one of the most important mosquito-borne viral disease in the world, 
and is responsible for almost 50 million infections annually [Gubler et al. 2006, WHO 
2010]. Up to 500000 cases of DHF and 22000 dengue associated deaths have been 
documented annually [WHO 2010]. In the past 50 years, incidence has increased 30 
fold. 2.5 billion-of the world’s population live in areas where dengue is endemic 
[Solomon et al. 2001]. This means that 2 in 5 of the global population are living in 
areas where dengue infection is prevalent.  
Before 1970, only 9 countries had documented cases of DHF, since then the 
numbers of countries with documented cases of DHF has quadrupled [WHO 2010]. 
Over the years, the spread of dengue have been exacerbated by the transport of the 
main mosquito vector, Aedes aegypti. Global distribution of dengue highly correlates 
with the distribution of its main vector [Corrêa et al. 2005]. Dengue mainly affects 
countries in the tropical and subtropical regions, particularly in South East Asia and 
Latin America; several affected nations are known to be hyperendemic (co-circulation 
of more than 1 dengue serotype) [Jacobs et al. 2005]. Other factors that were thought 
to contribute to the spread of the disease includes: rapid population growth, rural-
urban migration, inadequate basic urban infrastructure, and increase in amount of 
solid waste which provide suitable environment for Aedes larvae growth [Corrêa et al. 
2005]. The mosquito vectors that are responsible for the transmission of dengue are 






Figure 1.4: On the left is Aedes aegypti and Aedes albopictus is shown on the right. Both are the 
main vectors contributing to the spread of DENV. Aedes aegypti is a domesticated species and 
Aedes albopictus is a para-domesticated species, both species can be found in urbanized regions. 
[Adapted from CDC 2010] 
 
 
Figure 1.5: Global distribution of DENV. Most regions affected by dengue are located in the 
tropics with hot and wet climate. Tropical climate is favourable for the survival of Aedes aegypti 






1.1.6 Treatment of dengue 
There is no specific antiviral drug effective in the treatment of DF/DHF. 
Therefore treatment is limited to the management of symptoms and supportive 
therapy. Mortality rate of DHF/DSS can be up to 50% high without proper medical 
attention. The mortality rate can be reduced to 1% if supportive care and treatment is 
provided promptly [Tripathi et al. 1998]. The lack of an effective antiviral treatment is 
compounded by the absence of an effective vaccine in the market. However 





1.2 Antibody Dependent Enhancement (ADE) 
The phenomenon of ADE was first described in 1930s but the first definitive 
study in vitro was by Hawks in 1964 [Hawks et al. 1964]. ADE is the enhancement of 
viral infectivity due to the presence of antibodies at either non- or sub-neutralizing 
conditions. Due to the presence of four DENV serotypes, anti-DENV antibodies can 
be homotypic (antibodies target another DENV of the same serotype as the cognate 
DENV) or heterotypic (antibodies target DENV of a different serotype than the 
cognate DENV). ADE of DENV can be caused by a few conditions. Firstly, it could 
be due to homotypic antibodies diluted to a concentration where it becomes sub-
neutralising. Secondly, it could be induced by heterotypic antibodies which are 
diluted to a non-neutralising concentration. Lastly, it could be induced by antibodies 
which can cross-bind to both target DENV and the host cell surface receptors 
[Halstead et al. 2003]. ADE in vitro is not restricted to flaviviruses, several other 
viruses (eg, Ebola, Human Immunodeficiency Virus (HIV) and Severe Acute 
Respiratory Syndrome Coronavirus (SARS-CoV)) can also utilise ADE mechanism 
for infection (Takada et al. 2007, Füst et al. 1997, Kam et al. 2007). 
Even though definitive studies of ADE in vitro have been established for over 
40 years, there has been no definitive study in vivo to prove that ADE is possible in 
primate mammalian host. However, there is an instance where ADE has been 
demonstrated in vivo in the mouse model [Zellweger et. al. 2010]. Nonetheless, ADE 
mechanism is widely used to explain the occurrence of DHF. A high correlation 
between secondary dengue infection and DHF was established by Halstead et al in 
1970 [Halstead et al. 1970a], and he suggested that the anti-DENV antibodies raised 
during the primary infection could contribute to the severity during secondary 
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infection via ADE mechanisms. Maternal anti-DENV antibodies transferred to the 
infant during pregnancy were thought to be the contributing factor for DHF in new 
borns infected by dengue for the first time [Kilks et al. 1988]. Several studies have 
associated the occurrence of DHF with sequential DENV infection [Green et al. 2006, 
Guy et al. 2004, Halstead et al. 1970b]; and more often than not, ADE is suggested to 
be the cause of this association [Halstead et al. 2002]. Furthermore, high viral load in 
DHF is associated with increased severity of the disease and ADE is capable of 
inducing higher viral output per infected cell as demonstrated in vitro [Halstead et al. 
2003].  
1.2.1 Mechanisms of ADE 
It was first proposed that enhancement of virus infectivity is contributed by an 
overall increase in the binding affinity of virus-antibody complex for host cells that 
express FcγR. Thus, the antibody-bound virus increases the probability of the virus 
entering the cell as compared to virus not bound to any antibody. This contributes to 
the higher infection rate observed in ADE. The prerequisites for ADE are: 1) The 
antibody must be able to bind to the virus without neutralising the virus completely, 2) 
the antibody used must be able to interact with host surface molecules, and 3) the host 
cell must possess the receptors to interact with the antibody (via Fcγ-FcγR binding 
for homotypic and heterotypic antibodies).  
1.2.2 Fcγ-FcγR mediated entry 
For ADE of DENV, a heterotypic antibody which is cross-reactive to the 
target virus can be used to induce enhancement. However it must be noted that even 
though the antibody is heterotypic, at a high enough concentration it could still 
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neutralise the virus. Therefore, the heterotypic antibody must be diluted to a sub-
neutralising concentration before it could induce enhancement [Takada 2003]. 
Alternatively, a homotypic antibody can be use in place of the heterotypic antibody. 
Likewise, the concentration of the homotypic antibody in use is of a concern. It must 
be a level which it is non-neutralising but still at a level high enough to induce the 
enhancement effect [Morens 1987] (Refer Figure 1.6).  
 
Figure 1.6: Diagram showing the relationship between infection rate and antibody concentration 
in ADE. Neutralization occurs at higher antibody titres, neutralisation is lost with subsequent 
antibody dilutions and enhancement peak at an optimal antibody dilution. When antibody is 
diluted beyond peak enhancement, infection rates starts to decrease till it coincides with that of 
control. [Adapted from Halstead et al. 2003] 
Both heterotypic and homotypic antibody mediated ADE have similar 
mechanisms of enhancing infection. Usually the antibody used is of IgG subclass. 
Relying on the high affinity binding of the Fcγ portion of the antibody to the FcγR 
on the host cell, interaction of the virus and the host receptor which mediates viral 
entry is enhanced. This enhancement increases overall infection rate. Fcγ portion of 
the antibody-virus complex could also facilitate entry of virion via FcγR mediated 
endocytosis (refer Figure 1.7). FcγRI is known to have high affinity to IgG and is 
17 
 
one of the receptors involved in ADE [Kontny et al. 1988]. FcγRII which has a 
lower affinity for IgG has been known to be involved in ADE [Littaua et al. 1990, 
Rodrigo et al. 2006]. Fcγ-FcγR mediated mechanism has been widely studied, 
because of possible implications to DHF in sequential dengue infection. 
 
 
Figure 1.7A and B: Illustration of Fcγ-FcR mediated ADE. A) At high antibody titre, anti-
DENV antibody binds to surface of the virion. Steric hindrance from the antibody prevents 
binding of virus to host surface receptor. B) At enhancing antibody titre, antibody provides the 
steric hindrance that impedes viral entry, viral ligands can still interacts with the receptor on 
host cell for binding and entry. In addition the Fcγ portion of the antibody acts as a co-receptor 





1.2.3 IgM-Complement mediated entry 
Even though most in vitro studies utilized IgG for ADE, there is one instance 
where IgM was able to induce ADE in WNV as well [Cardosa et al. 1983]. Instead of 
the Fcγ -Fcγ R binding mechanism, it was postulated that classical pathway 
activation of complement by IgM results in attachment of complement protein C3 
fragment to WNV. The attachment of C3 fragment on the virus mediated ADE via its 
binding to complement receptor 3 on the host cell surface (refer Figure 1.8). 
 
 
Figure 1.8: Illustration of IgM-complement mediated ADE. IgM bound to DENV results in 
activation of classical complement pathway. This in turn results in the attachment of C3 
fragment to the virion. The attached C3 interacts with complement receptor on host surface. It 
was postulated that the C3-complement receptor interactions function as a co-receptor to 





1.2.4 Cross-binding antibody mediated entry 
Besides heterotypic and homotypic antibodies, antibody that cross bind the 
virus and host surface molecules could also induce ADE. This mechanism is not as 
well studied as Fcγ-FcγR mechanism. However, there are 2 independent studies 
demonstrating such mechanism is possible in vitro. Conjugation of anti-DENV E/prM 
antibody and anti-β2 microglobulin antibody yields a chimeric antibody that is 
capable of cross binding DENV to β2 microglobulin of host cell. Such chimeric 
antibody was shown to be capable of inducing ADE even in FcγR-/- host cells [Mady 
1992] (refer Figure 1.9). Using anti-prM IgG and in the absence of complement, 
Huang et al manage to induce ADE in FcγR-/- host cells, and it was discovered that 
the anti-prM IgG was able to cross-bind to Hsp60 on the host surface [Huang et al. 
2006] . While chimeric and cross-binding antibodies demonstrated that non-
specificity of the antibody can also enhances viral infection in vitro, there is no 
definitive evidence indicating that such a mechanism is a possible contributing factor 
to dengue severity in vivo as there has been an absence of proof that antibodies raised 
during DENV infection can cross-bind to host cell membrane proteins. 
 
Figure 1.9: Proposed mechanism of bi-specific antibody induced ADE. Chimeric bi-specific 
antibody which consists of 2 different Fab fragments conjugated chemically can induce ADE in 





1.2.5 Role of FcγR signalling in ADE 
Beside the traditional view of enhanced virus uptake via the Fcγ-FcγR 
mechanism in ADE, it was also proposed that ligation of the Fcγ portion of the 
antibody-virus complex with the host FcγR might result in FcγR signalling within 
the host cell. Both FcγR signalling together with the enhanced uptake of the virus 
could be the contributing factors to an overall increase in viral output per cell as 
observed in most ADE infection in vitro. This novel postulation explains ADE driven 
immunopathology such as the increased in viral load in DHF patients.  
Both FcγR I and IIA were identified as the FcRs responsible for mediation of 
ADE. Even though immunoreceptor tyrosine-based activation motif (ITAM) is found 
only on the cytosolic domain of FcγRIIA, it is still well documented that both FcγR 
I and IIA utilises ITAM for cell signalling [Abdel Shakor et al. 2004, Huang et al. 
1992, Indik et al. 1991, Kwiatkowska et al. 2003, Sobota et al. 2005]. ITAM is 
known to have an important role in FcγRIIA mediated ADE. It was demonstrated 
that ADE was completely abrogated when there is an absence or mutation of the Fcγ
RIIA ITAM domain [Moi et al. 2009]. FcγRIIIA also utilizes ITAM for its 
intracellular signalling but there is no definitive studies showing that FcγRIIIA is 
involved with ADE. 
Ligation of Fc to FcγR during ADE has consequences that may influence 
intracellular anti-viral response of the host cell. In vitro studies show that ligation of 
the FcγR during ADE induces IL-10 production [Mahalingam et al. 2002]. IL-10 is 
recognised as a key cytokine in anti inflammatory and immunosuppressive responses. 
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IL-10 upregulates suppressor of cytokine signalling 3 (SOCS3) which is responsible 
for repression of IFNα induced gene activation in monocytes [Ito et al. 1999, Song et 
al. 1998].  
During DHF, TNFα  level in the circulatory system is elevated and it is 
thought to be one of the contributing factors for plasma leakage observed in DSS 
[Cardier et al. 2005]. IL-10 is known to suppress TNFα via SOCS3 upregulation in 
vitro, this seem to contradict the hypothesis of ADE being the underlying mechanism 
for DHF. Therefore, it was speculated that local autocrine of IL-10 early in the 
infection contributes to the peak viraemia. The elevation of TNFα occurs during later 
stages of DHF (after viraemia had peaked), and by then systemic IL-10 level had 
already dropped [Green et al. 1999, Suhrbier et al. 2003]. 
The FcγR signalling during ADE not only induces IL-10 production in 
macrophages, it also suppresses IL-12, IFN-γ and IFN-α/β [Chareonsirisuthigul et 
al. 2007, Yang et al. 2001]. These cytokines are known for mediating both innate and 
adaptive intracellular anti-viral responses. Suppression of IL-12, IFN-γ and IFN-α/
β  result in downregulation of STAT-1 and IRF-1. STAT-1 and IRF-1 are 
transcription factors for iNOS gene which is responsible for nitric oxide production. 
Overall reduction in nitric oxide levels during ADE renders the host cell more 
permissive to viral replication. Therefore, it could contribute to the higher viral output 





Figure 1.10: Intracellular signalling triggered by Fc-FcR mediated ADE. ADE induces FcR 
signalling which can result in upregulation of IL-10 and reduced IL-12, IFN-γ and IFN-α/β. 
Solid lines indicate pathways enhanced by ADE. Dotted lines indicate pathways inhibited by 






1.3 Factors influencing ADE 
As discussed in earlier paragraphs, subclass of the antibody used in ADE 
infection can have an impact on the mechanism by which enhancement occurs, 
concentration of the antibody used is also of concern. Besides antibody subclass and 
concentration, there are other factors which can influence the level of enhancement in 
ADE infections. 
1.3.1 Specificity of antibody  
Most documented in vitro studies of ADE of DENV utilises antibody that 
target E protein of the viruses. However, there have been recent reports that anti-prM 
antibody is able to induce enhancement in vitro [Huang et al. 2006, Dejnirattisai et al. 
2010]. Anti-prM antibodies were known to be highly cross reactive among the 4 
serotypes, and were unable to fully neutralise DENV even at high concentration. 
Unlike most anti-E antibodies which show neutralisation at higher concentration, anti-
prM fails to neutralise DENV at high concentration of 30µg/ml. Not only did the anti-
prM fail to neutralise, it enhanced infection by more than 3 fold (from 20 to 70%) at 
30µg/ml concentration [Dejnirattisai et al. 2010]. Dejnirattisai et al (2010) 
demonstrated that the specificity of the antibody used in ADE is an important 
parameter that influences enhancement, less specific and highly cross reactive 
antibodies such as anti-prM antibodies are more prone to enhancement induction. 
1.3.2 Role of cholesterol depleting drugs on ADE 
A recent study has shown that the level of infection enhancement by ADE 
infection of differentiated U937 monocytic cell lines with DENV was dependent on 
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the presence of cholesterol and cholesterol-rich membrane micro-domains on the host 
cell. Association of FcγR with lipids rafts upon IgG binding was known to be crucial 
for Fc γ R receptor signalling [García-García et al. 2007, Kono et al. 2002, 
Kwiatkowska et al. 2001]. Drugs which deplete cholesterol and cholesterol-rich 
membrane micro-domains can disrupt lipid raft integrity [Reyes-del Valle et al. 2005], 
thereby having an adverse effect on ADE infection of the host cell. Nystatin, filipin 
and β-methyl cyclodextrin significantly lower ADE infection rate of differentiated 
U937 in vitro by disrupting the integrity of lipid rafts [Henry et al. 2010]. This drug 
induced reduction in ADE infection rate can be reversed by the supplementation of 
bovine fetal serum. Bovine fetal serum supplement replenishes the cholesterol that is 
needed for the formation of lipid rafts and proper ADE mechanism to occur [Henry et 
al. 2010]. 
1.3.3 Negation of ADE by C1q 
Complement proteins such as C1q could negate the enhancing effect observed 
in ADE infection as well [Modis et al. 2004]. Presence of complement in Fcγ-FcγR 
mediated ADE lowers the enhancement of infection significantly. Presence of C1q 
lowers the peak enhancement of ADE mediated by IgG greatly. This reduction effect 
is more profound with IgG subclasses, such as IgG2a. IgG2a is known to bind to C1q 
avidly. Given that C1q is a large multimeric protein and its binding site is in close 
proximity to that of FcγR binding site. It was suggested that C1q restriction of ADE 
is contributed by the blocking of Fcγ-FcγR interaction when C1q binds to the IgG 
involved [Mehlhop et al. 2007, Yamanaka et al. 2007]. Exact mechanism of the C1q 





1.3.4 Cytokines and enzymes affect host FcγR number and function 
Modulation of both function and expression of FcγRs on host cells are shown 
to have a great impact on ADE infection of DENV in vitro. Cytokines and enzymes 
that could up-regulate the number of FcγR on the host cell could potentially augment 
ADE mechanism, thereby enhancing infection rate. U937 cells treated with IFNγ is 
known to have an increased in peak enhanced infection rate (from 25% to 60%) under 
ADE condition. This was later proven to be contributed by the stimulation of U937 by 
the cytokine, causing an increase in number of FcγRI expressed per cell [Kontny et 
al. 1988]. Enzymes such as neuraminidase were also capable of modulating the 
expression and function of FcγRs. K562 erythroleukemic cell line pre-treated with 
neuraminidase was shown to be more permissive to the enhancing effect of ADE 
mediated infections. The enzyme was demonstrated to increase the expression of Fcγ
RII in K562 and also increasing the affinity of FcγRII [Mady et al. 1993].  
1.3.5 Potential of DC-SIGN to obscure ADE 
Other than the expression intensity of FcγRs on the host cell, presence of 
other receptors may also affect the infection enhancing phenomenon of ADE 
mechanism. Despite the fact that DC-SIGN is a receptor which facilitates DENV 
entry into DC [Navarro-Sanchez et al. 2003, Tassaneetrithe et al. 2003], expression of 
DC-SIGN negatively impacts the effect of ADE [Boonak et al. 2009]. Transduced 
K562 and U937 cells that express high levels of DC-SIGN were not able to support 
ADE infection of DENV at all. This could be attributed to the preferential uptake of 
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the virus by DC-SIGN, thus rendering FcγR-mediated entry non-operational. High 
level of DC-SIGN obscuring ADE was also reported in other flavivirus infection 
models [Goncalvez et al. 2007, Pierson et al. 2007]. 
1.3.6 Relationship between MOI and ADE 
The amount of virus used for the infection can have an impact on ADE as it 
influences the baseline infection rate. With a higher baseline infection rate there will 
be less room for enhancement. Therefore, it was generally observed that high 
multiplicity of infections (MOIs) obscure enhancement. MOI refer to the amount of 
viruses (in pfu/ml) exposed to each host cell during the viral absorption step of in-
vitro infection. ADE infection in peripheral blood mononuclear cell (PBMC) was 
observed at MOIs of 0.001 to 0.1. However, this enhancing effect was lost when MOI 
was increased beyond 1[Halstead 2003]. This is probably contributed by the high 
baseline infection rate due to the high MOI.  
1.3.7 Different cell types and virus strains affect level of enhancement under 
ADE conditions 
Different virus strains and cell types also affect the ability of DENV to 
undergo ADE infection. Myeloid cell lines that support ADE in vitro have different 
capacity to support ADE. Besides demonstrating that infection of human cell by 
DENV is modulated by different cell types and virus strains, Diamond et al. also 
demonstrated their impact on ADE of DENV infection. Using monoclonal antibody 
4G2 to induce ADE infection, U937 was demonstrated to be more permissive than 
THP-1 monocytic cell line across 4 different strains of DENV2. Comparing infection 
rates between different strains on U937 alone; DENV 2 N9622 strain was unable to 
induce any significant enhancement whereas DENV 2 16681 had a 23% increment in 
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infection rate due to the enhancing antibody. The difference in virulence of the strain 
and the susceptibility of different cell types to different DENV strains clearly affected 
the rate of enhancement [Diamond et al. 2000].  
Table 1.2: Summary of parameters and factors that could influence infection rate in ADE of 
DENV infection 
Factors affecting in vitro ADE Effects 
 
Specificity of antibody used Less specific antibodies are more likely 
to induce ADE 
 
Nystatin, filipin and β-methyl 
cyclodextrin (cholesterol depleting 
drugs) 
 
Depletion of cholesterol disrupts ADE 
C1q 
 
Presence of C1q negates ADE 
IFNγ and neuraminidase (cytokines and 
enzymes that augments the effects of Fc
γR) 
 
Augments and further increases 
enhancement induced by ADE 
DC-SIGN 
 
Presence of DC-SIGN obscures ADE 
MOI Depends, generally ADE is loss at higher 
MOIs 
 






1.4 Types of cells used for in vitro ADE studies 
 The pre-requisite for hosting ADE infection in cell is that the host must 
possess either FcγRI, II or both the FcγRs. There are several cell types that had 
been proven in previous studies to be able to support ADE of DENV infection.  
1.4.1 Peripheral blood mononuclear leukocytes 
 ADE of DENV was first demonstrated by Halstead et al. in 1977, it was 
established with peripheral blood mononuclear leukocytes (PBMLs) from primate 
origin. In their study, they did not manage to identify the exact leukocyte 
subpopulation in the peripheral blood that was responsible for ADE of dengue 
infection [Halstead et al. 1977]. A separate study by Yang et al. also managed to 
establish ADE of DENV infection in PBML [Yang et al. 2001]. PBML was 
commonly used in the past as a platform to study the effects of ADE because of its 
susceptibility to DENV infection. There is a subpopulation of the cells in PBML that 
possess at least FcγRI or II, given that it is a primary cell type, and it better 
represents in vivo conditions than secondary cell types [Ross et al. 2010]. However in 
both studies, the exact leukocyte subpopulation in the peripheral blood that is 
responsible for ADE of DENV infection was not identified. Contribution of 
confounding by-stander cells that do not support ADE may interfere with the 
observation made during the study of effects induced by ADE. Therefore, there is a 







 monocyte and macrophages 
It is widely recognised that cells from the myeloid linage are potential hosts 
for dengue infection in vivo. Furthermore, myeloid cell types possess at least one of 
the Fc γ R required; therefore it is likely that myeloid cells such as primary 
monocytes could be used to study ADE in vitro. Indeed, CD14
+
 monocytes isolated 
from PBMLs were susceptible to ADE of dengue infection [Kou et al. 2008]. Primary 
monocytes possess all 3 subclasses of FcγRs [Halstead et al. 2003]. Both FcγRI 
and II contribute to ADE of DENV infection in primary monocytes [Kou et al. 2008].  
Likewise for primary macrophages, macrophages extracted from the spleen were able 
to host dengue infection in the presence of enhancing titres of DENV-immune serum 
[Blackley et al. 2007]. Both primary monocytes and macrophages originate from 
myeloid cell linage and both support ADE in vitro. These make them an ideal 
platform for study of ADE in vitro as they represent in vivo conditions more closely 
than secondary cell lines. However, there is a major drawback when it comes to using 
primary cell types. Although they support ADE of DENV infection, they are not as 
permissive to non-enhanced DENV infection as compared to their secondary cell line 
counterparts [Halstead et al. 1981]. After 48 hours, less than 5% of the primary 
monocytes stained positive for E protein after exposure to DENV 2 16681 at a MOI 
of 5. Under the same conditions, only less than 1% of the primary splenic 
macrophages are detected as positive for DENV infection [Blackley et al. 2007].  
1.4.3 Monocytic cell lines 
THP-1 is a monoyctic secondary cell line that resembles primary monocytes 
and can support ADE. Just like monocytes, it utilises both FcγRI and II for ADE of 
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DENV infection [Chareonsirisuthigul et al. 2007, Paradkar et al. 2010, and Diamond 
et al. 2000]. Unfortunately it has the same drawback as primary cell types. ADE 
independent infection of THP-1 with DENV2 16681 at MOI of 10 only yields a mere 
0.2% infection rate after 96 hours of infection [Diamond et al. 2000]. 
Other monocyte-like secondary cell lines, such as, U937 and K562 also 
support ADE mechanism [Diamond et al. 2000, Kontny et al. 1988, Littaua et al. 
1990, Huang et al. 2006, Henry et al. 2010, Guy et al. 2004, Konishi et al. 2010]. 
U937 like its primary counterpart is also difficult to infect without the use of 
enhancing antibodies. Using DENV 2 NGC at a MOI of 5, only 2% of the U937 are 
stained positive for dengue antigen. Other strains (such as DENV2 16681, C0477 and 
K0049) yield an even lower rate of infection (<0.2%) [Diamond et al. 2000]. U937 
only possesses FcγRI and the absence of FcγRII on this cell implies that its 
mechanism of Fc-FcR mediated ADE is completely independent of FcγRII [Kontny 
et al. 1988]. This may not fully represent the ADE situation in vivo.  
Even though K562 is relatively more susceptible to DENV infection, its ADE 
mechanism only utilises FcγRII [Konishi et al. 2010, Littaua et al. 1990]. No doubt, 
in the presence of enhancing titres of antibody, K562 is able to achieve infection rate 
beyond 40%  at MOI 0.1 [Littaua et al. 1990]; the lack of FcγRI could be a handicap 
to the cell when its relevance of ADE in vivo is compared to primary cell types such 
as monocytes.  
Despite the lack of either FcγRI on U937 and or FcγRII on K562, both cell 
lines are still commonly used to analyse the mechanism of ADE due to their ease of 





1.4.4 Primary dendritic cell (DC) matured with Monocyte-Conditioned Medium 
(MCM) mimic 
DC which share common lineage as macrophage and monocytes was also 
identified as a possible platform to host ADE of DENV infection. In addition, 
immature DC (imDC) was also identified as one of the principle cell that DENV 
targets as a host for infection in vivo [Green et al. 2006, Marovich et al. 2001, Palucka 
et al. 2000, Wu et al. 2000]. Unlike primary macrophage and monocytes, monocyte-
derived DC expresses mainly FcγRII [Marovich et al. 2001, Bajtay et al. 2006, 
Boruchov et al. 2005]. Expression of FcγRII is adequate for DC to be a potential 
host to ADE infection of DENV, but imDC also expresses high DC-SIGN levels. It is 
known that presence of DC-SIGN obscures ADE. Therefore, Boonak et al. (2009) 
only managed to demonstrate ADE using matured DC (mDC). MCM mimic was used 
to mature the DCs because unlike LPS, MCM mimic does not induce Type I IFN 
secretion. mDC down regulates the expression of DC-SIGN on its surface thus 
making ADE mechanism feasible.  
1.4.5 Other secondary cell lines 
Although primary B cell was excluded as a host for both ADE dependent and 
independent DENV infection by Kou et al. (2008) and Blackley et al. (2007), these 
findings were only pertinent to primary B cells. BJAB, a secondary B cell line was 
demonstrated by Huang et al. (2006) to be able to respond to ADE infection of DENV. 
There are other non-monocytic secondary cell lines that are also used to study ADE in 
vitro, these cell types may not represent the subpopulation of leukocytes that is 
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commonly recognised as principal hosts for in vivo DENV infection. One of such 
secondary cell line is KU812. KU812 is a mast cell line, it express both FcγRI and II. 
It was demonstrated to be able to host DENV infection under ADE conditions but it is 
not clear if the cell uses both the FcγRs for this task [Brown et al. 2009]. KU812 
infected by DENV under ADE conditions was found to release large amounts of 
vasoactive cytokine [King et al. 2000]. Vasoactive cytokines are one of the factors 
leading to plasma leakage in DSS.  
In summary, there are several cell lines and cell types that can support ADE of 
DENV infection. Each platform has its own advantages and drawbacks. The selection 
of the platform for ADE studies will have to take the drawbacks of each cell type into 
consideration and compromises have to be made. Base on currently understanding, 
there is a lack of a ADE infection platform which is 1) not only susceptible to DENV 
under ADE condition but also highly susceptible to DENV under non-enhancing 
conditions, 2) derived from the same myeloid linage as monocytes, macrophages and 
DCs; and 3) resembles monocytes and macrophages in the sense that it utilises both 
FcγRI and II for ADE mechanism. 
 
 Table 1.3: Comparison of different cell types as platform for ADE study 















































FcγRI and II DENV 2 16681 5 0.15% 11% Blackley et al., 
2007 
THP-1 Secondary human 
monocyte leukemic cells 
FcγRI and II DENV 2 16681 10 <0.2% 1.4% Diamond et al., 
2000 
U937 Secondary human 
monocytic cell line 
FcγRI DENV 2 16681 10 <0.2% 23% Diamond et al., 
2000 
K562 Secondary human 
erythroleukemia cell line 
FcγRII DENV 2 NGC 0.125 3.15% 40.6% Littaua et al., 
1990 
mDC PBML-derived primary 
human cell 
FcγRII DENV 2 
S16803 
1 15% 40% Boonak et al., 
2008 






0.1 <1% 32% Huang et al., 
2006 
KU812 Secondary human mast 
cell-like cell line 
FcγRII DENV 2 16681 1 0.01% 23.96% Brown et al., 
2009 
HL-CZ Secondary human pro-
monocytic cell line 




1.5 Other competing hypothesis  
The capacity of a virus to produce disease in the host is known as virulence of 
the virus. Differences in viral virulence between the first DENV infection and 
subsequent infections could be another possible explanation for the high occurrence of 
DHF/DSS in sequential infections. This alternative hypothesis to ADE was postulated 
by Rico-Hesse et al. when it was observed that the more virulent DENV2 causes more 
cases of DHF/DSS than other serotypes [Rico-Hesse et al. 1998, 1997]. 
Original antigenic sin is the other hypothesis suggested by Halstead et al. in 
1983 due to observations made on DENV infected Thai children [Halstead et al. 
1983]. Instead of having neutralizing antibody against the current infecting DENV 
serotype, the children have high titers of neutralizing antibody against another DENV 
serotype which they had acquired in previous infection. The hypothesis of original 
antigenic sin in pathogenesis of DHF was again proposed by Mongkolsapaya et al. in 
2003 [Mongkolsapaya et al. 2003]. In original antigenic sin, the memory response to 
previous infections is resurrected in a new infection regardless of the different 
serotype. This rapid immune response resurrected from memory cells may result in T-
cell and B-cell clones that are of low affinity to the new infection [Alexander-Miller 
et al. 1996, Veiga-Fernande et al. 2000], thus it is less effective in clearing 
heterologous dengue infections resulting in increased disease severity.  
It was realized that T helper cells interact with viral protein fragments that are 
often conserved between different DENV serotype. Therefore, the helper T cell 
primed by the serotype from the first infection will be stimulated by the DENV of 
another serotype during the secondary infection. These helper T cells then activate 
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memory B cells that are specific for the first serotype. In the same way, CD8 positive 
T cells that are specific to the previous infection could be activated by the secondary 




1.6 DExD/H RNA helicases (DDX) involvement in virus infections 
DEAD-box (DDX) helicase is a family of RNA helicases that have implicated 
in regulatory processes that mostly involve RNA metabolism. The processes that are 
regulated by DDX include: 1) unwinding of RNA and removal of secondary structure 
motifs, 2) splicing of pre-mRNAs, 3) nuclear export of RNA, 4) translation initiation, 
5) transcriptional regulation, and 6) stabilization of mRNA [Rocak et al. 2004, Lost et 
al. 1994]. Due to their importance in regulation of transcriptional/translational, 
manipulation of DDX proteins by viruses is not uncommon. According to current 
understanding, at least 3 members of the DDX family are associated with intracellular 
viral sensing, and at least another 6 members are associated with viral replication. It is 
intriguing to note that some members of the DDX are targets of manipulation by more 
than 1 type of virus. Therefore, there is a need for us to better understand how DDX 
regulation during DENV infection and DENV ADE infection can impact the 
pathogenesis of the disease. 
DDX family together with DEAH-box (DHX) and Ski2 family of proteins are 
commonly referred to DExD/H family. Even though the three families contain 
similarities, these three families have distinct sequences in their conserved motifs 
[Wassarman et al. 1991]. There are 9 conserved motifs in the DDX family, they are 
Motif Q, I, Ia, Ib, II, III, IV, V and VI. Motif II (also known as the Walker B Motif) 
has the amino acid sequence D-E-A-D for DDX family members [Tanner et al. 2001]. 
DHX family have a D-E-A-H and Ski2 family have a D-E-x-H amino acid sequence 
in their Motif II instead (refer to Figure 1.11). DExD/H family is known to be able to 
utilise ATP or NTP for its function as a helicase [Cordin et al. 2006]. Motif Q, I, II, V 
and VI are known to bind to ATP [Cordin et al. 2006], whereas Motif I, Ia, II, III, V 
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and VI are known to interact with RNA [Tanaka et al. 2005]. Even though both DDX 
and DHX proteins can be stimulated by RNA to increase their NTPase activity, DDX 
proteins use mainly ATP in their activity whereas NTP usage is more dominant in 
DHX proteins [Tanner et al. 2003, Tanaka et al. 2005]. 
  
 
Figure 1.11: A schematic representation of conserved motifs of DDX, DHX and Ski 2 family members [Adapted from Tanner et al. 2001]. 
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1.6.1 DEAD-box helicase as a virus sensor 
 Besides being manipulated by virus for its replication, certain members of the 
DDX family were known to be sensors of single stranded viral RNA. In the presence 
of single-stranded viral RNA, DDX58 (also known as retinoic acid-inducible gene-I, 
RIG-1) will mediate the promoter activation of IFNβ [Schroder et al. 2008]. IFNβ 
is a type I interferon and it plays a crucial role in intracellular anti-virus responses. 
How DDX58 recognises single stranded viral RNA is yet to be fully elucidated, but it 
is known that the C terminal domain of DDX58 can bind to RNA [Cui et al. 2008, 
Takahasi et al. 2008]. RNA binding to C terminal domain of DDX58 results in 
exposure of caspase activation and recruitment domain (CARD). CARD is known to 
be responsible for subsequent signalling cascade [Yoneyama et al. 2004, Gee et al. 
2880]. DDX58, MDA5 and LGP2 form the RIG-like receptor (RLR) family. LGP2 
was demonstrated to be a positive regulator of DDX58 and MDA5 and it is suggested 
to be upstream of both DDX58 and MDA5 [Satoh et al. 2010].   
Signalling cascade of DDX58, MDA5, TLR3 and TLR4 all converges on the TANK-
binding kinase (TBK) pathway. However, only DDX58 and MDA5 utilises 
mitochondrial antiviral signalling (MAVS) protein on mitochondria as an 
intermediate signalling molecule to activate TBK/IKK [Seth et al. 2005]. TBK 
activation results in the phosphorylation of interferon regulatory factor 3 (IRF3) 
[Barral 2009]. Phosphorylated IRF3 is a known activator which promotes IFNβ 






Figure 1.12: Pattern recognition receptors including DDX58 and MDA5 (both are DExD/H RNA 
helicases) mediate the activation of TBK which results in the phosphorylation of IRF3 and DDX3. 
TLR3 and 4 associate with TRIF upon stimulation by their respective PAMPs also trigger TBK 
pathway. Phosphorylated IRF3 is a known activator of IFN β . It is not known how 
phosphorylated DDX3 contributes to the up regulation of IFNβ, but it was suggested that it act 





 DDX3 is one of the most studied DDX because it is one of the most 
commonly manipulated DDX during virus infection [Yedvalli et al. 2004, Owsianka 
et al. 1999, Mamiya et al. 1999, You et al. 1999, Ariumi et al. 2007, Schroder et al. 
2008]. Phosphorylated DDX3 is known to contribute to the production of IFNβ 
[Schroder et al. 2008, Soulat et al. 2008] (refer Figure 1.11). In order to interfere with 
IFNβ production as an evasion strategy, it makes sense for virus to inhibit DDX 3. 
Poxvirus K7 is shown to target DDX3 and interfere with IFNβ promoter activation 
[Schroder et al. 2008]. Not only does DDX3 contribute to IFNβ  production to 
hamper viral replication, DDX3 was able to bind to and inhibit Hepatitis B virus 
(HBV) polymerase in the viral nucleocapsids [Wang et al. 2009]. This inhibits the 
initial step of reverse transcription and hampers HBV replication. HIV-1 infection 
results in an upregulation of DDX3 [Yedvalli et al. 2004].  
On the other hand, HIV-1 Rev protein was demonstrated to interact with 
DDX3 to target partially spliced HIV-1 RNA to exportin 1 (CRM1) for nuclear export. 
Without the aid of DDX3 for nuclear exportation of partially spliced HIV-1 RNAs, 
viral replication will come to a halt as demonstrated in a DDX3 down regulation study 
by Yedvalli et al. (2004). It was speculated that DDX3 might assist in the unwinding 
of secondary structure within the HIV-1 RNA or the removal of RNA-bound proteins 
so as to facilitate RNA nuclear export. HCV cannot replicate in the absence of DDX3 
as shown in a DDX3- knockdown study conducted by Ariumi et al. [Ariumi et al. 
2007]. DDX3 was also found to interact with the Core protein of HCV, but it remains 
to be debated on how the DDX3-Core interaction modulates the functions of DDX3 





 DDX3 is not the only DDX that affects HIV-1 replication, DDX1 was also 
found to be associated with Rev protein of HIV. Interaction of DDX1 to Rev is 
postulated to modulate the cellular distribution of Rev and thus affect its function. For 
Rev to facilitate nuclear export, it needs to have nuclear/nucleolar subcellular 
distribution dominance [Neumann et al. 2001]. Down regulation of DDX1 alters the 
Rev distribution from nuclear/nucleolar to cytoplasmic dominance, thus adversely 
affecting the function of Rev which in turn negatively impacts the replication of the 
virus [Fang et al. 2005].  
DDX1 was also known to be involved in the replication of the coronavirus, 
Infectious Bronchitis Virus (IBV). Host cells that were infected by IBV relocate 
DDX1 from nucleus to cytoplasm indicating a shift in function of DDX1 [Xu et al. 
2010]. It is also noted that DDX1 binds to non-structural protein (nsp) 14 of both IBV 
and SARS coronavirus. Using knockdown studies of DDX1, it was suggested that 
DDX1 is needed for the efficient replication of IBV in vitro. However it remains 
elusive as to how DDX1-nsp14 binding aids in the replication of the virus. 
1.6.2.3 DDX5 
 SARS-CoV was also implicated with DDX5 in a study by Chen et al. Using 
yeast and mammalian cell two-hybrid systems, DDX5 was found to be a key binding 
partner of nsp13 of SARS-CoV. Inhibition of DDX5 results in suppression of viral 
replication. This suggests that DDX5 may be a co-activator of nsp13 [Chen et al. 
2009]. Nsp13 is a viral helicase that is involved in viral genome transcription and 
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viral proliferation [Thiel et al. 2003]. It appears that coronavirus not only manipulates 
DDX1 but also DDX5 for its replication. 
1.6.2.4 DDX24 
 Besides DDX5, DDX24 was also identified as an interacting partner of Rev 
protein of HIV-1. Besides being involved in nuclear export of viral genome, Rev also 
warrants efficient packing of viral genome into virus particles [Brandt et al. 2007]. It 
is the latter function that DDX24 is required for. In a study by Ma et al. (2008), 
absence of DDX24 was demonstrated to negatively affect HIV-1 packaging mediated 
by the Rev-dependent pathway. The exact mechanisms by which DDX24 interacts 
and influences Rev protein’s packaging ability was not fully explored in their study 
and remain elusive to date. 
1.6.2.5 DDX6 
 HIV-1 is not the virus capable of manipulating more than 1 member of the 
DDX; HCV not only interacts with DDX3, its replication is also associated with 
DDX6. Unlike DDX3, DDX 6 does not interact with Core protein [Rohit et al. 2010]. 
DDX6 is part of miRISC complex which was known to be associated with the 
processing of miRNA [Chu et al. 2006]. It is because miR-122 is a miRNA that is 
needed for efficient HCV replication [Henke et al. 2008, Jopling et al. 2005, Lanford 
et al. 2010]; it was therefore proposed that modulation of DDX6 could potentially 
affect both miR-122 processing and HCV replication. Indeed, over expression of 






 NS4A protein of JEV is demonstrated to inhibit type I IFN signalling by 
blocking phosphorylation in JAK-STAT signalling [Munoz –Jordan et al. 2003/2005, 
Liu et al. 2005/2006, Evan-Seeger et al. 2007]. DDX42 is discovered to bind to NS4A 
and overcome the JEV-induced IFN I antagonism [Cheng-Wen et al. 2008]. Therefore 
it was suggested that DDX42 could act as a sensor for RNA virus to induce IFNβ 
production but was sequestered by NS4A.  
 In summary, different members of the DDX family can have very different 
effects on the replication of the different viruses. Factors that may influence the 
functions of the DDX may include its subcellular distribution, interacting partners and 
state of phosphorylation. Therefore, DDX family of proteins can be a double edge 
sword to the life cycle of viruses. 
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Table 1.4: Summary of various DDXs manipulated by virus  
DDX Virus Effect of DDX 
on viral 
replication 




negative 5’-triphosphate ssRNA/ 
short ds RNA 
Activate IFNβ expression Barrel et al., 2009 
DDX3 HCV positive Core Unknown Owsianka et al., 1999, 
Mamiya et al., 1999, You 
et al., 1999 
HBV negative HBV polymerase Reverse transcription inhibition Wang et al., 2009 
HIV positive Rev Nuclear export Yedvalli et al., 2004 
Poxvirus negative K7 K7 sequest DDX3 from IFN-β 
promoter activation 
Schroder et al., 2008 
DDX1 HIV positive Rev Nuclear export Neumann et al., 2001, 
Fang et al., 2005 
IBV positive Nsp14 Unknown Xu et al., 2010 
DDX5 SARS-CoV positive Nsp13 Co-activate Nsp13 to function as a 
RNA helicase 
Chen et al., 2009 
DDX24 HIV positive Rev Viral genome packaging Brandt et al., 2007, Ma et 
al., 2008 
DDX6 HCV positive miRISC Process miR-122 Rohit et al., 2010 
DDX42 JEV negative NS4A Inhibit IFNβ suppression by 
NS4A 
Cheng-Wen et al., 2008 
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1.7 Objectives of current project 
 There are 3 main objectives in this project. First objective is to establish an 
ADE infection model for DENV using HL-CZ cell line, characterisation of the ADE 
infection model will also be covered in this objective. Secondly, the expression of 
DDX genes in ADE infected HL-CZ will be determined with microarray study, the 
results from the microarray analysis will be verified with real-time PCR analysis and 
Western Blot studies. Lastly, DDX genes selected based on second objective will be 
subjected to siRNA gene silencing to determine if a knock-down of the expression 








Chapter 2: Materials and Methods 
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2.1 Cell culture 
 HL-CZ cell were grown and maintained in 75cm
2
 Nunc tissue culture flask. 
RPMI 1640 supplemented with 10% fetal calf serum, 2% HEPES and 2% sodium 
bicarbonate was used as growth media for the cell. HL-CZ was obtained courtesy of 
Professor Vincent Chow. 
When the cells reached confluency, usually within 2-3 days, the cell 
suspension was transferred to 50ml Falcon tube to be washed with 1X PBS before it 
was resuspended with 5ml of growth media. The resuspended cells are split in a ratio 
of 1:5 for maintenance. 
 Baby hamster kidney fibroblast BHK-21 (ATCC number CCL-10) cells were 
grown and maintained at 37
o
C with 5% CO2 in 75cm
2
 tissue culture flasks (Nunc) in 
RPMI-1640 (Gibco) supplemented with 10% heat inactivated fetal calf serum (FCS), 
2% HEPES and 1.5% sodium bicarbonate. The cells are subcultured when it almost 
reaches complete confluency, usually within 2-3 days. The monolayer was rinsed 
once with 5 ml of 1 X PBS to remove cell debris and the monolayer was incubated at 
37
o
C for 2-5 minutes with 2 ml of pre-warmed (37
o
C) 1 X trypsin/versene solution 
(Gibco) to dislodge the cells. 6 ml of growth media was added to impede the 
trypsinization process, and the cells were subcultured in a ratio of 1:4. 





 tissue culture flasks (Nunc) in Leibotviz L-15 (Gibco) supplemented with 10% 
fetal calf serum (FCS) and 2% L-glutamine. The cells usually reach confluency within 
2-3 days and are subcultured in a ratio of 1:3. 
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2.2 Virus propagation 
The virus strain used in this study was dengue 2 New Guinea C strain (NGC) 
(Courtesy of A. Prof Ooi). It was propagated in C6/36 cell (Courtesy of Dr Alonso).  
The C6/36 monolayer was inoculated with 1 ml of DENV 2 NGC that contains 
approximately 1 X 10
6 
pfu. Viral absorption was carried out in 28
o
C for 1 hour with 
gentle rocking every 15 minutes interval. Following absorption, 8 ml of complete 
growth medium was added and the flasks were incubated at 28
o
C for 3 days. The 
culture supernatant were harvested and centrifuged at 10000g for 10 minutes to 
remove cellular debris, the resulting supernatant was aliquoted into 1 ml cryovials and 
stored at -80
o
C as virus stock. 
2.3 Virus quantification by plaque assay 
 2 days prior to plaque assay, BHK-21 cells are seeded into a 24 well plate at 
an estimated confluency of 90% which is approximately 2 X 10
5
 cells per well. The 






RPMI 1640. The 
monolayer was washed once with 1 X PBS before 100 µl of the diluted virus 
suspension was added to each respective well. Absorption of the virus by the 
monolayer was carried out at 37
o
C with 5% CO2 for 1 hour with rocking every 15 
minutes interval. After incubation, the virus suspension was removed and the 
monolayer was washed once with 1 X PBS before 1 ml of 1% (w/v) carboxymethyl 
cellulose (Sigma) in RPMI supplemented with 2% FCS was added to each well. The 
cells were incubated at 37
o
C with 5% CO2 for 6 days before it was fixed with 20% 
formaldehyde and stained with 200 µl of 0.5% (w/v) crystal violet (Sigma) for 1 hour. 
The plates were rinsed in water and dried prior to the scoring of the plaques visually. 




2.4 Infection and ADE infection of HL-CZ 
 HL-CZ cells were seeded into a round-bottom 96 well plate at a density of 1 X 
10
5
 cells per well. The virus (DENV NGC strain) was diluted in RPMI-1640 to 
achieve the required MOI. The cells were washed once with 1 X PBS before it is 
pelleted, the diluted virus was then added to the pelleted cells and resuspended well. 
The HL-CZ was left in 37
o
C for 2 hours with gentle rocking at every 15 minutes 
interval. After the absorption step, the virus-cell mixture is washed twice with 1 X 
PBS to remove any unabsorbed virus from the cells. The infected cells were incubated 
in maintenance media for 48 hour in 37
o
C, 5% CO2. 
 ADE infection of HL-CZ is executed at mainly at MOI of 0.4, using either 
humanized 3H5 (Hu3H5) or mouse 3H5 (Mo3H5) antibodies. The antibodies were 
gifts from Associate Professor Ooi Eng Eong. 25µl of the diluted virus at MOI of 0.4 





, 2.4 X 10
-3
, 2.4 X 10
-4
, 2.4 X 10
-5
 µg per 25µl). The antibodies-virus mixture 
was incubated at 37
o
C, 5% CO2 for 30 minutes before it was added to the washed and 
pelleted HL-CZ. The cells were allowed to absorb the antibody-virus complex for 2 
hours at 37
o
C, 5% CO2. The mixture was washed with 1 X PBS twice to remove any 
unbound antibody-virus complex from the cells. The viral-infected cells were 
incubated in maintenance media for 48 hour in 37
o
C, 5% CO2. IgG1 isotype control 
antibody for Hu3H5 and Mo3H5 was purchased from Sigma (Catalogue number 





2.5 Blocking of FcγR I and II 
 To abrogate the Fc capturing functions of FcγRI and II. Anti-Human CD64 
(FcγRI) and anti-Human CD32 (FcγRII) (eBiosciences, 16-0649 and 16-0329) 
were used to block receptor-ligand interaction of HLCZ to virus-antibody complexes 
during ADE infection of HL-CZ. Prior to the start of ADE infection, the cells were 
seeded at 1 X 10
6
 cells per ml per well in a 6 well plate. Based on the product 
information provided by eBioscience, the reported application usage concentration 
was 1µg/ml for 10
5
 cells. However, a higher amount (10µg/ml) of the antibodies was 
used to block the receptor at 37
o
C for 1 hour, since the cell amount was 10 times more 
than the recommended. For blocking of both FcγRI and II, 10µg/ml of anti-Human 
CD64 and 10µg/ml of anti-Human CD32 were used on 10
6
 HL-CZ simultaneously for 
1 hour. After 1 hour, the cells were used for ADE infection of HL-CZ as stated in 
previous paragraph. The isotype control antibody used for both anti-Human CD64 (Fc






2.6 Immunostaining  
The cell samples were permeabilized and fixed with Perm/Fix solution from 
BD pharmingen at 4
o
C for 20 minutes. The Perm/Fix solution was washed away with 
Perm Wash from BD pharmingen. The sample was blocked with 0.02mg Rat IgG 
(Sigma-Aldrich, Cat No: I8015-10MG) diluted in 20µl of Perm Wash for 10 minutes. 
After blocking, 0.1mg of Anti-Dengue Envelope antibody, clone Dengue 1-11(3), 
(AbD Serotec, MCA 2277) were used for primary antibody staining of viral-infected 
cells for 30 minutes, 4
o
C. The primary antibody was removed by washing with Perm 
Wash. Proceeding with secondary staining, 0.1mg of anti-mouse IgG2a/b FITC 
conjugated antibody (BD Pharmingen, 553399) was added and incubated for 30 
minutes, 4
o
C. The resulting cells were washed twice with FACS wash (1% bovine 
serum albumin, 0.1% sodium azide, 1 X PBS). The resulting cells were resuspended 
in 200µl of FACS wash for flow cytometry analysis.  
 For surface staining of cell surface markers, a direct staining approach was 
adopted. CD209 PerCP-Cy5.5 (Biolegend 330110) was used to stain for surface DC-
SIGN on HL-CZ and the isotype used was IgG2ak PerCP-Cy5.5 (BD Pharmingen 
552577). 
CD64 APC antibody (Biolegend, 305013), CD32 PE antibody (Biolegend 
303205) and CD16 FITC antibody (BD Pharmingen 555406) were used to stain for 
surface FcγRI, II and III respectively. The isotype control used for CD64 APC, 
CD32 PE and CD16 Alexa Fluor 647 were mouse IgG1k APC (eBioscience 17-4714-





2.7 Western Blot 
 2.5X 10
4
 cells were lysed using M-PER mammalian protein extraction reagent 
(Thermo Scientific 78503). Halt protease and phosphatase inhibitor cocktail (Thermo 
Scientific 78442) were also used to prevent enzymatic protein degradation. The cell 
lysate was added to equal volume of Laemmli sample buffer (Bio-Rad, CA, USA) and 
denatured at 100
o
C for 5 minutes. The denatured samples were loaded into 10% SDS-
PAGE gel. The gels were run in 1x SDS/Glycine buffer (25mM Tris  pH 8.3, 250mM 
glycine, 0.1% SDS) at 100V for 90 minutes. 
 After SDS-PAGE separation of the proteins, the proteins were transferred 
PVDF membrane (Bio-Rad, CA, USA). Electro-blotting was carried out at 20V for 24 
hours at 4
o
C. Non-specific binding sites of the membrane were blocked using 5% 
non-fat milk dissolved in TBST (1X tri-buffered saline with 5% v/v Tween 20) for 2 
hours at room temperature. All antibodies were diluted in a solution of 5% non-fat 
milk dissolved in TBST prior to usage. The membranes were washed 3 X 15 minutes 
with TBST before primary antibody solution was added for incubation overnight at 
4
o
C. The membranes were washed 3 X 15 minutes before secondary antibody was 
added. Secondary antibody was incubated for 1 hour at room temperature. The 
primary antibodies used in this project were: 1) mouse anti- β-actin (Clone AC-15, 
Sigma-Aldrich) at 1: 10000 dilutions. 2) rabbit-anti-DDX21 (Aviva System biology, 
San Diego CA, USA) at 1:800 dilutions. 3) rabbit-anti-DDX31 (Aviva System 
biology, San Diego CA, USA) at 1:400 dilutions. 4) rabbit-anti-DDX47 (Aviva 
System biology, San Diego CA, USA) at 1:400 dilutions. The secondary antibodies 
used were: 1) ImmunoPureTM donkey anti- mouse IgG peroxidase conjugated 





anti- rabbit IgG peroxidase conjugated (Thermo Scientific, Rockford IL, USA) at 1: 
20000 dilutions 
2.8 RNA Extraction 
 Total RNA extraction was carried out using RNeasy Mini Kit (Qiagen, 
74104). Protocol from the kit was strictly adhered to for the extraction of RNA from 
sample cells. RNase-Free DNase set (Qiagen, 79254) was also used together with the 
total RNA extraction kit to ensure all samples were free from genomic DNA 
contamination. Concentration of the extracted total RNA was quantified using 
NanoDrop spectrophotometer (Thermo Scientific, Wilmington, DE, USA). 
2.9 Microarray 
 Prior to amplification and biotinylation of the RNA samples, RNA integrity of 
the samples were assessed using RNA LabChip® (Agilent) and Agilent 2100 
bioanalyzer. Only sample with a RNA Integrity Number (RIN) of more than 7.5 were 
used for further microarray analysis. Integrity of the RNA samples used in this study 
is attached in Appendix 1 (refer Appendix 1.1). 
To amplify and biotinylated the RNA sample for Illumina® Sentrix Beadchip 
Array, Illumina TotalPrep RNA Amplification Kit from Ambion® (AMIL 1791) was 
used. The harvested RNA samples were reversed transcribed to synthesis first strand 
cDNA using ArrayScript™ reverse transcriptase. The cDNA then undergoes second 
strand synthesis and cleanup to become a template for in vitro transcription with T7 
RNA Polymerase. Biotinylated-UTP was used during in vitro transcription to generate 
biotinylated RNA copies. 
The amplified and biotinylated RNA is hybridized to Illumina® Sentrix 
BeadChip Array HumanWG-6 v3 using Hybridization Kit that was bundled with the 
BeadChip. Hybridization was done according to the hybridization protocol provided 
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by Illumina®. Streptavidin-Cy3 is added to the hybridized BeadChip to stain the 
biotinylated RNA. Excess Streptavidin-Cy3 was washed off with wash buffers 
provided by Hybridization Kit. Dried chips were stored in slide box until scanned. 
The prepared BeadChip was scanned at a scan factor of 1.3 and PMT 545. 
2.10 RT-PCR 
 Prior to qPCR, the extracted total RNA is subjected to cDNA synthesis. Total 
RNA was diluted to 2μg in a total volume of 11μl. The RNA was mixed with 2 μl 
of oligo(dT)15 primers (Promega, Madison, WI). The mixture was denatured at 70°
C for 5 mins and transferred immediately to ice. 5µl of reverse transcription buffers 
(Promega, Madison, WI), 5µl of 2.5nM dNTP (Promega, Madison, WI), 25U of 
Recombinant RNasin®  Ribonuclease inhibitor (Promega, Madison, WI) and 200 U 
of M-MLV reverse transcriptase (Promega, Madison, WI) were added to the mixture 
to a total volume of 25µl. Reverse transcription was carried out at 42
o
C for 60 minutes, 
followed by 35
o
C for 5 minutes to terminate the reaction. The cDNA transcripts were 
stored at 4
o
C for further use. 
2.11 qPCR 
qPCR was performed using iTaq SYBR Green Supermix with ROX (Bio-Rad 
Laboratories) on an Applied Biosystems (Foster City, CA) 7500 Real-Time PCR 
System. Following conditions were used for qPCR: 95
o
C for 3 minutes. Followed by 
40 cycles of 95
o
C for 15 seconds, 60
o
C for 45 second where acquisition of the SYBR 





C for 1 min, 95
o
C for 15 seconds and 60
o
C for 15 seconds for 





Table 2.1: List of primers used in qPCR and their respective NCBI REF number and sequences: 
 
Primer name NCBI REF no Sequence 3’ 5’ 
Forward beta actin NM_001101 AAGATAACCCAGATCATGTTTGAGACC 
Reverse beta actin AGCCAGTCCAGACGCAGGAT 
Forward DDX 21 NM_004728 GTGGGCAAGCTGGGGTTTTTAGGT 
Reverse DDX21 CTGGCCAGGGGCTACAATCAGGTTC 
Forward DDX31v1 NM_022779.7 CCCTTCAAGCAATGGAGTCAAAAATACA 
Reverse DDX31v1 CCACCAGGCGTCCAGGAGTTGAGATAAG 
Forward DDX31v2 NM_138620.1 ACCACCGAATGGCCGGAAAATGGA 
Reverse DDX31v2 CACGCGCCGGACAGCCAAGGAG 
Forward DDX47v1 NM_016355.3 GCGCCTTTGCTTTGCCCATTCTA 
Reverse DDX47v1 TGCAAGGGCCAAAGATTCAGACATT 
Forward DDX47v2 NM_201224.1 AGTTTGAAGCCCTGGGGTCCTCTATTG 
Reverse DDX47v2 TATTCAGTATTCGGTCGGCTTCATCCA 
Forward DDX49 NM_019070.3 CTACAAGCGGCCACAAGGAT 
Reverse DDX49 CTGCAAGATGGGAAGGACAAAC 
Forward DDX52v1 NM_007010.2 GCATGGTCGGGAACTTCTGGCTTCTGCT 
Reverse DDX52v1 CACTGCTGCTTTGTGGATCATGTGTATC 
Forward DDX54v2 NM_024072.3 CCGCCCAGCACTGCAGGAGAAGC 






2.12 siRNA Transfection 
 DharmaFECT (Dharmacon) transfection reagents were used to transfect HL-
CZs with siRNAs. 2.5 X 10
5
 of cells was serum starved for 4 hours in plain RPMI-
1640 prior to being seeded into each well in a 6-well plate at a volume of 1.6ml.  
To optimize the efficiency of siRNA, siGlo Red transfection indicators 
(Dharmacon) were used in place of siRNAs to quantify the percentage of cells 
transfected. Different concentrations of siGlo (15, 20 and 25µM final concentration) 
were used to determine the optimal concentration of siRNA to use.  It was found that 
25µM of siGlo give the highest transfection percentage.  
 Due to the toxicity of DharmaFECT as an cationic–lipid based delivery vector, 
transfection using various volumes (4, 8, 6, 10 and 15µl) of DharmaFECT 1, 2 3 and 4. 
The tranfected cells were stained with 7-AAD dye (eBiosciences) to assess cell 
viability after 24 hours; 10µl of DharmaFECT 3 was established to be the most 
efficient with highest cell viability.  
Therefore, 200µl of siRNA (at 25µM final concentration diluted in RPMI-
1640) and 200µl of DharmaFECT 3 (10µl of DharmaFECT diluted with 190µl of 
RPMI-1640) were mixed and incubated at room temperature for 20 minutes. The 
mixture was added to 1.6ml of the serum starved cells. The cells were incubated at 
37
o
C with 5% CO2 for 24 hours, before the medium was replaced with growth media. 
The cells were seeded for infection at this point of time. Alternatively they can be 
kept for another 24 hours for mRNA analysis or 48 hours for protein analysis. 
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The siRNA used in this project were: siGenome SMART pool Human DDX21 
(Dharmacon, M-011919-00-0005), siGenome SMART pool Human DDX31 






2.13 Statistical Analysis 
Data shown are representative of three sets of experiments (unless stated 
otherwise). Statistical analysis was performed using Student’s two-sided t-test and 
differences were considered statistically significant when p < 0.05 and highly 
significant when p < 0.01. 1 way ANOVA analysis was also used, when p < 0.05 











3.1 Absence of DC-SIGN on HL-CZ 
HL-CZ under non-enhancing condition was susceptible to dengue infection at 
various MOIs [Liu et al. 1991]. To ensure the HL-CZ is a viable platform for 
supporting ADE studies, one of the criteria is that the infection mechanism of HL-CZ 
must not be dependent on DC-SIGN. DC-SIGNs had been recently proven to obscure 
ADE [Boonak et al. 2009]. DC-SIGN were expressed on macrophages and DC 
[Mummidi 2001], and it is not known whether HL-CZ as a pro-monocytic cell line 
expresses such receptor.  
HL-CZs were therefore tested for the absence of DC-SIGN. From Figure 3.1, 
there was no considerable change in mean fluorescence intensity (MFI) of HL-CZ 
stained with anti-DC-SIGN Per-CP antibodies. Therefore, the data suggest that the 
susceptibility of HL-CZ to DENV was not dependent on DC-SIGN mediated 
mechanisms. 
 
Figure 3.1: Absence of DC-SIGN (also known as CD209) on the surface of HL-CZ. Immuno-
staining for CD209 and flow cytometry analysis of the HL-CZs indicates the absence of CD209 as 
there is no significant change (p=0.47, p>0.05) in the MFI of CD209 staining (MFI: 3.02±0.69) as 




3.2 Establishment of ADE infection in HL-CZ 
HL-CZ was identified as a cell line that was capable of supporting high yield 
dengue infections [Liu et al. 1991]. However, its potential to support ADE infection 
was not explored in the study by Liu et al. (1991) In order to characterize ADE 
infection of dengue using HL-CZ, an ADE infection profile was performed to 
determine the enhancing titer of Hu3H5 required to achieve peak enhancement. 5 X 
10
4









µg) diluted in 50µl of RPMI-1640. After 30 minutes in 37
o
C, the 
antibody-virus complex was added to 1 X 10
5
 HL-CZ for absorption for 2 hours. The 
infected cells were stained for dengue envelope protein to assess its infection rate after 
another 2 days of incubation at 37
o
C. Plaque assay analysis using supernatants of the 
infected cells were also carried out. The data for plaque analysis is appended as 
Appendix 1.2A/B. The infection rate observed in Figure 3.2 differ from the plaque 
assay data because the supernatants were subjected to at least 1 free-thaw cycle prior 
to the analysis. This will compromise the efficacy of the plaque assays resulting in 
less than 1 log difference in pfu while the infection rate observed in Figure 3.2 is over 
49%.  The overall trend of enhancement is however still observed in the plaque assay 
analysis. Similar discrepancies are observed between all infection rates and plaque 




Figure 3.2: ADE profile of HL-CZ at MOI 0.5 induced with Hu3H5 antibody. Peak enhancement  
was first observed at 3X10
-1
µg of Hu3H5 (infection rate: 49.5%). Baseline infection rate, with no 
antibody involvement, was observed to be at 24.7%.  
* Peak fold enhancement was at 2 fold (fold change = 49.5/24.7). The peak fold change was highly 





Refer Appendix 1.2A/B for supplementary details and plaque assay verification. 
 
Enhancement was first observed at the second dilution of the antibody (3X10
-
1
µg of Hu3H5). The enhancement was maintained even when the amount of Hu3H5 
was lowered by another 10-fold to 3X10
-2
µg. However, the infection rate returned to 
its baseline level (~24.7%) when the amount of Hu3H5 was diluted to 3X10
-3
µg and 
beyond. It was also noted that the peak enhancement at 3X10
-1
µg of Hu3H5 resulted 
in a 2-fold increment in infection rate using the baseline infection rate as a basis for 
comparison (figure 3.2). 
From this data, it was derived that ADE occur at an antibody: virus ratio of 
3X10
-1
µg: 5 X 10
4
 pfu (equivalent to 6ρg: 1pfu). Next, we determine if maintaining 
the same antibody: virus ratios for ADE profile but changing the MOI used will have 




3.3 Enhancement is maintained as long as antibody: virus ratio remains 
To ascertain, if the same antibody: virus ratio was able to induce infection 
enhancement even when the MOI is changed. The experiment was repeated at a lower 
MOI of 0.3 (40% lower than MOI 0.5). This results in 3 X 10
5
 pfu of virus being used 
per 1 X 10
5
 HL-CZ. Since the amount of virus used was reduced by 40%, to maintain 
the antibody: virus ratio, the amount of antibody used was also modified to range 
from 1.8ug to 1.8 X 10
-4
µg instead of 3µg to 3 X 10
-4
µg all diluted in 50µl of RPMI-
1640. 
 
Figure 3.3: ADE profile of HL-CZ at MOI 0.3 induced with Hu3H5 antibody. Peak enhancement 
first observed at 1.8X10
-1
µg of Hu3H5 (infection rate: 38.1%). Baseline infection rate was 
observed to be at 4.44%.  
* Peak fold enhancement is at 8.6 fold (fold change = 38.1/4.44). The peak fold change was highly 
significant (p= 1.5 X 10
-18
, p<0.01). 
Refer Appendix 1.3A/B for supplementary details and plaque assay verification. 
Referring to figure 3.3, the enhancement occurred at the second dilution as 
expected. This time the amount of antibody used was 1.8 X 10
-1
µg per 3 X 10
5
 pfu 
(equivalent to 6ρg: 1pfu). At the dilution of 1.8 X 10-2µg, Hu3H5 was still able to 
induce enhancement but at a lower level than at 1.8 X 10
-1
µg of Hu3H5. The 
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enhancement was at 38.1% and 27.8% for 1.8 X 10
-1
 and 1.8 X 10
-2
 µg of Hu3H5, 
respectively. There was an 8.6 fold difference between baseline and peak infection 
rate. The fold enhancement was larger than it was at MOI of 0.5 even though the peak 
enhancement occurs at the same antibody: virus ratio. Enhancement was lost at 1.8 X 
10
-3
µg of antibody and beyond. 
From the 2 ADE infection profiles, we suggest that peak enhancement can be 
achieved regardless of MOI, as long as the antibody: virus ratio was maintained at 6
ρg: 1pfu. This may only be true for a low to moderate level of MOIs, as it was tested 
in previous studies that enhancement was lost with higher MOIs [Halstead et al. 2003]. 
It was also observed in this study that higher MOI of 0.5 have a lower peak fold 
enhancement of ~2 fold as compared to 8.6 fold at MOI of 0.3. It was also not certain 
whether this ratio will work on other cell types that support ADE, because there are 
other cellular factors that affect ADE (e.g. subclass of Fc γRs available). To 
determine the range of MOIs that ADE can be observed in HL-CZ, peak ADE 






3.4 Reduced fold enhancement with increasing MOI 
To further study the range of MOIs which ADE in HL-CZ can be induced, 
peak enhancement at various MOIs was compared to their respective basal infection 
rate. To achieve peak enhancement, Hu3H5 was added at a antibody: virus ratio of 6
ρg: 1pfu.Therefore, 0.6, 1.2, 2.4, 3, 4.8 and 6 X10-1µg of Hu3H5 was co-incubated 
with 1, 2, 4, 5, 8 and 10 X 10
4
 pfu of virus, respectively. The resulting antibody-virus 
complexes were used to infect 1 X 10
5






Figure 3.4A: ADE peak enhancement of HL-CZ induced by Hu3H5 at various MOIs. Grey bars 
represent peak enhancement induced by Hu3H5 at indicated MOIs. Black bars represent their 
corresponding baseline infection rate. Basline infection rate seem to start to plateau at MOI 1 
with an infection rate of 39.9%. Likewise for peak enhanced infection rate at MOI 1 (infection 
rate: 58.3%). Comparing the baseline infection rate to their respective peak enhanced infection 
rate, the changes were all highly significant with every p<0.01.  
Refer Appendix 1.4 for supplementary details. 
 
 
Figure 3.4B: Illustrates the peak fold changes for various MOIs. Values are calculated from the 
data shown in Figure 3.4A. This chart shows that peak fold enhancement was not consistent 
throught the various MOIs. Highest peak fold change was achieved at MOI 0.3 and it decreases 




The infection rate these peak enhanced virus at various MOIs was represented 
by the grey columns labeled as ―ADE‖ in Figure 3.4A, their non-enhanced 
counterpart were the black columns labeled as ―Baseline‖. The results showed that 
with increased MOI, both baseline and ADE peak infection increases, but the fold 
enhancement in ADE actually decreased when MOI was beyond 0.3 (refer Figure 
3.4B). This decrease in fold enhancement at higher MOI was also observed in 
previous studies by Halstead et al. [Halstead et al. 2003]. It was also noted that the 
infection rate of HL-CZ starts to saturate at MOI of 1 as the increment of MOI from 
MOI 0.8 to 1 did not result in much increment of infection rate. This saturation of 
infection rate was observed not only for baseline infection but also for ADE infection. 
This allow us to determine the dynamic range of MOIs that could be used in further 
study, as too high an MOI will relinquish the enhancement effect of the antibody 
(refer figure 3.4B at MOI ≥ 0.5). Whereas, too low an MOI used will yield low peak 
enhancement infection rate (refer MOI 0.1 at figure 3.4A), which may affect the 
detection of gene expression changes due to low quantities of mRNA yield from the 
small population of viral-infected cells. 
In summary, peak enhancement can be achieved with antibody: virus ratio of 6
ρg: 1pfu using HL-CZ as the infection platform, but the fold increment in peak 
enhancement compared to its basal infection rate differ with different MOIs. 




3.5 Peak enhancement infection rates at peak enhancing antibody: virus ratio (6
ρg: 1pfu) for MOI 0.4 is equivalent to non-enhanced infection rate at MOI 0.8 
(Equivalent) 
In the past, to compare gene expression changes of cell line infected under 
ADE to non-enhancing condition, cells undergoing ADE infected cells were often 
compared to cells at baseline infection as a control. Using cells at baseline infection 
rates as control is confounded by the different infection rates between the 2 sample 
groups. Therefore, any gene expression changes can be contributed by not only by 
difference in infection mechanism but also the difference in infection rate of the 2 
samples groups. 
To compensate for the low infection rate in baseline controls, we raised the 
MOI of the non-enhanced DENV-infected cells such that its infection rate was 
comparable to that of the ADE samples. This resulted in different amount of virus 
used in the 2 sample groups, but it negates the differential gene expressions which are 
contributed by the differences in infection rates. 
As shown in Figure 3.7A, peak enhancement at MOI of 0.4 using Hu3H5 
(HuADE at ~40% infection rate) has an equivalent infection rate to that at MOI of 0.8 
under non-enhancing condition (~36.6% infection rate). According to one way 
ANOVA analysis, there is no significant difference between the infection rates of the 
3 groups in Figure 3.7A (p>0.05).  
For subsequent experiments, HuADE infection will be carried out at MOI of 
0.4 at peak enhancement of Hu3H5. The equivalent treatment group will be infected 
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at MOI 0.8 at non-enhancing conditions. Therefore both groups yield similar infection 
rates as shown. 
 
Figure 3.5A: HuADE and Equivalent have similar infection rates. These 2 differentially treated 
groups of HL-CZ will be acquired for microarray analysis to determine the differential gene 
expression.  
* There is no significant differences in infection rate among the 2 groups according to 1-way 
ANOVA analysis (p= 0.09, p>0.05). Refer to Appendix 1.6 for supplementary details. 
 
Besides the 2 samples groups that were acquired for further studies, an isotype 
control and baseline control was established as shown in Figure 3.7B. The purpose of 
isotype control is to demonstrate that only dengue-binding 3H5 antibodies can induce 
ADE. A non-binding antibody (with same Fc subclass IgG1) at the enhancing 
antibody: virus ratio of 6ρg:1pfu was not able to induce any enhancement. Thus the 
infection rate of the isotype control for ADE was not significantly different from that 






Figure 3.5B: Baseline and IgG isotype control have similar infection rates. There is no significant 
differences in infection rate among the 2 groups (p= 0.24, p>0.05). This indicate that even at 
enhancing titres, the IgG isotype antibody which cannot bind to the virus will not induce ADE 





3.6 Characterizing the role of FcγR on HL-CZ as a platform for ADE 
In order to better understand the capacity of HL-CZ for supporting ADE 
infection of dengue, it was necessary for us to identify the subclass of FcγRs 
expressed on HL-CZ. It had been reported that both FcγR I and II were capable of 
supporting ADE [Kontny et al. 1988, Littaua et al. 1990].  Therefore, it is necessary 
for HL-CZ to express FcγR I, FcγR II or both the FcγRs to support ADE. To 
investigate the expression of Fc γ R on HL-CZ, the cells were stained with 
flourochrome conjugated anti- FcγR I (CD64), II (CD32) and III (CD16) antibodies 




     
     
   
Figure 3.6A: Expression of FcγR I (CD64), II (CD32) and III (CD16) on HL-CZ. HL-CZ stained 
with anti-CD64, 32, and 16 antibodies are compared with HL-CZ stained with their respective 
isotype control. There is a significant amount of CD64 expressed on HL-CZ (p= 2.3 X 10
-11
, 
p<0.01) when comparing the MFI of its isotype control (MFI 2.94 ± 0.78) to the actual CD64 
stained cells (MFI 13.5 ± 1.51). Likewise for CD32, isotype control is significantly lower (p= 5.1 X 
10
-12
, p<0.01) in MFI (MFI 3.09 ± 0.2) as compared to CD32 stained cells (MFI 117 ± 3.26). CD16 
was not detected as the isotype control have a MFI (MFI 1.59 ± 0.65) that is similar (p= 0.35, 
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p>0.05) to that of CD16 stained cells (MFI 1.65 ± 0.82). The scatter plots shown is representative 




Figure 3.6B: Positive control for Figure 3.5A, the setup of the experiment are the same as in 
figure 3.5A except that U937, K562 and NKL cells were used for staining of CD64, 32 and 16 
respectively. These cell lines have been known to express the respective receptors. Thus, they 




Fluorescence intensity of the stained cells was indicated by the x-axis. From 
Figure 3.5, it is observed that there was a shift in mean fluorescence of the cells 
stained with anti-CD64 APC (MFI 13.5 ± 1.51) as compared to the CD64 isotype 
APC control (MFI 2.94 ± 0.78). This indicates the presence of CD64 on HL-CZ. 
Likewise for CD32, there was a general increase in the mean fluorescence intensity of 
the cells stained with anti-CD32 PE (MFI 117 ± 3.26) compared to its isotype control 
(MFI 3.09 ± 0.2). These results suggest the presence of both FcγR I and II. The test 
for CD16 was negative as indicated by Figure 3.5, both the cells stained with isotype 
control antibody (MFI 1.59 ± 0.65) and the CD16 FITC stained cells (MFI 1.65 ± 0.82) 
have identical level of fluorescence.  Positive controls for antibody staining of these 
Fc receptors have been depicted in Figure 3.6B. 
In conclusion, HL-CZ possesses both FcγR I and II. Both FcγR I and II 
were known to support ADE in other cell lines. Even though HL-CZ is a pro-
monocytic cell line, unlike primary monocytes, it does not express a significant level 
of FcγR III. 
To further investigate the role of FcγR I and II in ADE infection of HL-CZ, 
functional grade neutralizing anti-FcγR I and II antibodies were used to block 




Figure 3.7: Blocking of CD64 and CD32 disrupt the enhancement of infection induced by Hu3H5 
at MOI 0.4. HuADE refers to HL-CZ infected with DENV at MOI 0.4 together with Hu3H5 
under enhancing conditions. Equivalent refers to HL-CZ infected with MOI 0.8 (under non-
enhancing condition) to achieve equivalent infection rate to that of HuADE.  
1
 There is significant lowering of infection rate when HL-CZ are blocked with either anti-CD64 
or anti-CD32 antibody prior to ADE infection (p<0.01) compared to HuADE.  
2
 Blocking of both CD64 and CD32 also lowered the infection rate significantly (p<0.01 compared 
to HuADE).  
3
 When infection is independent of ADE (Equivalent), blocking of CD34 or CD32 did not affect 
infection rate significantly (p>0.05 for both). 






The adding of functional grade anti-CD64 antibody prior to utilizing the cells 
for ADE infection will negate the role of FcγR I in HL-CZ. Therefore, any 
enhancement of infection on the treated HL-CZ is mainly contributed by FcγR II. 
From the results (Figure 3.6), CD64 blocked HL-CZ was still able to support ADE, 
giving an enhanced infection rate of 25.7%. This level of infection is lower than that 
untreated HL-CZ (38%), but it is still higher than basal infection rates. 
The result was similar for the blocking of FcγR II, ADE infection fell to 
15.7% compared to untreated HL-CZ in ADE conditions. Blocking of FcγR I and II 
separately did not totally abrogate infection enhancement completely, however it did 
lower the level of enhancement significantly. This suggests that both FcγR I and II 
were utilized in ADE mechanism in HL-CZ, any reduction in the level of either Fcγ
R I or II can adversely affect ADE mechanism in HL-CZ. 
Next we block both FcγR I and II prior to exposing the cells to enhancing 
titres of antibody-virus complexes. However, blocking of both receptors did not return 
the infection rates to its baseline levels. It remains at (17%) which is similar to HL-CZ 
deprived of FcγR II function. This could possibly due to the inability of the antibody 
to completely block out the presence of the receptors even at high concentrations, as 
the function of the antibodies might have reached its saturation point. We also do not 
rule out the possibility of the presence of an unknown receptor that might be 




A non-binding isotype control antibody was also used as a control in ADE 
infected HL-CZ, to demonstrate that the Fc portion of the anti-CD64 and CD32 
antibodies was not the cause of the reduction in infection in the anti-CD64 and CD32 
blocking experiments.  
Next the amount of virus used was raised to achieve an infection rate similar 
to that of ADE at MOI 0.4. This new MOI level that can achieve an infection rate 
similar to that of ADE at MOI 0.4 was labeled as ―Equivalent‖ in Figure 3.6. The 
non-enhancing MOI required to do so was MOI 0.8. The cells were blocked with anti-
CD64 and CD32 antibodies separately before it was exposed to dengue at MOI of 0.8 
at non-enhancing conditions. This did not significantly reduce the high infection rate 
of ~38%. This suggests that the blockage of CD 64 and 32 only affected ADE 
mechanism and not conventional non-enhancing infection mechanisms. 
In summary, we verified that HL-CZ is capable to supporting dengue infection 
as stated in a previous study by Liu et al. [Liu et al. 1991]. We also established HL-
CZ as an ADE infection platform. The peak enhancing antibody: virus ratio using 
Hu3H5 and dengue 2 NGC was also established in this study. Characteriztion of Fcγ
R subclasses expressed on HL-CZ was also demonstrated. The role of FcγRI and II 
in supporting ADE infection of HL-CZ was also explored. The ADE infection profile 
of HL-CZ at various MOIs was also studied and the relationship of peak fold 





3.7 Microarray comparison of HuADE and Equivalent  
 
 
Figure 3.8: Heat map of microarray analysis. Color range indicates the relative change in 
induction. Red coloration indicates higher induction and blue coloration indicates lower 
induction.  From the column labeled HuADE set1 and HuADE set 2, generally HL-CZ infected 
under HuADE conditions have higher expression of the DDX genes as indicated by the orange-
red bars in their columns. Refer Appendix 1.7a for fold changes expressed in numerical form 
and appendix 1.7b for full list of 4138 differentially regulated genes. 
To identify genes that were differentially expressed in HL-CZ that undergo 
ADE infection mechanism, samples from the HuADE and Equivalent treatment 
groups were subjected to microarray analysis. We analyzed global gene profile of the 
three treatment groups using Illumina Sentrix® BeadChip Array. Using Equivalent 
treatment group as the control for comparison, 1 way ANOVA analysis of the data 
identified 4138 genes that were significantly changed in expression among HuADE 
treatment group (p <0.05). Each array targets more than 47000 probes derived from 
the National Center for Biotechnology Information Reference Sequence RefSeq 
Releases 38, dated November 7 2009. 
Out of the 4138 genes which were differentially expressed when comparing 
HuADE to Equivalent group, we selected a group of genes that might be of relevance 
to virus pathogenesis. The selected group of genes belongs to the DDX family. DDX 
family members of genes were chosen because of their role in RNA processing and 
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metabolism. As discussed in the introduction, DDX family of genes is involved in the 
pathogenesis of several viruses.  
The heat map (Figure 3.8) shown indicates the relative changes in induction, 
dark blue represent -1.5 fold change and bright red represents 1.5 fold change. 
Generally, HuADE have higher expression of the selected DDX gene transcripts as 
indicated by the orange coloration in their respective columns. The above mentioned 
inconsistencies will be addressed in post-microarray verification analysis. 
A large number of genes were identified by ANOVA, but the fold changes of 
the genes were less than 2 fold for most of the 4138 genes. Fold changes of less than 2 
fold for most of the gene changes is not commonly observed in Illumina platform as it 
was claimed that the system can detect changes ranging from 0 to 65535 fluorescence 
units. These inaccuracies were the shortcomings of microarray and could be attributed 
to errors committed during microarray analysis such as bleaching of fluorescence 
during staining of slides, improper hybridization or RNA to the probes, or degradation 
of the cRNA during handling. Since all the samples and replicates were all loaded into 
a single array chip, any processing error will affect not 1 but all of the samples on the 
chip resulting in consistently low fold changes as seen here throughout all samples 
and replicates. To compensate for these flaws and to validate the expression data, the 




3.8 qPCR and protein expression verification of selected DDXs  
qPCR analysis of the genes of interest were carried out to verify the fold 
change and to eliminate any false positive detection by microarray.  
From the 7 DDX genes that were selected for qPCR verification, only DDX21, 
31v1 and 47v2 were shown to be significantly different in level of mRNA expression 










Figure 3.9A: qPCR verification of gene expression at mRNA level. Only DDX21, 31v1 and 47v2 
are found to be significantly upregulated in both HuADE samples (p= 5.3 X 10
-8
, p<0.01). DDX49 
down-regulation in HuADE samples was not sufficiently significant to warrant further 
investigation. Other DDX tested did not have any significant changes when compared to 






mRNA expression difference may not translate to differences in protein 
expression. To validate the protein expression of DDX 21, 31 and 47, Western Blot 
analysis were carried out using cell lysate harvested from the 2 sample groups 
(HuADE and Equivalent). It was observed that cells that belong to HuADE treatment 
groups express higher levels of DDX 21, 31 and 47 than cells that were under the 
Equivalent treatment group.  
Using the Equivalent group as basis for comparison, there was significant 
increase in the protein expression of DDX21, 31 and 47 when the cells were under 
HuADE treatment. This difference was observed in 2 samples groups which have 
identical infection rates but differing infection mechanisms. 
 
Figure 3.9B: Western Blot analysis of DDX21, 31 and 47 expressions in HuADE and Equivalent 
samples. Equivalent samples have lower band intensity for all 3 DDX when compared to HuADE. 
Membrane was stained with DDX21 antibody first, stripped and restained for DDX31, 47 and 
subsequently beta actin. Membrane stained with DDX 21, 31 and 47 antibodies were exposed for 
10minutes and beta actin stained membrane was exposed for 5 seconds. DDX21, 31, 47 and beta 
actin molecular weights are 86, 64, 50 and 42 kDa, respectively. The Western Blot shown is 






3.9 siRNA transfection of HL-CZ reduces both DDX mRNA and protein 
expression at 48 hours and 72 hours respectively 
To study if the increased expression of the DDX protein in HuADE treatment 
groups was essential for supporting ADE, a gene silencing experiment was carried out. 
The DDX proteins of interest were knocked-down via transfection of the HL-CZ with 
the respective siRNAs. The cells that were knocked-down in the expression of the 
DDXs were infected under HuADE and Equivalent conditions and assessed for 
changes in the infection rate.  
At 48 hours post-transfection, the siRNA-treated cells were harvested and 
analyzed at mRNA level using qPCR (Figure 3.10A). There was a 9 fold reduction in 
DDX21 mRNA in siRNA treated HL-CZ. For DDX31, both DDX31v1 and 
DDX31v2 transcripts were targeted by the siRNA. Targeting both available mRNA 
transcript variants was to ensure protein expression reduction. Availability of more 
than 1 transcript variant may render the silencing of just 1 of the transcript variants 
redundant, as the other transcript variant may compensate for the silencing. DDX31 
transcript variants 1 and 2 were reduced by 6.2 and 8.4 fold respectively when 
DDX31 siRNA was introduced to HL-CZ. For DDX47v1 and v2 silenced HL-CZ, the 
mRNA levels were reduced by 23.7 and 12.4 folds when compared to untreated HL-
CZ, respectively. The overall reduction of mRNA level of DDX21, 31 and 47 by 
siRNA further warrant the analysis of their efficacy at protein expression levels. 
HL-CZ silenced with DDX21-targeting siRNA was harvested at 72 hours 
post-transfection. This harvested cell lysate were analyzed by Western Blot to 
determine if DDX21 protein was reduced by the DDX21-targeting siRNA. The 
experiment was repeated for DDX31 and 47. From the Western Blot analysis shown 
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in Figure 3.10B, there was decreased intensity of the relevant protein bands in HL-CZ 
cells treated with the appropriate siRNAs. Even though there was no complete 
abolishment of the targeted proteins, a general reduction in their levels should suffice 
to partly compensate for their rise observed in HuADE treated samples. This will 
enable us to determine which DDX plays a critical role in ADE infection mechanism. 
Since each SMART pool siRNA cocktail consist of 4 different siRNA 
sequences targeting the same isoform of the gene, there is a need to deconvolute 
individual SMART pool of siRNAs and transfect HL-CZ cells with scrambled 
sequences of DDX21, 31 and 47 siRNA to ensure minimal off-target effects by the 
siRNA on different isoforms of the gene. However, in this experiment we assumed 
that off-target effect by SMART pool siRNAs is negligible and did not have a 




Gene Fold Decrease Standard 
deviation 
p-value 
Control 1 0 - 
DDX21 9.14 1.12 p<0.01 
DDX31v2 6.29 0.28 p<0.01 
DDX31v2 8.41 1.09 p<0.01 
DDX47v1 23.80 1.93 p<0.01 
DDX47v2 12.42 1.63 p<0.01 
 
Table 3.1: Silencing of DDX21, 31 and 47 resulted in a decrease in their mRNA level as indicated 
by the fold decrease. This demonstrates the efficiency of the siRNA on a mRNA level. mRNA 
were harvested 48 hours post transfection for qPCR analysis. All p<0.01 when compared to 
control. Refer Appendix 1.9 for graphical representation of Table 3.1. 
 
Figure 3.10: Silencing of DDX21, 31 and 47 resulted in a decrease in their protein level as 
indicated by the Western Blot analysis. DDX21 silenced HL-CZ (row 1 column 4) expressed 
lower band intensity as compared to HL-CZ control (row 1 column 1), HL-CZ transfected with 
GAPDH siRNA control (row 1 column 2), and HL-CZ transfected with non-targeting siRNA 
control (row 1 column 3). DDX 31 silenced HL-CZ have very little amount of DDX protein 
expression as the band is hardly visible. Likewise for DDX47 which expressed lower amount of 
DDX 47 proteins in HL-CZ silenced with DDX47siRNA. The proteins were harvested 72 hours 
post transfection for Western Blot. The Western Blot shown is representative of 3 independent 






3.10 Impact of DDX31 and 47 on ADE infection 
Using HL-CZ that had been transfected with siRNA which targets the 3 DDXs 
individually, we infected the cells at MOI of 0.4 under HuADE conditions. And we 
compare their infection rate to cells that were silenced and infected under Equivalent 
treatment. For HL-CZs transfected with non-targeting siRNA or GAPDH targeting 
siRNA, the infection rate between Equivalent and HuADE did not differ significantly. 
DDX21 silenced cells did not differ in their infection rate between the 2 comparison 
groups either. However, DDX 31 and 47 showed marked decrease in HuADE 
infection rate when compared to their respective Equivalent infected samples (Figure 
3.11). This suggests perturbation of DDX31 and 47 protein levels during infection 
will adversely affect the ability of HL-CZ cells to support ADE.  
Comparing all the HuADE infected samples to control (infection rate 26.7%), 
only DDX31 and DDX47 silenced samples have shown decrease in infection rate 
(18.5% and 17.5%). Comparing all the Equivalent infected samples to control 
(infection rate 31.4%), all the samples have similar infection rate (p<0.05). However 
using a more stringent significance level of 0.01 instead of 0.05, DDX47 Equivalent 
samples (infection rate 27.8%) was slightly lower than the control. 
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Figure 3.11: 24 hours post-transfection with siRNA, the cells were infected under HuADE or 
Equivalent conditions to determine whether ADE is impaired by  silencing of the indicated DDX 
genes. White bars indicate non-infected control, Grey bars indicate Equivalent infected samples 
and Black bars indicate HuADE infected samples.  
1
 DDX21 silenced HL-CZ did not have any significant changes in their Equivalent (34.5%) and 
HuADE (32.8%) infection rates (p>0.05). Comparing DDX21 HuADE and control HuADE 
(28.7%), there also is no significant changes (p>0.05) 
2
 DDX 31 have a significantly lowered HuADE infection rate (18.5%) when compared to control 
HuADE (28.7%) (p= 4.5 X 10
-11
, p<0.01).  
3
 DDX 47 also have a significantly lowered HuADE infection rate (17.9%) when compared to 
control HuADE (28.7%) (p= 1.3 X 10
-12
, p<0.01).  
4
 The Equivalent infection rate (29.8%) of DDX31 was not significantly affected by the silencing 
when compared to control Equivalent (31.4%).  
5
 However, Equivalent infection rate (27.7%) of DDX47 was lowered slightly (p= 0.039, 





In summary, we have established HL-CZ as a platform for ADE infection and 
demonstrated its ability not just to support ADE infection but also to support non-
enhancing infection of dengue at various MOIs. The absence of CD209 assures us that 
ADE infection of HL-CZ is plausible. Peak enhancement can be achieved in HL-CZ 
regardless of the MOI as long as the antibody: virus ratio is maintained at 6ρg:1pfu.  
HL-CZ expresses both FcγRI and II which are the 2 FcγR subclasses demonstrated 
to be responsible for ADE in vitro. HL-CZ is dependent on both its FcγRI and II to 
support ADE and absence of either one of the FcγR subclass will impair its ability to 
support infection enhancement. The versatility of HL-CZ as a dengue infection model 
allows us to approach ADE studies from a different perspective. 
We have identified a list of genes that are modulated in cells undergoing ADE 
infection when compared to cell under non-enhancing Equivalent infection. The DDX 
family of genes was selected for further study based on its role in RNA processing 
and metabolism. It was found that not all the 3 DDX genes that were positively 
identified as potential regulators of ADE were capable of affecting ADE infection rate. 
Silencing of DDX21 did not reduce the infection rate in HuADE treatment group. 
Whereas silencing of DDX 31 and 47 did reduce infection rate by a significant level. 










Chapter 4: Discussion  
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HL-CZ is a human pro-monocytic cell line that was established in 1989 by Liu 
et al. [Liu et al. 1989], since then it has been used as a platform for infection by 
viruses. JEV, EV71 and DENV are the few reported viruses that can infect HL-CZ 
[Lin et al. 2008, Liu et al. 1991]. HL-CZ has been used as a platform for DENV 
isolation by Liu et al., and they demonstrated the DENV susceptibility of HL-CZ 
compared to C6/36 [Liu et al. 1991]. It was found that HL-CZ yields more virus 
progeny than C6/36 thus suggesting that HL-CZ could be used as a host cell for future 
study on DENV infections. 
To our knowledge, we are among the first to use HL-CZ as a platform for 
ADE of DENV infection. In this study, we fully establish HL-CZ as a cell type that 
can not only sustain ADE independent DENV infection but also support ADE 
infections. At MOI of 0.4 HL-CZ is able to achieve ADE infection rates of 36.4%. 
Comparing to other cell types that are able to achieve ADE infection, only K562 is 
able to achieve a peak ADE infection above 40% with a lower MOI of 0.125, no other 
contending cell line has achieved a peak infection rate of more than 30% in previous 
studies using their optimal MOI and concentration of antibodies. (Refer Table 1.3).  
However, the use of HL-CZ as an in vitro model is a simplified approach of the in 
vivo situation. This is because in vivo ADE may involve more than 1 cell type and 
may not necessarily be restricted to monocytic cell types as discussed in the 
introduction of this study. 
Referring to the ADE profile of HL-CZ at MOI 0.3 (Figure 3.3). It was also 
noted that at 1.8µg of antibody, the infection rate did not fall below baseline level for 
MOI of 0.3. Whereas in ADE profile with MOI 0.5 (Figure 3.2), the infection rate at 
3µg of Hu3H5 resulted in a 5 fold decrement in infection rate. This could be possibly 
due to the fact that even at high titers of Hu3H5, there will still be a small percentage 
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of virus not neutralized [Dejnirattisai et al. 2010]. These viruses which escape 
neutralization contributed to the <8% of the infected cells, and the neutralization of 
infection rate saturates at that level. The baseline infection rate at MOI of 0.3 was 
almost as low as the infection rate at which neutralization saturates, therefore at MOI 
0.3 with 1.8µg of Hu3H5, the infection rate was similar to its basal infection rate. 
The FcγRs that were responsible for the ADE infection of DENV in HL-CZ 
cell line was also determined to be both FcγRI and II. Flow cytometry data suggest 
that HL-CZ does not possess any surface FcγRIII, although antibody staining in our 
positive control cell line was weak. Observations made in the blocking of FcγRs 
during ADE infection indicate that both FcγRI and II are utilized for mediation of 
ADE in HL-CZ; this is similar to primary monocytes and macrophages which uses the 
same set of FcγRs for ADE infection of DENV. In contrast to primary monocytes 
and macrophages, HL-CZ is far more susceptible to DENV infection. This versatility 
in the ability of HL-CZ to be infected by DENV, under both ADE dependent and 
independent conditions, is a characteristic which is not easily achievable in other 
secondary cell line. Besides expression of FcγR I and II, HL-CZ is also known to 
possess CD15, CD34, and CD11b on its surface [Liu et. al. 1991]. 
Similar to HL-CZ, K562 is susceptible to both ADE independent and 
dependent infection. It was known that primary monocyte and macrophages use both 
FcγRI and II in the ADE infection process, but K562 only possess FcγRII. 
Therefore there could be a distinct difference between the ADE process between 
K562 and its primary counterparts. K562 ADE mechanism may resemble that of 
primary imDC (which possess only FcγRII) more than primary monocytes (which 
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possess both FcγRI and II). HL-CZ however does not have this drawback as it 
possesses and uses both FcγRI and II for ADE infection. This was also one of the 
main reasons why HL-CZ was developed as an ADE platform for this study. Just as 
any other cell lines used to study ADE, HL-CZ has it limits. HL-CZ is a pro-
monocytic cell line. Though it possess some characteristic of monocytes, it is possible 
that it also retains some characteristics of bone marrow precursor cells. Given that 
HL-CZ is a pro-monocytic cell line, it also shares the same myeloid linage as 
monocytes, macrophages and DC, these 3 cells are the principle PBML derived cells 
that can support DENV infection. 
The Hu3H5 antibody was used to induce ADE, Hu3H5 is a chimeric antibody. 
It possesses Fab domains from the original Mo3H5 antibody but carries a human Fc 
motif belonging to IgG1 subclass. Mo3H5 is a murine monoclonal antibody that was 
shown in previous studies by [Littaua 1990] to be able to induce ADE. It specifically 
binds to the E domain of DENV 2; therefore it has neutralizing capability against 
DENV2 at high concentration. However, when diluted to a concentration that is sub-
neutralizing, the enhancing capability of Mo3H5 will manifest itself. We opted to use 
Hu3H5 because it carries human IgG1 and thus better represent in vivo human 
conditions. 
With the aid of microarray analysis, we identified more than 4000 genes 
differentially regulated under ADE conditions. Many of the genes associated with 
both type I and II IFN were also differentially expressed (e.g. IFITM1, IFI6, IFI32, 
IRF2BP and ISG20), this indicate perturbation of both the IFN signaling pathways in 
ADE infected cells. This coincides with the results demonstrated by 
Chareonsirisuthigul et al. (2007) and Yang et al. (2001).  
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It is intriguing to note that several DDX members were also differentially 
regulated in ADE infected samples. DDX was known to be manipulated extensively 
by HCV for its replication [Owsianka et al. 1999, Mamiya et al. 1999, You et al. 
1999, Ariumi et al. 2007, Rohit et al. 2010]. Since both HCV and DENV are 
flaviviruses, the up regulation of DDX in samples infected with DENV under ADE 
condition warrant further study. Microarray aids in the identification of the genes, but 
it may not be entirely accurate. Therefore, there was a need for us to verify the 
expression with qPCR. Western blot analysis further verifies that the differential 
expression in mRNA levels was translated to protein level. Eventually only DDX21, 
31 and 47 were selected for further investigation. 
Using siRNAs a knock down study was executed to determine if the 
shortlisted DDX21, 31 and 47 were crucial for ADE infection of DENV. Post siRNA 
transfection verifications were also done to validate the efficacy of the siRNA in 
reducing the protein expression after 72 hours. Both DDX31 and 47 responded to the 
siRNA transfection, and ADE mediated infection of HL-CZ was severely impaired by 
the knock-down of DDX31 and 47. An equivalent infection was also slightly affected 
for DDX 47, but not to the same extent as HuADE mediated infections. DDX21 
knock-down however did not yield any significant change in infection level of both 
HuADE and Equivalent infection.  
It is known that virus output per cell infected under ADE conditions was much 
higher than that under non-ADE conditions [Halstead et al. 2003]. This high viral 
output per cell meant that there is a higher rate of viral replication within the host cell 
and more viral RNA genome produced in cell infected under ADE condition as 
compared to non-ADE conditions. We speculate that high amount DDX 21, 31 and 47 
was triggered as a cellular response to the large amount of single-stranded viral RNA 
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synthesized under ADE conditions. However, only DDX 31 and 47 contributed to the 
stabilization of viral RNA in cytoplasm. Silencing of DDX31 and 47 thus results in 
more degradation of viral RNA within the host. This in turn is reflected in lesser viral 
output and subsequently lower rate of infection.   
Alternatively the lack of response from the silencing of DDX 21 could simply 
be due to insufficient silencing by the siRNA. It was noted that DDX21 protein 
expression was highly unregulated in samples under both HuADE and MoADE 
treatment. siRNA silencing may not be adequate to overcome the high expression 
levels we observed. 
Another plausible explanation is that, the low amount of DDX21 in Equivalent 
samples were induced by the high MOI used as compared to HuADE samples 
infected with less virus. Therefore silencing of DDX21 did not trigger any lowering of 
ADE infection as the differences in protein expression between the 2 sample groups is 
due to confounding factors in the experiment setup. However, differences in MOI 
were unlikely to have attributed to the differences in protein expression of DDX31 
and 47. This is because silencing of these 2 genes abrogated the enhancement of 
infection and did not affect their Equivalent control much.  
Another speculation is that DDX31 and 47 up-regulation could be mediated by 
FcγR signaling during ADE to assist in viral replication. Whereas DDX 21 up 
regulation could be due to other confounding factors in the experiment setup. This 
postulation explains why silencing of DDX 31 and 47 affects ADE infection rate but 
DDX21 does not. However we are not sure if the up-regulation is mediated by FcγRI, 
II or both, since both FcγR contributes to enhanced infection rate. 
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The exact mechanism by which DDX31 and 47 contributes to the ADE 
process is yet to be elucidated. Given that DDX’s role in RNA metabolism and 
processing, it is highly probable that DDX31 and 47 are involved in the processing of 
DENV genome under ADE conditions. We do not know if DDX 31 or 47 interacts 
with any viral proteins but we do not exclude the possibility that it may bind to viral 
protein to regulate replication as in the case of HCV’s C protein interacting with 
DDX3.  
Nonetheless, this current study unveils 2 DDX proteins that could be involved 
in the molecular mechanism of ADE infection. Future study on the localization of 
DDX31 and 47 during ADE infection could help to further elucidate the function of 
DDX31 and 47, as the function of DDX could be associated with its subcellular 
distribution [Neumann et al. 2001]. 
 In summary, we managed to establish a new platform for the study of ADE 
using HL-CZ. The characteristic of the HL-CZ that attribute to its ability to sustain 
ADE infection was also explored to the fullest extent that we could. Using a different 
approach we revisited the different types of genes that were differentially expressed 
under ADE conditions as compared to non-enhancing conditions. DDX was given a 
closer examination due to their possible implication in viral replication. Indeed, base 
on our observations, it is possible that DDX31 and 47 are crucial components required 
for sustaining the high rate of replication under ADE conditions. 
 Future studies could include the possibilities of eluding the mechanism by 
which DDX31 and 47 are up-regulated during ADE. As we are unsure if the up-
regulation of DDX is induced by FcγR signaling or by the increased in viral genome 
per cell during ADE. The role of DDX31 and 47 in ADE infected HL-CZ can also be 
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explored so that we can have a complete understanding of the observations made in 
this current study. The experiments can also be repeated in another cell line to ensure 
that the up-regulation of DDX31 and 47 is not restricted to HL-CZ but to all other 
primary cell types. Double silencing of DDX 31 with 47 can be carried out to 
investigate if it synergistically reduces ADE infection rates. Also blocking of other 
receptors known to be present on HL-CZ, such as CD15, CD34 and CD11b can be 
carried out to see if it affects the binding of antibody-virus complexes to HL-CZ 
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Appendix 1.1: RIN number of RNA samples acquired for microarray analysis. The RIN can 
range from 0-10. High integrity of the samples is reflected by a larger RIN. Only samples with 










Baseline 24.7 5.02 - 
ADE (3µg of Hu3H5) 4.97 0.42 p<0.01 




49.5 6.33 p<0.01 
ADE (3 X 10
-2
µg  of 
Hu3H5) 
47.2 3.80 p<0.01 
ADE (3 X 10
-3
µg  of 
Hu3H5) 
16.8 2.78 p>0.05, not 
significant 
ADE (3 X 10
-4
µg  of 
Hu3H5) 
17.4 3.11 p>0.05, not 
significant 
Appendix 1.2A: Exact values of data from Figure 3.2. HuADE profile at MOI 0.5. p-value was 




Appendix 1.2B: Supernatants of samples from Figure 3.2 were harvested, freeze-thawed for 1 











Baseline 4.4 0.62 - 
ADE (1.8µg of Hu3H5) 6.3 2.85 p>0.05, not 
significant 




38.1 5.56 p<0.01 
ADE (1.8 X 10
-2
µg  of 
Hu3H5) 
27.8 5.80 p<0.01 
ADE (1.8 X 10
-3
µg  of 
Hu3H5) 
4.1 0.16 p>0.05, not 
significant 
ADE (1.8 X 10
-4
µg  of 
Hu3H5) 
4.6 0.28 p>0.05, not 
significant 
Appendix 1.3A: Exact values of data from Figure 3.3. HuADE profile at MOI 0.3. p-value was 
calculated by comparing with Baseline. 
 
 
Appendix 1.3B: Supernatants of samples from Figure 3.3 were harvested, freeze-thawed for 1 






Conditions Infection rate (%) Standard deviation 
Baseline  
MOI 0.1 1.6 0.08 
MOI 0.2 3.0 0.01 
MOI 0.3 4.4 0.62 
MOI 0.4 7.2 2.33 
MOI 0.5 16.8 3.75 
MOI 0.8 33.3 5.94 
MOI 1.0 36.9 6.31 
ADE 
MOI 0.1 6.08 0.08 
MOI 0.2 19.2 0.15 
MOI 0.3 32.1 5.56 
MOI 0.4 36.5 0.85 
MOI 0.5 41.5 3.50 
MOI 0.8 55.5 0.50 
MOI 1.0 58.3 0.30 
Appendix 1.4: Exact values of data from Figure 3.4A. Peak enhancement at various MOIs and 













HuADE 38.1 1.23 Baseline  p<0.01 
CD64 blocked HuADE 25.7 1.63 HuADE p<0.01 
CD32 blocked HuADE 15.7 1.22 HuADE p<0.01 
CD64 & 32 blocked 
HuADE 





Isotype control blocked 
HuADE 
36.0 2.69 HuADE p>0.05, not 
significant 








37.1 6.86 Equivalent p>0.05, not 
significant 
Baseline 7.15 2.33 - - 











with for p-value 
calculation 
p-value 




MoADE 44.9 3.14 
Equivalent 36.6 1.98 




5.84 0.04 Baseline p>0.05, not 
significant 
Appendix 1.6: Exact values of data from Figure 3.7A and B.  Infection rate of HuADE, MoADE, 
and Equivalent treatment groups that is harvested for microarray analysis. Baseline and isotype 












p<0.05 as level of 
significance) 
DDX21 2750719 +1.40 +1.11 0.0049 
DDX31v2 6370392 +1.12 No change 0.0099 
DDX47v1 3940379 
 
+1.21 -1.16 0.0157 
DDX47v2 4040672 +1.21 -1.10 0.0267 
DDX49 450309 +1.19 +1.22906 0.0275 
DDX52v1 6940328 +1.13 -1.04 0.0387 
DDX54v2 4760301 +1.10 +1.34 0.003 
Appendix 1.7a: Analysis of data from Figure 3.8. Heat map is expressed in numerical values for 
calculation of p-value and 1 way ANOVA analysis. 
Appendix 1.7b: Similar to appendix 1.7a, except that this is a full list of all the 4138 differentially 
expressed genes as determined by 1 way ANOVA analysis using p-value <0.05. Genes that are not 




p<0.05 as level 
of significance) 






870110 0.015617 1.2969 up 1.32 up C15orf39 
830441 0.028978 1.11263 up 1.04 up SCYL1BP1 
3130152 0.003595 1.19448 down 1.14 down  
5080746 0.006401 1.31426 up 1.31 up FLJ20718 
2480672 0.018854 1.14302 down 1.04 down  
6400477 0.016401 1.03969 down 1.41 down  
4760255 6.89E-04 1.34478 up 1.07 down ARHGDIA 
3310056 0.003973 1.33693 up 1.65 up NOMO1 
290685 0.039843 1.31344 down 1.08 down SLC6A15 
770639 0.007858 1.03775 up 1.1 down PDLIM7 
3450367 0.003113 1.14331 down 1.12 down  
1980014 0.015606 1.0542 up 1.08 down RNF6 
126 
 
3520092 0.006178 1.16574 down 1.21 up BAX 
450762 0.001589 1.05917 up 1.46 up FCGR2A 
5390575 4.25E-04 1.09006 up 2.23 up CUGBP2 
7320707 0.023927 1.1965 down 1.48 up LOC654103 
6900440 0.028708 1.09192 down 1.26 up SLC25A1 
2900224 0.018888 1.13759 down 1.37 down ENTPD4 
2320343 0.005437 1.25185 down 1.21 down MAMLD1 
2510253 0.036854 1.21781 down 1.46 down C10orf35 
2030754 0.046992 1.0887 up 1.3 up GHDC 
5090291 0.011183 1.18144 up 1.01 down ATG4C 
7150017 0.036487 1.13678 up 1.37 up C6orf48 
2690528 0.008875 1.2593 down 1.02 down SHMT1 
7160239 0.024885 1.92931 down 2.09 down FOSB 
1410398 0.02231 1.03852 up 1.37 down CCNYL1 
2060112 0.012089 1.03244 down 1.29 down CCNYL1 
3930132 0.041243 1.0871 down 1.08 up TUBA3D 
4480368 0.00558 1.0885 down 1.34 up TMEM60 
7560114 0.022494 1.19148 down 1.09 up KLHDC8B 
870176 0.02776 1.19516 up 1.05 down TFG 
510114 0.017101 1.10148 down 1.06 up CCNB1IP1 
2970703 0.013584 1.16273 up 1.2 down RNF125 
2470681 0.029068 1.36689 down 1.1 down MGC16703 
4150176 0.023828 1.50289 up 1.09 up LOC644544 
7320370 0.011154 1.45987 up 1.51 up STAT4 
1050347 2.33E-04 2.06683 down 1.03 down TUBB1 
6200390 0.030762 1.17173 down 1.01 down PRIM1 
7050601 0.015471 1.13922 down 1.14 down LOC647910 
2630364 0.015957 1.05009 up 1.09 down  
2900674 0.021415 1.4265 down 1.29 up IGSF3 
1410630 0.012685 1.11189 up 1.07 up  
5960653 0.045781 1.18351 up 1.02 up TMEM55A 
6220382 0.038081 1.28517 down 1.45 down CD68 
1110440 0.022551 1.08216 up 1.18 down WDR77 
2630692 0.00316 1.27778 up 1.23 up ACACA 
4060646 0.034679 1.1659 up 1.22 down TCERG1 
6270706 0.040668 1.19206 up 1.42 up SMG7 
5550114 0.048006 1.19431 down 1.04 down SMG7 
3360594 0.043707 1.03906 up 1.09 down  
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6580735 5.33E-04 1.31288 up 2.73 up ACSM3 
3840632 0.010215 1.25541 up 2.15 up ACSM3 
1990196 0.018587 1.46958 down 1.15 down DACT3 
240546 0.016068 1.01828 up 1.2 down SCAND1 
3370040 0.023247 1.25419 up 1.03 down  
5360392 0.013484 1.14855 down 1.39 down TP53INP2 
6940646 0.005213 1.1285 up 1.22 up LCN12 
4050382 0.00276 1.50646 up 1.18 up CCDC109A 
4050215 0.021066 1.14504 down 1.2 down  
5820753 0.002952 1.08927 up 1.34 up RBCK1 
1510722 7.61E-04 1.06457 down 1.56 up RNF130 
7320494 0.00265 1.1824 down 1.17 up ZFPM1 
3290291 0.020843 1.39084 down 1.26 down SLBP 
870730 0.033282 1.13027 up 1.11 up  
1820274 0.047503 1.30393 up 1.39 up HERC1 
4180279 0.019914 1.03748 down 1.17 down THAP1 
5820500 0.040154 1.20119 down 1.09 down C1orf35 
7160180 0.037375 1.03231 up 1.21 down UCHL3 
2000162 0.021172 1.1974 up 1.18 up C5orf20 
6020692 0.012905 1.00436 up 1.34 up  
1030427 0.039405 1.08015 up 1.11 up CUTA 
6130110 0.039766 1.08602 down 1.04 down LOC255649 
5340703 0.016852 1.22983 down 1.16 up KRCC1 
2370538 0.006197 1.07994 up 1.44 up KRCC1 
10358 0.018567 1.2384 down 1.2 up SPN 
6510541 0.012135 1.08691 down 1.09 up  
5900685 0.034366 1.08621 down 1.06 up ADD1 
4890392 0.031672 1.29141 up 1.01 up  
2630619 0.015506 1.06953 up 1.19 up RNF20 
4590026 0.004168 1.09551 up 1.17 down IMPDH2 
60706 0.037974 1.02178 up 1.14 down SDCCAG3 
3190189 0.006324 1.07681 up 1.18 down TTRAP 
6520026 0.028949 1.00867 up 1.19 up NUCB1 
510164 0.019459 1.41912 down 2.2 down PKLR 
150343 0.015452 1.10154 up 1.39 up  
6940086 0.012649 1.26465 down 1.59 up GYPE 
3520300 0.018979 1.10287 down 1.2 up GYPE 
5700070 0.024713 1.22825 down 1.15 down ALPL 
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1230730 0.039593 1.2064 down 1 up SLC30A5 
3060192 0.013383 1.18 down 1.4 down GINS3 
1340039 0.007956 1.06599 down 1.4 down TFPI 
4850731 0.014082 1.01166 down 1.22 down TFPI 
1510736 0.041127 1.02715 down 1.18 down KLC1 
2340671 0.026024 1.25885 down 1.22 down MAEA 
1660056 0.028202 1.6369 down 1.25 down  
2600301 0.035759 1.05698 down 1.03 up ZNF565 
6520605 0.020967 1.27982 up 1.2 down SMNDC1 
4890463 0.04106 1.08073 up 1.14 down EXOSC10 
4060626 0.003763 1.0954 up 1.06 down ROR1 
730332 0.015197 1.22029 up 1.46 up MSN 
150692 0.022429 1.0654 down 1.31 down SLC26A6 
4590440 0.041844 1.05131 up 1.43 down ABL1 
6060475 0.037289 1.00208 up 1.25 up BMPR2 
6510360 0.030467 1.31463 down 1.04 up C1orf97 
2650707 0.010793 1.15397 up 1.02 up C11orf72 
2490343 0.013152 1.22276 down 1.18 up GRK4 
5050113 0.045753 1.10076 down 1.02 up LIG1 
70528 0.010262 1.24312 up 1.13 down BBS7 
6560114 0.010433 1.16319 up 1.06 up LOC727942 
3930519 0.047539 1.05393 up 1.25 up  
7400193 0.026004 1.06343 down 1.11 down  
110674 0.032337 1.13701 up 1.04 up PTER 
6550717 0.040858 1.31539 down 1.07 up LOC644404 
1660528 0.014377 1.19813 down 1.08 down CKLF 
510025 0.039912 1.10489 down 1.49 down SMC2 
2650494 0.017044 1.04111 down 1.14 down SMC2 
3360400 0.009169 1.09439 down 1.07 down SMC2 
6400647 0.019719 1.1041 up 1.21 down EHD4 
1340671 0.020082 1.03147 up 1.14 down COL9A1 
7150092 0.002876 1.18643 up 1.24 up SUDS3 
7160072 0.003503 1.00107 down 1.09 up  
2600025 0.005374 1.16094 up 1.07 down PSMD14 
6100112 0.029218 1.10802 up 1.24 up STXBP1 
4230689 0.001178 1.13288 up 1.13 up  
290053 0.036514 1.65592 down 1.35 down DGCR8 
5050288 0.016491 1.11741 up 1.22 down LOC388946 
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3120221 0.018897 1.31377 down 1.05 up APOBEC3C 
3120189 0.041522 1.11451 up 1.09 up LOC648476 
450674 0.018495 1.29435 down 1.24 down C10orf128 
1510731 0.025344 1.47527 down 1.14 down KIAA1875 
4760079 0.018098 1.34946 down 1.19 up ADARB1 
3190639 0.005025 1.2636 down 1.18 down POU3F4 
6860278 0.001118 1.46728 down 1.22 up NINJ2 
2260129 0.024352 1.10778 down 1.14 up MS4A6A 
3190193 0.048373 1.15401 up 1.12 up PRKCQ 
2320397 0.020952 1.14599 up 1.19 up  
5820452 0.03687 1.11231 up 1.04 down  
870736 0.030023 1.23857 down 1.46 up KIAA1545 
7000356 0.007067 1.05504 down 1.43 up RXRA 
7610070 0.019407 1.05558 up 1.18 up PMEPA1 
770162 0.001424 1.05262 down 1.16 down SPIN2B 
3140543 0.030659 1.43332 down 1.14 up ZMAT3 
5960292 0.022351 1.00788 down 1.09 down  
6840609 0.006084 1.41207 down 1.36 up CGB1 
3850161 0.027197 1.08106 up 1.34 up KTELC1 
3840100 0.009484 1.38378 up 1.19 up SEC31A 
5390372 0.0063 1.55519 down 1 down C2orf64 
3180048 0.015234 1.04834 down 1.44 up IDH1 
6270670 0.028084 1.04061 down 1.55 up IDH1 
6060767 0.010792 1.17298 up 1.18 up AASDHPPT 
5090392 0.017704 1.09418 up 1.25 up GMPR2 
4780735 0.026059 1.25126 down 1.07 up SAMD5 
3800544 0.002255 1.23851 up 1.17 down NCK1 
5960725 5.25E-04 1.10576 down 1.86 up GRB10 
5270021 0.012673 1.17521 up 1.35 up UBE2E2 
50193 0.033966 1.03852 down 1.35 up ZNF318 
70167 0.001756 1.30815 down 1.4 up LY96 
6550035 0.037879 1.05601 up 1.36 down EIF5 
1240195 0.0297 1.13744 down 1.24 up PAGE2 
6450605 0.00236 1.06136 down 1.4 up DDOST 
4560717 0.006423 1.13816 down 1.36 up MDK 
3180288 1.61E-04 1.20102 down 1.23 up C11orf17 
4610154 1.85E-04 1.50345 up 1.03 up C1orf103 
6560209 0.01954 1.10477 up 1.01 up  
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5550746 0.008846 1.02985 down 1.16 down TIRAP 
5700451 0.046968 1.10318 up 1.43 up FKBP9L 
5670626 0.042935 1.02847 down 1.04 up DPM1 
4890379 0.010426 1.05649 down 1.03 up LOC650804 
1570414 0.022611 1.17712 down 1.04 down NAT5 
1510091 0.010088 1.27821 up 1.34 up VPS36 
6770315 0.044539 1.03547 down 1.07 down LOC391656 
780082 0.024459 1.08324 up 1.02 up LOC441771 
3420546 0.030483 1.15175 down 1.07 down C11orf36 
1510072 0.041489 1.10766 up 1.17 down PITRM1 
6200554 0.022592 1.35639 down 1.26 up CYCS 
670270 0.04622 1.19035 up 1.06 up LOC644586 
2230253 0.004044 1.33195 up 1.03 down ADAT3 
6560025 0.022772 1.14072 up 1.04 down  
520332 0.001761 1.13707 down 1.2 up B4GALT7 
2650762 1.91E-04 1.09496 down 1.59 up ITM2C 
1110669 0.027565 1.0329 down 1.44 up ITM2C 
4280561 0.025531 1.03563 up 1.23 down ACTR1A 
5290403 0.00104 1.173 up 1.04 up WDR59 
4490484 0.012976 1.17524 down 1.02 up ANKRD20A1 
4560619 0.017877 1.24061 down 1.23 down HEPACAM2 
3290152 0.048918 1.1211 down 1.02 down ZNF3 
4590020 0.01612 1.05519 up 1.48 down YOD1 
5550619 0.004148 1.0078 down 1.17 down ADPGK 
2970754 0.013414 1.29078 down 1.05 down NY-SAR-48 
5080131 0.005323 1.17349 up 1.07 down MGST1 
5860152 0.014268 1.08262 down 1.33 down CD44 
6130538 0.015458 1.10558 down 1.29 up PFN2 
7550719 0.030401 1.07643 down 1.09 up MTL5 
5560360 0.021289 1.41019 down 1.21 up RIPK5 
1570092 0.01344 1.21508 down 1.45 down TUBB6 
5340017 0.001553 1.97793 down 1.1 up H19 
360372 0.024582 1.12891 down 1.03 up  
5340465 0.02067 1.13722 down 1.05 down  
7050553 0.01184 1.31188 down 1.1 up  
7320021 0.005607 1.33647 down 1.21 down HMBS 
6900086 0.010183 1.14535 down 1.22 down ADAMTS1 
2940131 0.034971 1.49034 down 1.39 down LOC644979 
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2230575 0.009573 1.07 up 1.48 down LOC642267 
4220193 0.00232 1.05625 up 1.44 down SIGIRR 
20048 0.03778 1.25963 up 1.04 down HIST2H2BF 
2630333 0.002129 1.3914 down 1.12 down CYB5D2 
4480343 0.010496 1.1197 down 1.09 down FLJ46010 
7050220 0.005914 1.04089 down 1.56 up NMU 
990615 0.020293 1.11883 up 1.48 up MTCP1 
4920707 0.035549 1.1774 up 1.14 down BIRC2 
5080471 0.014521 1.25744 down 1.42 down MAP3K6 
6280019 0.047585 1.21486 down 1.03 up NPHP4 
7320437 0.019259 1.25375 up 1.13 down DSCR3 
5670543 0.040117 1.14942 up 1.01 down DKFZP586H2123 
1410348 0.040812 1.02939 up 1.13 down ATG12 
5390180 0.001402 1.14243 up 1.3 up ASXL1 
110711 0.038139 1.0685 down 1.3 up TM2D2 
4560164 0.002742 1.01847 up 1.41 down PDLIM7 
150543 0.020088 1.34352 down 1.23 up FAM83D 
4920593 0.022011 1.55092 up 1.04 down CDKN2C 
4220164 0.002298 1.03362 up 1.25 up LOC642321 
1340241 0.002167 1.34926 down 1.55 up C5 
1990053 0.002421 1.13689 up 1.03 down POLRMT 
3990379 0.016573 1.12305 down 1.14 up ITGB7 
6960014 0.041467 1.78935 down 1.25 down MTMR9 
4830739 0.031384 1.09425 down 1.36 down MAGEA12 
7330612 0.026342 1.02906 down 1.19 up ATP5G2 
2710019 0.025219 1.13256 down 1.38 down MPDU1 
5860477 0.004268 1.24013 up 1.59 up CANX 
5290025 0.043858 1.01563 up 1.1 up C14orf156 
670072 0.037092 1.11762 up 1.04 down EWSR1 
1090482 0.012125 1.16857 up 1.03 up ARL6 
4010719 0.02773 1.10328 up 1.33 up CSF2RA 
20010 0.005708 1.36505 up 1.28 up CARS 
6130400 0.044345 1.01138 up 1.1 up  
5810309 0.008091 1.12942 down 1.15 down SIRPB2 
2850435 0.011379 1.05918 up 1.13 down SIAH1 
520008 0.019551 1.28017 up 1.24 up 
ANKHD1-
EIF4EBP3 
360014 0.022879 1.12036 up 1.12 up CDH23 
5050477 0.037029 1.17329 down 1.08 up PIAS2 
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4780414 0.015948 1.10047 up 1.23 up RPL32 
7400070 0.030109 1.45685 up 1.12 up TBC1D22B 
2230465 2.52E-04 1.01464 up 1.4 down PGBD2 
2060091 0.048226 1.16659 down 1.03 down DAG1 
6290279 0.046573 1.19243 up 1.03 down PKHD1 
870392 0.048566 1.11401 up 1.11 down LOC644873 
3420088 0.034653 1.2365 up 1.12 down MTG1 
1990156 0.036846 1.2127 down 1.06 up FLJ46020 
270619 0.018682 1.16658 up 1.28 up GTF3A 
1570538 0.003997 1.15992 up 1.13 down GTF2E2 
2650332 0.035391 1.03208 down 1.15 down ZNF749 
520020 0.004124 1.06476 up 1.04 up LOC650454 
770131 0.016046 1.24636 up 1.13 up SCFD2 
7210041 0.007038 1.17331 up 1.01 up C1QL2 
1770070 0.016063 1.07646 down 1.01 up SUPT4H1 
5420427 0.012295 1.31765 down 1.04 down TUG1 
6400411 0.010594 1.05266 down 1.18 up TM9SF1 
4250538 0.001419 1.33183 down 1.4 up STAT3 
5090619 3.95E-04 1.38655 down 1.39 up STAT3 
580403 0.00305 1.1054 down 1.58 up DFNA5 
6330273 0.03639 1.14647 down 1.01 up  
2850437 0.005026 1.03945 down 1.39 up LOC441124 
4180377 0.004542 1.33646 down 1.25 down ARHGDIG 
3710575 0.036422 1.0866 up 1.02 down LOC647786 
990519 0.019318 1.14842 up 1.1 up LOC647521 
4610731 0.013845 1.3966 down 1.42 down CHAF1B 
3060474 0.012494 1.00162 up 1.19 up SLC23A2 
5310497 0.018102 1.04036 down 1.11 up  
6040020 0.030529 1.17422 down 1.19 up  
4610041 0.029555 1.14376 down 1.18 up LOC728473 
4280343 0.003956 1.06407 down 1.17 down COASY 
2120445 0.030258 1.21315 up 1.01 down BXDC2 
1110722 0.043909 1.22381 up 1.06 down BXDC2 
650180 0.00286 1.03105 up 1.32 up  
510048 0.041804 1.03589 down 1.14 up WDR45 
50592 0.044386 1.01128 down 1.26 down WDR45 
1010110 0.014657 1.09837 down 1.43 up TMEM9 
6020487 0.032485 1.14272 up 1.17 up USP39 
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6100524 0.01457 1.04684 up 1.17 up ARFGEF1 
5690368 0.029947 1.11749 up 1.06 up CYP4A22 
730541 0.012217 1.15028 down 1.47 down PCID2 
4280632 0.0093 1.07002 up 1.34 up GAS6 
7560482 0.035795 1.15816 up 1.06 up TBX1 
1400121 0.034921 1.49646 down 1.23 up SLCO2B1 
6580441 0.011473 1.73543 down 1.1 up SLCO2B1 
4780463 0.007473 1.29094 down 1.09 up RAB6B 
4540682 0.032772 1.19575 down 1 down PALM 
3440037 0.019739 1.06152 down 1.42 up PALM 
2650164 0.018745 1.09153 down 1.25 up FLJ10986 
5390646 0.032722 1.03656 up 1.05 down SETDB2 
5570730 0.034867 1.13144 up 1.14 down TICAM1 
2710291 0.025257 1.55073 up 1.32 up  
3390167 0.034702 1.09301 down 1.01 up LOC389832 
4920619 0.012155 1.14424 down 1 up SUZ12 
6760661 0.003315 1.18815 down 1.97 up CAPN5 
5670112 0.00688 1.17543 up 1.6 up ANKRD27 
6130333 0.049954 1.04462 down 1.05 down PDGFA 
870463 0.006274 1.01686 up 1.17 up USP51 
7570433 0.026371 1.03193 up 1.09 down NPSR1 
5890121 0.016547 1.05183 down 1.22 down NRG4 
160639 0.01751 1.18815 up 1.15 up EBAG9 
3420707 0.031725 1.10981 up 1.02 down  
3890551 0.032691 1.21294 down 1.11 up CMTM3 
5340113 0.002418 1.11424 up 1.03 down  
3450377 0.016214 1.10305 down 1.21 up RNF5P1 
650646 0.042478 1.02801 down 1.19 up ABCC10 
6100521 0.028178 1.17729 down 1.08 up PHF11 
5080450 0.011858 1.02046 up 1.66 up ZBTB16 
6290392 0.02832 1.05359 up 1.09 down SRRM1 
1010575 0.013588 1.31003 up 1 up C16orf87 
6420296 0.04016 1.23209 down 1.01 up MRPL2 
7380333 0.014456 1.09771 down 1.08 up DKFZp686I15217 
1660551 0.011481 1.1149 up 1.19 down SLC5A3 
2340709 0.010988 1.20418 up 1.55 up ZMYM3 
160008 0.038858 1.08038 up 1.06 down CTPS2 
5550100 0.031078 1.02736 up 1.06 down LOC92154 
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2100653 0.016263 1.22451 up 1.43 up MLL5 
3120707 0.007029 1.08874 up 1.16 up CUTA 
2480326 0.008965 1.31126 up 1.27 up HSP90B1 
6040452 0.018996 1.21902 down 1.17 up C12orf56 
3420561 0.009877 1.23004 down 1.2 down RPA2 
4290736 0.019026 1.15187 up 1.38 up MAP2K2 
5290291 0.04916 1.03305 up 1.11 down PRAMEF5 
770132 0.018501 1.1125 down 1.14 up TSPYL5 
150424 0.038079 1.41344 up 1.11 up PPIL2 
6770446 0.038857 1.12986 up 1.54 up SPAG6 
3170592 0.026738 1.25828 up 1.36 up UGCGL1 
7650725 0.003103 1.39153 up 1.54 up UGCGL1 
7610152 0.030653 1.12613 up 1.35 up UBAP2L 
2680035 0.013022 1.06749 down 1.08 down  
5360619 0.025846 1.03934 down 1.24 up CDC16 
6980088 0.018133 1.34087 down 1.09 down MAGEA1 
150095 0.029104 1.24451 down 1.02 up TP53BP2 
6900187 0.007114 1.124 up 1.19 up LOC644468 
1500600 0.008462 1.13811 down 1.06 up RAB37 
1300592 0.019329 1.0115 up 1.2 down DNMT3A 
6520139 0.008688 1.44404 down 1.26 down FGFR3 
2850402 0.027498 1.19596 up 1.13 up PFN1 
4010553 0.014004 1.15745 down 1.08 up B4GALT6 
6940520 0.044142 1.39567 up 1.15 up ANKRD17 
610376 0.001329 1.11024 up 1.18 up NUDCD2 
1070619 0.020818 1.1215 down 1.05 up  
4060066 0.031568 1.09465 down 1.19 down  
5890072 0.030003 1.0924 up 1.33 up TRAPPC9 
1470072 0.028217 1.23962 up 1.09 up PBRM1 
610164 0.044087 1.58405 down 1.16 up FYN 
6660047 0.002664 1.10527 up 1.49 up KIAA0090 
5260408 0.002492 1.13326 down 1.13 up RPH3AL 
650709 0.017021 1.04606 down 1.21 down RNF34 
6860452 0.011878 1.12509 up 1.26 up PDCD2 
4810471 0.047345 1.02772 up 1.14 up ACOT1 
6840356 0.035403 1.10028 down 1.07 up MGEA5 
4900440 0.015037 1.13916 down 1.41 down CIB1 
4900386 0.029299 1.09071 down 1.37 down TOP3B 
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520682 0.017404 1.22076 down 1.57 down CPA4 
10142 0.011104 1.00594 up 1.29 up CD164 
4880747 0.022539 1.12228 down 1 up SLC16A11 
4390612 0.001121 1.27733 down 1.08 down CCDC14 
6220600 0.009404 1.02277 up 1.51 up LOC113386 
2470358 0.00948 1.13683 down 1.4 down IFNGR1 
290273 0.034709 1.19953 down 1.48 up  
430196 0.0266 1.03142 down 1.25 down MRPL14 
2070184 0.028373 1.2833 up 1.31 up NTHL1 
6560576 0.005028 1.13049 down 1.21 down OCRL 
3170608 0.034472 1.00708 down 1.06 up C12orf61 
10189 0.004118 1.08487 up 1.1 down C19orf24 
7610538 0.031106 1.64931 up 1.03 up H1FX 
2070427 0.027182 1.12678 up 1.14 up CBFA2T3 
1030053 0.008139 1.24727 down 1.63 down MZF1 
1070551 0.018663 1.03576 up 1.27 down CSRP2BP 
10176 0.003995 1.04295 down 1.33 up TAF15 
5690064 0.007095 1.40767 up 1.39 up LASS6 
4280132 0.019573 1.23292 up 1 down DSCR8 
6840626 0.004058 1.11713 down 1.09 down PTGS1 
380301 0.002567 1.18067 down 1.23 down  
5870626 0.033097 1.15587 down 1.26 down  
2900112 0.011453 1.09395 down 1.36 up PPIB 
4010224 0.016291 1.07762 down 1.01 down PRB1 
7100121 0.026123 1.15664 up 1.29 up HNMT 
2600398 0.018771 1.14177 down 1.11 down  
4480446 0.033918 1.08152 down 1.09 up  
5960647 0.012854 1.44996 up 1.16 up IGSF10 
2060014 0.003019 1.27578 down 1.06 up  
7330187 0.04047 1.01677 down 1.1 up  
2710228 0.003568 1.12307 up 1.23 up LOC653103 
1580719 0.043684 1.56554 up 1.35 up THADA 
7380113 0.010409 1.08065 up 1.2 down ABCF1 
2190273 0.018605 1.33485 up 1.01 down ABCF1 
6900037 0.015187 1.19479 up 1.44 up HDGF2 
6550669 0.018916 1.31048 down 1.18 down  
5700189 0.016469 1.12207 down 1.31 up TCTN1 
3310181 0.047276 1.40644 up 1.43 up C6orf89 
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5560026 0.017027 1.2819 down 1.17 down GTF2IRD2B 
1010528 0.013215 1.03932 down 1.63 up HES1 
2940446 0.026527 1.07455 down 1.75 down TGM2 
3060224 0.005707 1.20636 down 1.11 down  
270050 0.014813 1.10151 up 1.1 down ECE1 
4210088 0.019305 1.15013 down 1.18 up CKS1B 
510632 0.033406 1.12039 up 1.13 down KLHL35 
730068 8.22E-04 1.37679 up 1.05 down JARID1A 
1260039 0.015872 1.18336 down 1.03 down THBS3 
2260068 0.013134 1.03253 down 1.1 up  
2260601 0.033446 1.1495 down 1.03 up  
6370639 0.035105 1.15364 up 1.3 up MINPP1 
2850494 7.84E-04 1.04873 up 1.18 down ATL2 
5340341 0.007371 1.29064 up 1.05 down PPIG 
2000767 0.006327 1.02285 down 1.39 down KLHL36 
2750446 0.026248 1.11743 down 1.69 down SNORD36A 
60634 0.042068 1.08939 up 1.22 down FAM18B 
2690519 0.023983 1.17506 up 1.13 down PRAME 
6590544 0.020717 1.14161 down 1.2 down CATSPER1 
1850041 0.02381 1.2169 down 1.02 down DPM2 
2570553 0.044138 1.19699 up 1.16 up LOC652615 
6420192 0.004612 1.12023 up 1.02 down LOC651012 
6560672 0.001294 1.12125 up 1.04 down HNRPR 
3890670 0.00592 1.29699 down 1.06 down DCAKD 
2140039 0.047677 1.11627 down 1.14 up GJB7 
4670520 0.01265 1.14508 up 1.03 up C16orf70 
5670136 0.04991 1.01729 up 1.43 up SLC39A3 
5260603 0.017935 1.20364 up 1.03 up FAM90A6P 
3180289 0.008758 1.05169 down 1.38 up ETV6 
6400465 0.015447 1.05361 down 1.11 up PTPN6 
240131 0.037937 1.0568 up 1.01 down  
5910291 0.005608 1.09686 down 1.72 down RASL11A 
670026 0.009408 1.26846 up 1.09 down CRLF3 
7050204 0.046092 1.21957 up 1.2 up KIAA1737 
830601 0.012174 1.0794 up 1.04 down ADAM30 
1570561 0.009907 1.2801 up 1.43 up FOXK2 
4590154 0.003701 1.0371 up 1.15 down ZDHHC8 
3940376 0.006782 1.39859 down 1.28 down SGK3 
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3190270 0.048034 1.02912 down 1.18 up  
4230059 0.032313 1.1231 down 1.13 down  
6760541 0.015309 1.06664 down 1.46 up TTC18 
1260538 0.026902 1.07054 down 1.09 up ATP6V1G2 
7510471 0.031374 1.17082 up 1.01 down LOC649151 
1110349 0.026396 1.02157 down 1.29 down C21orf57 
4850079 0.010214 1.11386 down 1.52 up WDR5 
5310368 7.08E-04 1.31269 down 2.88 up SPINK4 
3870753 0.015835 1.09384 up 1.18 up KCNG3 
1660358 0.007371 1.0751 down 1.04 up PRB1 
7610450 0.034765 1.0513 down 1.09 up RAD51L3 
1500246 0.011225 1.21854 down 1.14 up ARV1 
5670202 0.032531 1.37589 down 1.12 up TUBAL3 
5420731 0.035792 1.11976 down 1.39 up CNKSR3 
6660139 0.016692 1.24015 up 1.3 down KIAA1219 
630278 0.031043 1.09766 up 1.11 up H1F0 
3830470 0.029049 1.09212 up 1.03 down PLB1 
7400653 0.016271 1.03164 down 1.18 up PFKFB4 
7160192 0.022553 1.15128 down 1.29 down SLC17A8 
6840072 0.01964 1.2043 up 1.36 up PTEN 
4810053 0.031429 1.04948 down 1.31 down ANKRD13C 
5090097 0.045977 1.2896 up 1.04 up SYS1 
3170504 0.011856 1.23205 down 1.13 down HPS4 
290731 0.038116 1.05587 down 1.28 up POLD1 
1400474 0.014437 1.10788 down 1.46 up MYO1D 
6180678 0.00127 1.52217 down 1.06 up TMEM143 
6650630 0.037415 1.00094 up 1.42 up SESN2 
7200168 0.014328 1.00687 up 1.31 up PDGFRL 
6380338 0.019872 1.09022 up 1.17 up POLB 
6220170 0.041482 1.20208 down 1.47 down HTF9C 
6380239 0.025146 1.20758 down 1.34 down SGIP1 
2690446 1.81E-05 1.42572 down 1.3 down MYL4 
670010 0.006642 1.06293 up 1.12 down LOC650298 
1410189 0.047701 1.15938 up 1.01 up RWDD2B 
7570196 0.031254 1.41238 down 1.3 down TSPAN9 
2600048 0.001753 1.15732 up 1.02 up  
1240593 0.024631 1.17253 down 1.22 up CFLAR 
6660553 0.001194 1.14696 down 1.3 up INHA 
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1030367 0.019061 1.19586 down 1.01 up  
4280187 0.027324 1.10184 down 1.02 up JUB 
630167 0.029375 1.24802 down 1.48 down SDCBP 
5670333 0.042967 1.0194 down 1.24 up ROCK2 
5290717 0.015301 1.13927 down 1.43 down ZUFSP 
7200601 0.02589 1.56263 down 1.07 down MUC1 
7400537 0.010725 1.21991 down 1.03 up GSTT1 
1260086 0.003162 1.01508 down 1.51 down ID2 
3850398 0.008726 1.01641 up 1.81 down STX2 
5670528 0.016022 1.3705 up 1.02 up RFX3 
6760546 0.011714 1.1277 up 1.25 down TIPARP 
2680435 0.003375 1.32517 up 1.03 up MRPL1 
4610356 0.020309 1.06418 down 1.01 up FAM130A2 
3870095 0.009785 1.18011 up 1.35 down PTPN21 
1440754 0.008729 1.17837 down 1.37 up OPRL1 
4560022 0.003392 1.1655 up 1 up C2orf25 
7050546 0.042224 1.11061 down 1.38 down  
6220685 0.004786 1.07355 down 1.17 up C3orf1 
240524 0.01329 1.26011 up 1.08 up PHC3 
2510386 0.002755 1.07204 up 1.35 up WDR36 
5050047 0.021849 1.04745 down 1.08 up KIAA1967 
940647 0.010414 1.17918 up 1.07 up  
6200630 2.16E-04 1.078 up 1.19 down RBM22 
3990195 0.034788 1.23501 down 1.25 down LOC650921 
830364 0.017792 1.04064 up 1.35 up DMC1 
4070541 3.96E-04 1.04327 up 1.19 down  
5560010 0.029263 1.12361 down 1.07 down CPSF4 
5960327 0.044389 1.00914 down 1.12 up  
5050661 0.004544 1.16635 down 1.05 down LOC649905 
1170161 0.022161 1.19197 up 1.12 up  
1400446 0.010325 1.13856 up 1.5 down ADFP 
6220630 0.008997 1.12062 up 1.32 up SLC35B3 
1450504 0.042934 1.11386 down 1 down  
150100 0.04569 2.36372 down 3.76 down S100A3 
2120414 0.047499 1.00597 up 1.08 down  
5910138 0.030593 1.0475 up 1.02 up NGDN 
1410075 0.003617 1.0783 down 1.42 up WIPI2 
1340193 0.012114 1.3553 up 1.14 up DHX30 
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7040647 0.020022 1.01252 up 1.4 down SLC26A11 
3840767 0.001561 1.41473 down 1.44 up TSPAN7 
460010 0.003188 1.83024 down 1.36 up TSPAN7 
5700343 0.029107 1.31966 down 1.37 down BAIAP2L1 
6960209 0.044069 1.42554 up 1.08 up CBL 
2230603 0.019255 1.16991 up 1.07 up AP3B1 
6660010 0.004742 1.25732 down 1.73 down SNORD31 
3190524 0.041118 1.1627 down 1.17 down KNTC1 
6620441 0.015071 1.02712 up 1.17 up SDAD1 
770619 0.04141 1.04628 down 1.24 down STAM 
1450291 0.009538 1.09048 down 1.1 down FSD1 
2510221 9.14E-04 1.20241 up 1.15 up DKFZp686J0529 
1300497 0.024847 1.03189 down 1.16 up SPCS1 
1580338 0.013705 1.20753 up 1.01 down KIAA1267 
1850079 2.45E-04 1.61812 up 1.59 up KIAA1267 
4560246 0.01957 1.08687 up 1.19 down ATP5I 
5260605 0.004051 1.46829 down 1.11 down LOC400464 
650242 0.019494 1.12757 down 1.02 down FBXO36 
3170521 0.011966 1.19777 up 1.27 up  
5090754 0.001055 1.25223 down 1.34 down KIAA0101 
460050 0.039761 1.1322 down 1.18 down LOC388524 
1510044 0.012091 1.15002 down 1.05 down SLC27A4 
1440056 0.034393 1.04962 down 1.07 down  
4010152 0.008078 1.02335 up 1.06 down CNR1 
3440386 0.008121 1.35674 down 1.35 down ECM1 
1340593 0.034409 1.15405 up 1.02 up GPC3 
3190364 0.033207 1.16959 up 1.09 down MGA 
3890017 0.024325 1.22978 up 1.07 down CTNNA1 
3060307 0.025481 1.02576 down 1.25 down  
5490661 0.012869 1.06728 down 1.01 down LOC650475 
4480246 0.035315 1.03313 down 1.18 up HDLBP 
1990487 0.045795 1.10728 down 1.31 up XRN1 
4880333 0.014562 1.25462 up 1.42 down FLJ40504 
20241 0.028325 1.01147 up 1.22 up SLC7A1 
7210671 0.041166 1.0862 up 1.16 up  
60437 0.001441 1.16648 up 1.81 up PLOD1 
5130288 0.027164 1.36027 down 1.03 down YPEL1 
5810176 0.00233 1.19342 down 1.57 up RASSF5 
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520678 0.030924 1.1143 up 1.19 down CD53 
5690519 0.00332 1.33496 down 1.19 up PLTP 
7100753 0.002119 1.25974 down 1.55 up FOXD4L1 
2900725 0.025936 1.31573 down 1.14 down CYP27B1 
5340292 0.010335 1.03844 up 1.23 down LOC168474 
5270167 0.002552 1.01395 down 1.29 down GNL3 
4640100 0.031004 1.27319 down 1.05 down LOC644621 
4280041 0.011343 1.03518 up 1.12 up SSR2 
1820671 0.049292 1.00794 up 1.3 up C12orf39 
1430647 2.84E-04 1.08572 down 1.33 down TAX1BP3 
2100739 0.022898 1.01475 down 1.1 down  
1410601 0.00559 1.18897 up 1.12 up  
2810653 0.010944 1.1158 down 1.02 down PPIE 
5570110 0.011165 1.40012 down 1 up TRIOBP 
3440259 0.021413 1.16835 down 1.42 down BTBD7 
1070546 0.04584 1.00907 down 1.22 up AQR 
4290161 0.036233 1.22971 up 1.19 up TTC7B 
3390730 0.039316 1.09139 down 1.18 up DOLK 
1450156 0.002506 1.18704 down 1.13 up MAGOH 
50543 0.046755 1.11931 up 1.47 up  
5890349 1.26E-04 1.18851 up 1.01 up STAU1 
4860356 0.005265 1.01754 up 1.18 down BYSL 
620037 0.002261 1.29019 down 1.14 down  
5260270 0.004332 1.12402 up 1.17 up SERPINA13 
50619 0.036207 1.0159 down 1.08 up LOC728772 
6980296 0.041357 1.00504 down 1.19 down  
4010187 0.013408 1.0599 up 1.22 up UGCGL2 
4280692 0.015926 1.02477 down 1.22 up PARP1 
610315 0.043593 1.30737 up 1.19 up TMEM38B 
7550243 0.031365 1.32071 up 1.1 down TMEM38B 
4390066 0.038666 1.03015 up 1.07 down LIN37 
7510128 0.048786 1.21807 down 1.03 up CT45-4 
6480594 0.011421 1.18407 down 1.23 down  
4280035 0.002814 1.10817 up 1.13 up DKFZP781G0119 
6370068 0.00844 1.13531 down 1.24 down GNL1 
4570333 0.044714 1.10381 up 1.13 down YARS2 
1010181 0.001669 1.33152 up 1.81 down SAMD8 
2810132 0.034814 1.03691 up 1.1 down  
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3060703 0.038782 1.26606 down 1.23 up LOC81691 
6760040 0.018276 1.22149 up 1.11 up LOC646109 
4590446 0.038829 1.11403 up 1.19 down MSL3L1 
4010139 0.02605 1.08338 up 1.22 up BANK1 
2100541 0.019707 1.10178 up 1.08 down  
2970619 0.020414 1.19581 down 1.04 up ESPL1 
1990253 0.006746 1.11829 down 1.32 down TDG 
3940114 0.025693 1.08322 up 1.05 up  
3180653 0.007246 1.13743 up 1.24 down SON 
580438 0.020013 1.16748 down 1.04 down LOC642879 
2940767 0.001192 1.15609 down 1.07 up CEBPE 
4480592 0.036076 1.19303 down 1.01 down CHMP6 
6100324 0.02016 1.28078 up 1.2 up TMEM126B 
2480100 0.030902 1.19361 up 1.08 up MGC13057 
510129 0.030736 1.24574 down 1.47 down AP4B1 
830593 0.039619 1.18908 up 1.2 down VIM 
7050019 4.73E-04 1.48127 up 1.26 down VIM 
1450403 0.018077 1.04751 up 1.32 up TMEM129 
2100148 0.015742 1.02216 down 1.07 up  
4850440 0.009278 1.05566 down 1.62 down HEATR3 
1510609 0.04206 1.16792 up 1.07 down NME1-NME2 
6130370 0.031572 1.10446 down 1.01 up CCDC82 
3140138 0.03383 1.22088 down 1.26 down C12orf47 
6200647 0.016234 1.00396 down 1.15 down IBTK 
3130458 0.018006 1.0625 up 1.01 up AFAP1 
2750538 0.028838 1.09321 down 1.12 down LOC642637 
4390288 0.025201 1.09625 up 1.14 down TH1L 
7570152 0.040798 1.11583 up 1 up  
6580544 0.005274 1.1689 down 1.21 down LOC644774 
6840156 0.030355 1.01281 up 1.33 up GMDS 
7150168 0.026572 1.06653 down 1.2 up RBM8A 
2350762 0.009441 1.10449 up 1.56 down C12orf5 
1070762 0.015986 1.04228 down 1.26 up PSRC1 
4560711 0.005822 1.05332 down 1.07 up RBM19 
4810435 0.001709 1.15983 down 1.11 up SCARB2 
1510161 5.88E-04 1.35167 down 1.43 down PAEP 
6290475 0.037651 1.53292 up 1.15 up HECW2 
6060326 0.046152 1.10872 up 1.22 up ZNF295 
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2810017 0.001222 1.12533 down 1.03 up  
2060338 0.014011 1.04171 up 1.11 up C8orf47 
6560736 0.039567 1.1105 down 1.06 down LOC643672 
2970070 0.035924 1.14955 up 1.04 down OPCML 
3420692 0.040581 1.01506 down 1.11 up C5orf15 
270228 0.001312 1.15229 down 1.07 up ZNF311 
20750 0.005724 1.12604 down 1.46 up STAR 
1770519 0.048139 1.01061 up 1.15 up PDRG1 
4890634 0.021818 1.07503 down 1.24 down CLSPN 
5720746 0.002849 1.12783 down 1.06 up CDV3 
3130356 0.003442 1.03013 down 1.12 up CDV3 
4730148 0.022766 1.2085 up 1.03 down KTN1 
6620053 0.02261 1.28561 down 1.14 down LOC649431 
1300025 0.033348 1.1244 up 1.06 up C3orf60 
240437 0.028513 1.06876 down 1.25 down CICE 
3710564 0.044321 1.09369 up 1.13 down FLCN 
4280189 0.037845 1.18524 up 1.02 down  
2510671 0.047939 1.02224 up 1.03 up  
2340491 0.022653 1.26401 down 1.21 down FLJ30058 
5550500 0.001787 1.07551 up 1.15 up MXRA7 
7610189 0.007423 1.08133 down 1.24 up ZNF706 
6960463 0.033089 1.18391 up 1.07 up LOC647540 
7510079 0.003962 1.52896 down 1.15 down CETP 
5080324 0.005367 1.19106 up 1.07 up  
5420358 0.008554 1.3398 down 1.14 up CD99L2 
1440014 0.026415 1.10257 up 1.05 down MYO5B 
4610670 0.008112 1.01633 up 1.39 up EPB49 
4640240 0.035866 1.02728 up 1.68 up CALB1 
1190075 0.034424 1.09429 up 1.15 down RPP38 
360379 0.035264 1.10866 up 1.17 up VIP 
620292 0.00904 1.11163 down 1.32 up ZNF594 
20403 8.32E-04 1.14218 up 1.22 down TOR1AIP1 
6900079 0.001886 1.40854 down 1.39 down PCNA 
1230523 0.010603 1.06112 up 1.17 up COMMD3 
7040286 0.007747 1.38021 down 2.31 down ACSL5 
3120609 0.003613 1.18105 down 1.15 down PPOX 
4860341 0.009857 1.35242 down 1.01 down C18orf24 
4860093 0.015546 1.06359 down 1.01 up LOC653888 
143 
 
7040360 0.046259 1.02863 up 1.19 down LOC643598 
4880397 0.032833 1.13162 up 1.2 down ZBTB17 
5560246 0.040309 1.05922 down 1.21 up TPM1 
5050575 0.043926 1.23354 down 1.06 up ASB13 
360673 0.016613 1.06328 up 1.31 up SNX19 
4830110 0.018896 1.19417 up 1.1 up KRTAP12-2 
3180537 0.046842 1.12713 up 1.05 up CBX2 
2070403 0.003411 1.0264 down 1.32 up CABLES2 
1010082 0.013531 1.70194 down 2.31 down  
4220575 0.006841 1.01114 down 1.18 up TSHR 
2000040 0.011388 1.21036 up 1.13 up LOC642765 
6620176 0.045771 1.38648 up 1.18 up GTPBP8 
4050719 0.003423 1.05202 up 1.29 up ZNF71 
6660673 0.005363 1.27375 up 1.01 up WAC 
3360451 0.027018 1.30095 up 1.15 up BANP 
6180274 0.031059 1.02796 up 1.05 down LOC645349 
1090523 0.031493 1.08934 down 1.15 up RYK 
2230148 0.025863 1.04611 up 1.18 up WDR7 
5360156 0.016026 1.14175 up 1 down IFITM1 
7200156 6.73E-04 1.19153 down 1.91 up ITGB2 
7050440 0.009793 1.05702 down 1.29 up ADRB1 
4730682 0.017674 1.25862 up 1.03 down EXOC3 
3450138 0.012471 1.30156 up 1.05 up CTSC 
5260239 0.025629 1.0259 up 1.12 down CDV3 
840292 0.003193 1.1577 up 1.33 down RBM15 
4050626 0.021506 1.02928 up 1.08 down TBL1Y 
5260403 0.024542 1.08021 up 1.12 up ST3GAL5 
5670400 0.012739 1.16286 up 1.16 up PEPD 
5080326 0.005821 1.01378 up 1.15 up PSMA6 
5490730 0.049023 1.17913 down 1.12 up BTF3L4 
1710066 0.011356 1.10378 up 1.02 up C2orf66 
3890176 0.017055 1.14158 up 1.26 up EIF4EBP1 
450278 0.024841 1.07638 up 1.04 down RAB11FIP1 
4830382 0.015217 1.1808 down 1.05 up CPEB2 
4590424 0.004456 1.20688 up 1.14 up PDCD2L 
6760110 0.005727 1.14043 down 1.07 up FANCL 
4570100 0.005038 1.11279 down 1.28 down LOC283050 
6450465 0.009945 1.0651 up 1.13 up LOC646951 
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2690521 0.003712 1.10214 up 1.3 down  
1410706 0.02447 1.27005 down 1.15 down IKIP 
2510220 0.009526 1.13036 down 1.3 up IFI35 
6370243 0.015178 1.03511 up 1.03 up CCDC7 
1710204 0.021249 1.081 up 1.46 up ADAT1 
110451 6.25E-04 1.1267 up 1.47 up SSR1 
4920189 0.035444 1.1769 down 1.18 up C18orf54 
5490358 0.018929 1.05992 down 1.18 up L1TD1 
2060037 4.70E-04 1.17409 up 1.79 down ZBTB43 
6400176 0.001597 1.15043 down 1.61 down IRF7 
6590451 0.020241 1.16248 up 1.07 up CLEC7A 
4760709 0.015957 1.12397 down 1 down LOC643422 
6420524 0.005254 1.00236 down 1.11 up  
6960470 0.012505 1.16575 up 1.08 down  
2570112 0.004034 1.5131 down 1.49 down ABLIM1 
780113 0.049504 1.25816 up 1.05 up  
2630176 0.012185 1.05048 up 1.26 up MAPT 
60139 0.034585 1.13958 up 1.18 up  
2570100 0.034515 1.21769 down 1.21 up ABCA7 
1500470 0.043066 1.04233 up 1.05 down MED25 
2100373 0.044366 1.16835 down 1.12 up DUSP5P 
4570347 0.010176 1.1744 up 1.12 up  
3460148 0.037313 1.14015 up 1.08 up UBE2D3 
1340142 0.019683 1.14508 up 1 up  
6770243 0.024576 1.15754 up 1.11 down ATE1 
3520427 0.028571 1.45121 up 1.18 down ATE1 
6200242 0.026621 1.0476 down 1.31 up NLK 
270487 0.030063 1.18918 down 1.02 up SH2D3C 
520189 0.004103 1.33008 up 1.77 up HYOU1 
6380048 0.027123 1.25112 up 1.33 down RNF217 
4290543 0.035742 1.03816 up 1.37 down TXN 
2100735 0.024922 1.59821 up 1.08 down ATF2 
3460491 3.13E-04 1.134 up 1.26 down LSM12 
380026 0.002276 1.47143 down 1.22 down C1orf116 
2190519 0.022901 1.15032 up 1.05 up ICAM4 
7400661 0.026112 1.27213 up 1.14 up  
6370392 0.009974 1.19918 up 1.01 down DDX31 
2640528 0.010164 1.02558 down 1.13 down C16orf35 
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6040537 0.021076 1.23546 down 1.01 down DIABLO 
7050626 0.009583 1.25305 up 1 down PCNX 
7050735 0.012858 1.19076 up 1.06 up MSX2P1 
2710187 0.003157 1.12629 down 1.64 down ATXN7L2 
730487 0.011076 1.24873 down 1.02 up RARS2 
4610687 0.030334 1.15031 up 1.26 down CEPT1 
1780348 0.049158 1.04407 up 1.15 down FH 
3850131 0.01179 1.05962 down 1.17 down YWHAQ 
2630372 0.001062 1.09864 down 1.24 up  
1240471 0.014085 1.14071 up 1.19 up CDKL3 
7150068 0.001504 1.22706 up 1.8 down HDAC9 
3990605 0.035063 1.11656 up 1.28 up DET1 
1030364 0.044961 1.1183 up 1.06 down NDFIP2 
4490332 0.034861 1.25968 up 1.06 up PRR8 
6350189 0.020489 1.12588 down 1.17 down MGC4677 
3390068 0.024917 1.06275 down 1.32 down E4F1 
6660626 2.98E-04 1.03626 down 1.39 up BRD3 
3940551 0.019582 1.11678 down 1.22 down HARS 
610504 0.047875 1.15846 up 1.03 up  
5900612 0.005133 1.07201 down 1.2 up ZNF32 
6110053 0.039045 1.07233 up 1.18 up ZNF32 
5900240 0.041218 1.15986 up 1.14 up MRPL18 
5560370 0.030079 1.1286 down 1.26 down MGC3207 
4860402 0.007788 1.05413 up 1.19 down MGC3207 
5960528 0.027612 1.09264 up 1.22 down FAM108B1 
3520465 0.023366 1.14454 down 1.14 down  
3290575 0.02534 1.08108 down 1.14 up C21orf87 
540703 0.001378 1.20134 up 1.01 up RFESD 
2640114 0.04917 1.10557 up 1.18 down NECAP1 
4050010 0.012746 1.00275 down 1.14 up FLJ42709 
5900524 0.046521 1.04728 up 1.08 down LACTB 
6550601 0.036732 1.05169 up 1.13 down  
3370326 0.026568 1.26558 up 1.47 up IL18R1 
4290288 0.033588 1.08356 up 1.1 up COLQ 
6130630 0.044825 1.2968 down 1.2 down PRR5 
4060064 0.018365 1.11344 down 1.65 up HMMR 
4920730 0.017255 1.06725 up 1.23 down FAM91A1 
6110367 0.034458 1.13559 down 1.46 down PIGL 
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5670187 0.014441 1.1349 down 1.17 down 
DKFZp686O2416
6 
5050707 0.037164 1.25551 down 1.16 up ANGPTL6 
5340544 0.036053 1.04645 up 1.07 up  
5670114 0.040628 1.36131 down 1.12 down TTC32 
7040372 0.004572 1.1365 up 1.05 down GPAM 
2850048 0.01342 1.00753 up 1.07 down SPZ1 
5080192 0.003668 1.25494 down 1.21 up SERPINE2 
2510731 0.0105 1.09553 up 1.29 up OGFOD1 
3400138 0.033094 1.09102 up 1.09 up CASC4 
5550279 0.008641 1.01855 up 1.08 down ENTPD1 
2120152 0.003018 1.8238 down 1.36 down SLC4A1 
3800041 0.043639 1.17715 up 1.3 up RCOR3 
6840039 0.03756 1.00889 up 1.16 up C9orf100 
4920066 0.033276 1.95712 up 1.47 up SFMBT2 
5720598 0.010416 1.23116 up 1.05 up MYO1B 
3370278 0.020432 1.25433 down 1 down PARD6G 
2510201 0.015917 1.47711 down 1.34 up ESPNL 
5860066 0.004038 1.07624 down 1.2 up NMT2 
650626 0.012686 1.18982 down 1.05 down C16orf68 
7550626 0.019466 1.14413 down 1.28 up BIRC5 
6350446 0.002352 1.19277 down 1.48 up TSC22D3 
1850021 0.04497 1.22062 up 1.01 up SLC25A43 
3120292 0.005132 1.11179 up 1.44 up ALS2CR13 
4890270 0.001117 1.35374 down 1.9 up LY6E 
1770433 0.045887 1.00072 down 1.15 down YWHAG 
4730520 0.028268 1.00092 down 1.07 down MYCBPAP 
6060451 0.044881 1.13522 down 1.04 down SDCCAG3 
4590753 0.040635 1.07522 down 1.11 down  
5220289 0.006703 1.00297 up 1.12 up MEI1 
5490706 5.34E-04 1.05453 down 1.01 up  
2350288 0.025989 1.11626 up 1.02 down  
6620670 0.020104 1.10399 down 1.3 down WDR75 
7000577 0.029217 1.04224 up 1.42 up GYPC 
7210398 0.016618 1.08976 up 1.43 up GYPC 
4010343 0.003526 1.36194 up 1.03 down TYW3 
1010161 0.002435 1.14761 up 1.14 down ARL4A 
1440259 0.014961 1.25094 down 1.29 up PCM1 
5700088 0.008564 1.18355 down 1.18 down KLF11 
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3360731 0.019141 1.15494 down 1.18 down KLF11 
160181 3.26E-04 1.17217 down 1.07 up FOXRED2 
7210278 1.69E-04 1.09237 down 1.27 down RBM11 
6450543 0.001177 1.04622 down 1.51 up CST3 
7040544 0.031015 1.07816 up 1.19 up CCDC53 
6960139 0.006397 1.14803 up 1.21 up LOC648972 
1820341 0.018331 1.45591 up 1.15 up INTS6 
3190452 0.034973 1.00982 up 1.21 up DNAJB11 
1090152 0.04574 1.03411 down 1.12 up  
6270475 0.016898 1.06076 up 1.23 down DUS3L 
3290564 0.002647 1.55115 up 1.13 down AKAP12 
4890487 0.027116 1.24633 down 1.16 up B2M 
1400240 0.034909 1.1269 up 1.03 up LDHB 
840463 0.002567 1.04738 up 1.14 up  
380079 0.037049 1.36613 up 1.05 up SPATA7 
2000441 0.024306 1.28016 down 1.19 up PERLD1 
4730605 1.33E-04 1.06481 down 1.28 up AURKA 
3460474 0.01907 1.3163 down 1.28 down ASIP 
2900338 0.036733 1.23395 up 1.31 up GAS2 
7380372 0.043365 1.10331 up 1.38 up ZMYM4 
6180114 0.009154 1.02517 up 1.28 down DCDC5 
6420736 0.005967 1.34927 down 1.23 up DNAJC12 
7650224 0.03404 1.16083 up 1.11 up OR51I2 
830379 0.014011 1.16515 down 1.19 down MRPS11 
5860626 0.00312 1.21285 down 1.2 down MRPS11 
4480753 0.0346 1.14467 up 1.07 down LOC220686 
4050376 0.013047 1.02086 down 1.5 up GYPE 
2120097 0.037249 1.32073 down 1.1 down CHAF1A 
3800768 0.04867 1.51198 up 1.11 up SCN9A 
2970441 0.008261 1.10072 up 1.05 down  
5390706 0.041489 1.08601 down 1.16 down  
4280600 0.010621 1.08094 up 1.09 up  
1240243 0.010172 1.00541 up 1.62 down ATL3 
6860228 0.008552 1.3461 up 1.11 down C5orf41 
2900477 0.014351 1.1199 down 1.08 up MED9 
7380100 0.006212 1.12608 up 1.93 down MCL1 
7400053 0.041616 1.22078 down 1.15 up SLC22A18 
1260427 0.049713 1.01086 up 1.14 down LOC392145 
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3130296 0.020732 1.09943 down 1.26 up AMY2A 
4280113 0.010052 1.20972 down 2.87 down NFKBIA 
3830563 0.001947 1.19518 down 1.39 up EFHC2 
770239 0.023231 1.00489 up 1.09 up HM13 
3370164 0.008691 1.1452 up 1.02 down ATP1A1 
60553 0.03299 1.01268 up 1.27 up NDFIP1 
6280341 0.015722 1.08641 down 1.36 down PTS 
4050437 0.016224 1.01247 up 1.61 down PTS 
3310131 0.048631 1.06486 up 1.06 down  
5960471 0.004442 1.12545 down 1.17 up BCL9L 
1850482 0.006235 1.18088 down 1.08 down TNK2 
7550722 0.020982 1.05324 down 1.09 up ZMYM6 
3450056 1.71E-04 1.18476 down 1 down KIAA0495 
4250364 0.01983 1.10838 up 1.44 up HPGD 
670673 0.037678 1.05461 down 1.35 up BCL2L1 
3800711 0.04479 1.2713 up 1.14 up PCGF5 
160242 0.041743 1.36765 down 1.49 down C13orf15 
2070349 0.023308 1.01678 down 1.2 down SNRPB 
3190379 0.008799 1.22553 up 1.38 down TGFBR3 
2650678 0.022531 1.07547 down 1.29 down RSPH3 
4810709 0.039805 1.14628 up 1.29 down CSNK2A1P 
1170537 2.77E-04 1.11463 down 1 up CREB5 
5050202 0.012476 1.26144 down 1.32 down XGPY2 
3850689 0.04754 1.15783 up 1.11 up  
1780735 0.028028 1.10663 up 1.03 down C12orf67 
1580402 0.001862 1.06891 up 1.31 up SLC35B2 
2480075 0.006131 1.2067 down 1.39 up ATF7IP2 
5090632 0.019703 1.17728 down 1.01 up LGALS9 
4810497 0.009298 1.78717 down 1.23 up DMKN 
3170274 0.003006 1.40155 up 1.3 down OSBPL8 
7560768 0.045419 1.06454 down 1.07 up  
3890048 9.37E-04 1.2705 up 1.08 up INOC1 
5360148 0.012673 1.1894 up 1.01 up LIPA 
2340626 0.01005 1.07913 up 1.23 down TFB1M 
5700520 0.010438 1.16964 up 1.09 down PRMT5 
5080039 0.040916 1.21107 down 1.2 down  
2600431 0.014941 1.15492 down 1.32 up SLC43A3 
2510209 0.049402 1.12341 up 1.04 up KDELR1 
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3940711 0.013753 1.01563 down 1.06 up B3GALT3 
240152 0.009395 1.27298 down 1.08 up MGC57346 
2630711 0.007113 1.41589 down 1.43 down MCM4 
540368 0.017059 1.62825 up 1.43 up GAB2 
2470543 0.042737 1.24349 down 1.02 up  
2970025 0.037815 1.13504 down 1.02 down SEPW1 
5360390 0.014383 1.19071 down 1.13 down C8orf37 
3060347 0.02676 1.05439 down 1.2 down TTC4 
5360524 0.002396 1.1428 up 1.21 down CACYBP 
5910093 0.014571 1.11843 down 1.19 up PCDH10 
6940678 0.025337 1.02057 up 1.26 down LOC653972 
6220441 0.010265 1.23105 up 1.27 down CISD1 
20392 1.81E-04 1.33008 up 1.13 down CISD1 
4850180 0.036774 1.24945 down 1.18 down LYVE1 
5260215 0.008132 1.19108 down 1.23 up OPTN 
1190138 0.022825 1.21313 down 1.35 up TXK 
3140441 5.19E-04 1.17761 down 1.45 up AK2 
4230671 0.044399 1.17416 down 1.01 up SLA2 
5900187 0.002429 1.05771 down 1.24 down HUS1B 
5340332 1.84E-04 1.13386 up 1.63 up LOC729101 
4880750 0.047152 1.18148 up 1.28 down SOCS5 
2360364 0.005514 1.02149 up 1.17 up LOC440356 
2000747 0.004892 1.06612 up 1.73 up CYP2F1 
60630 0.003894 1.36613 down 1.72 down GLA 
3360750 0.006384 1.33205 up 2.11 up GPR98 
1770546 0.044136 1.10785 up 1.07 up ATIC 
1190609 0.024255 1.01722 down 1.24 down MORG1 
240392 0.010915 1.03522 down 1.07 up  
4640142 0.022985 1.22655 down 1.2 down STK19 
4260612 0.021671 1.25498 down 1.28 down STK19 
50301 0.026452 1.21735 up 1.09 up EEF1E1 
4730619 0.039699 1.26599 up 1.23 up CNOT6L 
510725 0.026458 1.04895 up 1.21 down NDUFA10 
6220722 0.002684 1.22754 down 1.2 up MSRA 
1400427 0.002706 1.16928 down 1.32 up KCNG1 
3440491 0.002062 1.23667 down 1.33 up GALC 
2030441 0.016769 1.26036 up 1.06 down SPATS2 
620692 0.025024 1.11765 down 1.04 down SLC25A42 
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10747 1.79E-04 1.03154 down 1.85 up DOCK2 
5310066 0.045273 1.04376 up 1.08 down  
510612 0.024337 1.1005 down 1.3 up RNF208 
2340521 0.020457 1.08809 up 1.3 up C17orf61 
5080162 0.046926 1.09719 up 1.16 down KTN1 
3290612 0.0351 1.11465 down 1.06 down KIAA0565 
4900193 0.005249 1.15095 up 1.28 up ZCCHC7 
2480731 0.047194 1.02641 down 1.25 down NARG2 
540221 0.005231 1.22668 up 1.25 down NOL1 
2140291 0.044926 1.18963 down 1.16 up MMAB 
6660369 0.047748 1.02441 up 1.1 up GCNT2 
7200735 0.040262 1.09099 down 1.07 down GCNT2 
6660377 0.021538 1.29964 up 1.2 up THOC2 
650372 0.018546 1.14914 up 1.07 up UBE2Z 
130022 0.005491 1.33685 down 1.02 down CDCA5 
940706 0.015497 1.11431 down 1.22 up AP1S2 
2750133 9.88E-04 1.18858 up 1.06 down ZNF26 
2570328 0.005478 1.13553 up 1.66 up TRIB2 
1850086 0.032888 1.02136 down 1.1 down  
2710546 0.015625 1.11313 up 1.14 up COG4 
2760750 0.026367 1.01953 up 1.19 up ZNF556 
3460167 7.80E-04 1.164 up 1.6 up NAP1L1 
4480017 0.003214 1.02951 down 1.31 up SLC22A15 
5420309 0.011962 1.1163 down 1.31 up AURKA 
5050338 0.024223 1.06335 up 1.05 up FFAR3 
6900241 0.002527 1.57112 down 1.22 down ABCB9 
5290598 0.001543 1.23796 down 1.11 down ABCB9 
270524 0.005027 1.27521 up 1.25 up P15RS 
4390193 0.042052 1.08156 down 1.41 up CPZ 
5870072 0.019587 1.12872 down 1.2 down FLJ13305 
3400747 0.047846 1.48996 up 1.19 up LEPR 
1510170 0.033325 1.26333 down 1.17 down NLRP2 
2630161 0.033326 1.18002 up 1.12 down NOL11 
3520040 8.80E-04 1.27661 up 1.32 up YARS 
1510746 0.009971 1.15491 up 1.35 up BET1 
70044 0.001692 1.03128 up 1.23 up JTB 
2070367 0.04052 1.11046 down 1.49 down SERTAD2 
3360743 0.034243 1.05239 down 1.2 up NUDT6 
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2320392 0.03912 1.35486 down 1.02 up C12orf65 
60438 0.031451 1.09757 up 1.16 up FLJ20397 
2630224 0.030516 1.36492 down 1.1 up LOC93622 
3460356 0.037064 1.11816 down 1.19 down ADAMTSL5 
6130615 0.002508 1.2285 down 1.2 up PARP3 
6250546 0.004394 1.62113 down 1.39 down ARHGEF19 
5820600 0.006323 1.16325 down 1.16 up REEP6 
450161 0.035617 1.04941 up 1.16 down FAHD1 
3610228 0.033698 1.00204 down 1.47 down PEA15 
3610553 0.00333 1.12026 down 1.19 up GUSB 
5260014 0.01494 1.01087 down 1.3 up CDKN3 
4120047 0.009281 1.19545 down 1.22 up  
4220242 0.004203 1.06285 up 1 down FLJ38377 
2710520 0.015484 1.03347 down 1.22 up ATPBD4 
1340408 0.001774 1.02194 up 1.07 down UGT1A7 
4760669 0.019954 1.08704 up 1.08 up ZNF613 
3800706 0.004458 1.28603 down 1.25 down TM4SF19 
150162 0.00395 1.62467 down 1.33 down FNDC4 
130646 0.033652 1.01877 down 1.15 down RALGPS2 
7040670 0.015313 1.02854 down 1.38 up DHRS3 
160397 0.014489 1.10592 down 1.11 up CSPG5 
2450315 0.037953 1.1582 down 1.14 down  
4180372 0.030131 1.10806 down 1.28 up  
5390056 0.024909 1.26941 up 1.18 down RIOK1 
1440064 0.036107 1.06243 up 1.01 down  
7150615 0.018876 1.12896 up 1.09 down  
2970440 0.011299 1.01358 up 1.04 down  
5700162 0.013837 1.31812 up 1.02 down ZCCHC16 
2190523 0.018902 1.23938 up 1.01 down FRMPD2 
240025 0.025394 1.124 up 1.48 up CNPY3 
7510367 0.003017 1.26482 down 1.11 up GPR160 
110431 0.01099 1.16142 down 1.56 down KRT18 
5220086 0.033842 1.41436 up 1.26 up  
6100717 0.040486 1.16461 up 1.12 up SLC7A14 
4830687 0.035415 1.07822 down 1.2 up BCAS3 
7200044 0.004369 1.27826 down 1.19 up SH3BGRL2 
450468 0.002343 1.33806 up 1.21 down MRPL44 
1660356 0.005333 1.03893 down 1.1 up SERPINB10 
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130037 0.024693 1.22566 down 1.31 down PHF5A 
70598 0.035308 1.08929 up 1.02 up  
1500491 0.001565 1.0863 down 1.3 up PDE6D 
1070370 0.022587 1.14469 up 1.03 down LOC653641 
2900047 0.025015 1.08426 up 1.23 up C7orf11 
1690240 0.012038 1.04944 down 1.23 up C5orf4 
3610414 0.002132 1.06939 down 1.15 up TADA3L 
5670440 2.78E-04 1.08037 down 2.83 down TNFRSF9 
730482 0.035535 1.45672 up 1.44 up IKZF1 
1260465 0.029898 1.10447 down 1.1 down OR4F4 
7200392 0.042462 1.20541 up 1.02 up C1QBP 
1710477 0.034982 1.1669 down 1.1 up FLJ42957 
3180521 0.003132 1.04351 down 1.5 down SPRYD3 
130048 0.00782 1.25829 up 1.09 down KIAA1958 
4150193 7.04E-04 1.20225 down 1.43 up CD47 
3130196 0.02843 1.14258 down 1.08 up KCTD15 
4670092 0.020152 1.20577 up 1.09 down TRAP1 
990161 0.020033 1.17814 down 1 down CDIPT 
5420152 0.038579 1.22984 down 1.14 down AMHR2 
2190717 0.004573 1.34818 down 1.7 down IL18BP 
5960343 0.044001 1.26941 down 1.4 down PRIC285 
6280059 0.042461 1.19786 up 1.39 up PPM1E 
5570767 0.036814 1.28476 up 1.29 up PPP2R1A 
5910095 0.038103 1.07017 down 1.23 up CCDC115 
60703 0.026604 1.32274 up 1.21 up RELL2 
70243 0.043798 1.22871 up 1.23 up C19orf29 
7400543 0.007247 1.0193 down 1.1 up LOC647471 
1940465 0.018287 1.05892 down 1.04 up AGER 
4830685 0.024452 1.09635 down 1.22 up FBLN1 
730440 0.034096 1.02481 up 1.25 down RELB 
2690201 0.04872 1.11415 up 1.08 up OR8D1 
4730403 0.001654 1.60954 down 1.41 down HMBS 
580692 0.027134 1.34831 down 1.2 down ID1 
20296 0.010267 1.08326 down 1.09 up C4orf15 
4560672 0.025745 1.19547 up 1.14 up ENPEP 
2490066 3.64E-05 1.04647 down 1.56 down CD2BP2 
4120037 0.010418 1.43967 up 1.02 up CBL 
2030349 0.033253 1.07405 up 1.17 up BOLL 
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6200014 0.008397 1.24639 down 2.17 down ZNF165 
5090215 0.001495 1.66391 down 1.22 up IFI6 
3190246 1.18E-04 1.29517 down 1.32 up CHN2 
2750593 0.026419 1.19247 down 1.13 up LOC344595 
4200474 0.015012 1.01284 down 1.24 down WRNIP1 
4280735 0.006869 1.01688 up 1.24 down CASP9 
1430114 0.034005 1.16515 up 1.23 down NAPG 
4280092 0.009847 1.32277 down 1.3 down SPANXA1 
7330368 0.006189 1.09026 down 1.11 up QRICH2 
4220070 0.03767 1.15393 down 1.3 up C8orf44 
3460184 0.046217 1.17916 up 1.01 down C19orf53 
130386 0.025698 1.27051 up 1.09 down TNRC6A 
5050528 0.024469 1.09125 up 1.07 up KIAA0738 
7400133 0.006195 1.20142 up 2.12 up CUGBP2 
4150553 0.00226 1.10561 up 1.16 down TAF13 
3190731 0.017013 1.00177 down 1.24 up WDR78 
60349 0.013156 1.50192 down 2.33 down MAPK13 
6280189 0.039595 1.17364 down 1.31 down HPS4 
5720424 0.013574 1.02821 down 1.2 up NRP1 
7050131 0.032854 1.16767 up 1.04 down ATP6V1A 
4120707 0.013288 1.23386 up 1.1 down COL4A3BP 
4590070 0.01766 1.13073 down 1.01 up NHSL2 
5260196 1.80E-04 1.2955 down 1.31 down BCL7C 
5270315 0.014203 1.20083 up 1.04 up WDR12 
4850674 4.12E-04 1.64281 up 1.97 up PSAT1 
4560671 0.002767 1.04269 up 1.43 up SLC39A3 
1230386 0.001977 1.12957 down 1.17 down MIER1 
4760035 0.034092 1.26569 down 1.14 down  
20170 0.016159 1.13478 down 1.26 up ZNF385A 
830619 0.02663 1.33159 up 1.05 down DDIT3 
6980382 0.005842 1.18424 down 1.07 up GTSE1 
2230619 0.00267 1.30553 up 1.39 down HIST1H4E 
3520278 0.013376 1.03373 down 1.24 up GALK1 
4060576 0.029327 1.34841 up 1.06 up SLC35D2 
4900338 0.011433 1.14072 up 1.4 up C7orf13 
70142 0.002745 1.20852 down 1.19 up NR5A1 
4560450 0.008019 1.16481 down 1.38 down E2F7 
4670209 0.034828 1.21891 up 1.01 up  
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5090026 2.01E-04 1.42068 up 3.6 up COL15A1 
4280523 0.03401 1.09302 down 1.02 down CD200R1 
2600136 0.03598 1.0375 down 1.6 down LOC143666 
6020086 0.043798 1.07356 up 1.05 down  
7050292 0.012258 1.12895 up 1.02 down  
6510220 0.029307 1.13176 up 1.19 up LOC650407 
4230609 0.019358 1.16848 up 1.03 up ARSD 
7560463 0.034997 1.0776 down 1.12 down  
3170037 0.031826 1.4815 down 1.4 down  
6280609 0.022081 1.11585 up 1.17 up TSGA14 
6370288 0.012445 1.15305 up 1.17 down C17orf68 
2350228 0.024177 1.059 down 1.15 up WDR5B 
5550240 0.035582 1.0769 up 1.21 down ZNF675 
4730040 0.010371 1.08294 up 1.34 up LOC642255 
3140612 0.043382 1.29289 up 1.04 up  
20692 0.03422 1.24765 up 1.12 down HINT3 
7150291 0.021819 1.2145 up 1.01 up TRMT2A 
4120386 0.002222 1.38175 down 1.34 up PCOLCE 
4280228 0.024862 1.06689 down 1.47 up IVNS1ABP 
2450133 0.003921 1.00729 up 1.13 up  
5270112 9.74E-04 1.14413 up 1.23 down HMGCS1 
5690279 0.0151 1.48917 up 1 down FARS2 
4070689 0.030721 1.15313 down 1.21 down  
6650156 0.047974 1.15586 up 1.08 up LOC440607 
3450403 0.029108 1.09635 up 1 down OCLM 
7040368 0.039233 1.05827 down 1.07 down RNF12 
1340605 0.016414 1.04761 down 1.15 down LOC644766 
4850739 0.013572 1.13024 up 1.05 up MBTPS2 
2900133 0.046695 1.16924 down 1.16 down LOC646631 
3060722 0.022474 1.00059 up 1.1 down DAXX 
650605 0.005908 1.34327 up 1.05 down LOC388789 
1050674 5.01E-04 1.07363 down 1.11 down  
7560661 0.025925 1.15388 down 1.41 down UBE2L3 
6100736 0.011935 1.02043 up 1.09 up  
6250154 0.017649 1.09362 up 1.31 up LZTFL1 
3930253 0.005141 1.02229 down 1.32 up ZNF12 
5090044 0.027681 1.0055 down 1.31 down TFG 
5550133 0.018408 1.19507 up 1.05 down TFG 
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1090564 0.035673 1.26568 down 1.09 down TMEM175 
3440689 0.041842 1.15624 down 1.44 down ACYP1 
5910148 0.004566 1.07861 down 1.37 down ACYP1 
5870228 0.006868 1.00657 down 1.17 up ADSL 
7040397 0.006296 1.17461 up 1.15 up PRRC1 
7050674 0.039025 1.10055 down 1.17 down LOC643596 
610152 0.001356 2.38455 up 1.07 up DAB2 
630079 0.019374 1.09042 up 1.16 up  
450092 0.045193 1.10223 down 1 up WIPF2 
7650017 0.003088 1.08172 up 1.93 up SERPINH1 
4590477 0.005435 1.22793 down 1.2 up MAP4K1 
870747 0.035572 1.03793 down 1.55 down LOC644964 
1470184 0.038753 1.07026 up 1.26 up CLSTN1 
2750184 0.011695 1.26299 down 1.11 up CALM3 
1940180 0.009895 1.14883 down 2.13 up PSMB9 
4880554 1.01E-06 1.06333 down 1.2 up SALL2 
1500131 0.003014 1.44451 up 1.53 down CPEB4 
4390301 0.01392 1.04906 down 1.26 down TRPV2 
2810500 0.039866 1.16043 up 1.28 down DNAL1 
4120377 0.013512 1.14389 up 1.06 up C2orf47 
2100274 0.030249 1.08873 up 1.27 up SYTL2 
2900497 0.004699 1.18358 down 1.13 down PA2G4P4 
1400543 0.020611 1.17278 up 1.13 down LOC653108 
4040170 0.046971 1.018 down 1.2 up HBQ1 
4060609 0.038191 1.11407 down 1.06 down  
6370594 0.002392 1.16028 down 1.18 up PPAPDC2 
6280332 0.01853 1.32735 down 1.25 down CXCL16 
160148 0.035378 1.00772 down 1.25 down AK3L1 
5310411 7.63E-05 1.12659 down 1.91 down H2AFJ 
2690047 9.39E-04 1.12017 down 1.31 up ARL6IP1 
870484 0.004239 1.23894 up 1.17 up LACE1 
7210139 0.020722 1.91109 down 1.88 down PRSS8 
6330184 0.00149 1.56472 down 1.18 down HBBP1 
5870687 0.018818 1.07265 down 1.6 up ZNF629 
7610433 0.01745 1.10424 up 1.42 up SLC1A5 
4050372 0.044885 1.11048 up 1.16 up FLJ20850 
1980484 0.007921 1.24553 up 1.36 up EFHD1 
5090053 0.023936 1.1082 up 1.15 down FDX1L 
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6060719 0.048868 1.30014 down 1.09 up RPL39L 
6900672 0.034593 1.16767 down 1.08 up RPL39L 
5360717 0.025743 1.21512 down 1.18 down TBC1D10A 
7330131 0.016334 1.23139 down 1.02 up GLT8D3 
6290452 0.007037 1.4507 down 1.19 down NAT1 
4040608 0.010557 1.07133 down 1.06 down STEAP1 
3440754 0.035673 1.27578 down 1.09 up IL32 
1050709 0.006696 1.23098 down 1.22 down RPL8 
1070152 0.027425 1.13047 down 1.39 down IL17RB 
2450435 0.030115 1.16829 down 1.27 down  
520482 0.032448 1.08598 down 1.42 down RNF11 
5050402 0.007991 1.11659 up 1.42 down HIST1H2BK 
4570440 0.020067 1.54457 up 1.18 up QKI 
6100424 0.035383 1.21023 down 1.44 down HEMGN 
4150414 0.00664 1.04722 down 1.68 up STK11 
2360452 0.011524 1.19987 down 1.48 down PFKP 
6770270 0.002237 1.306 down 1.01 up ASRGL1 
6420739 3.33E-04 1.16189 up 1.11 down PGM3 
5270064 0.043649 1.08678 down 1.33 down SHROOM4 
4250301 0.00532 1.22742 down 1.33 up FLJ31568 
650273 0.004538 1.18203 up 1.04 down DALRD3 
4250020 0.004592 1.22255 down 1.34 down CPNE1 
2650753 0.008543 1.00949 down 1.48 up KIAA1324L 
4200601 0.025036 1.42958 up 1.01 down TMEM48 
4810477 0.04423 1.04426 down 1.07 up MMP28 
610397 0.027147 1.08894 down 1.05 up AIM1L 
4730360 0.009881 1.00443 up 1.13 up PLA2G4A 
840475 0.016089 1.13829 up 1.36 up GGTLC2 
5560504 0.02392 1.42009 up 1.53 up TIAL1 
3850754 0.00571 1.16976 down 1.09 up KIAA1683 
4150563 0.046332 1.06314 down 1.31 up C16orf35 
6060608 0.006746 1.03734 up 1.08 up  
4610608 0.008057 1.00628 up 1.33 up LOC731049 
4390274 0.021068 1.0532 up 1.13 down SNRP70 
3710154 0.037251 1.07798 up 1.4 up SLC7A2 
7100139 0.002844 1.13675 up 1.04 down TCF21 
2630202 0.035402 1.29195 down 1.31 up FLJ45248 
1690368 0.024003 1.11304 down 1.08 down LOC440864 
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4260414 0.042282 1.11877 up 1.17 up H2AFY 
730608 0.007521 1.00738 down 1.23 up LOC285550 
1500661 0.022158 1.13681 down 1.23 down DLEU2 
360463 0.019579 1.15039 down 1.14 up SRR 
1430477 0.005525 1.45726 down 1.34 up CTSL2 
60136 0.010473 1.12745 down 1.43 up CPVL 
520376 0.005022 1.23693 down 1.21 up TMEM216 
1470112 0.032855 1.01509 down 1.04 up  
6620192 0.01737 1.17674 up 1.08 up LOC648898 
10463 0.013361 1.11317 up 1.4 up PDIA6 
6200561 0.04121 1.07033 down 1.03 up CCDC28B 
4780136 0.048733 1.02055 down 1.13 down UFC1 
1110300 0.003718 1.27627 down 1.49 up TMEM154 
2230433 0.043358 1.20934 down 1.21 up TMEM154 
4220446 0.018584 1.10497 up 1.1 up LOC649804 
430411 0.048908 1.28433 down 1.11 down TOR3A 
5900468 0.047996 1.10147 down 1.45 up HDAC4 
2690215 3.19E-04 1.10409 up 1.22 down C1orf77 
1940196 0.002744 1.38372 up 1.17 down LEPR 
5260221 0.038584 1.16156 up 1.05 down ATAD1 
5340551 0.020163 1.16819 up 1.02 down ATAD1 
4890112 0.040305 1.33286 up 1.01 up ZNRD1 
7040161 0.00949 1.01557 down 1.35 down HELLS 
450309 0.027515 1.1867 up 1.23 up DDX49 
7000703 0.034603 1.04758 down 1.07 up POLR3K 
1260148 0.021309 1.24252 up 1.19 up  
6110386 0.027507 1.02966 down 1.23 up PRCP 
5570494 0.003646 1.02218 up 1.09 down MRPL33 
1010059 0.04306 1.18083 up 1.02 down LOC653765 
2750709 0.034857 1.00985 up 1.15 down LSM12 
3890475 0.001384 1.39163 down 1.11 down CENPN 
1050240 0.019458 1.18779 down 1.23 down POLD4 
3780100 0.048323 1.23281 down 1.35 down OSBP2 
6270095 0.038821 1.17017 up 1.07 down BRI3 
1570553 0.022117 1.0331 up 1.9 down IL8 
7160056 0.024412 1.00263 down 1.1 up KRT222P 
1850379 0.022886 1.06052 down 1.21 up LETMD1 
650634 0.031819 1.19405 down 1.15 up SLC25A39 
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1240255 0.021545 1.27243 up 1 up  
1770162 0.031692 1.10305 up 1.07 down CCNL2 
6520129 0.022447 1.42984 up 1.03 down ZNF148 
4280609 0.018396 1.08446 up 1.09 down  
770195 0.025914 1.18677 up 1.05 up  
6510192 0.013295 1.47283 up 1.46 up GBF1 
6620475 0.022609 1.11116 up 1.08 down ORC2L 
1850259 0.047689 1.29833 up 1.04 up NFIC 
7560338 0.028041 1.06257 up 1.06 down DDR1 
7040148 0.042932 1.22779 up 1.25 down WDR47 
4070288 0.030858 1.17283 down 1.11 down  
2750356 0.032184 1.00366 down 1.16 up COL6A2 
2690427 0.039163 1.14534 up 1.18 down TBC1D23 
6760543 0.001206 1.34072 up 1.12 down UBAP1 
1710070 0.00677 1.14612 up 1.88 up ITGAM 
520446 0.022629 1.02511 down 1.42 up COMT 
3990719 0.038164 1.24895 up 1.08 up LOC652215 
6350270 0.029436 1.23309 up 1.21 up SON 
6840195 0.043317 1.14844 up 1.18 up  
4220133 0.037613 1.03516 up 1.09 up  
7000324 0.012398 1.13278 down 1.03 down TTC30B 
3400301 0.020234 1.036 up 1.49 up  
460504 0.005471 1.19941 down 1.19 up CCBP2 
6770403 0.007953 1.32383 down 1.09 up EPM2AIP1 
2750259 0.001949 1.20483 up 1.42 down ZMYM5 
3780687 0.019361 1.02843 down 1.08 down  
450193 8.55E-04 1.157 up 1.15 down MOSPD2 
2650148 0.035748 1.11156 up 1.01 up WDR41 
4830500 0.030241 1.42237 up 1.35 up IPO4 
6290725 0.009661 1.34239 down 1.04 up FYN 
1030544 0.033581 1.03417 down 1.14 down  
620438 0.015477 1.17752 up 1.62 up SPAG6 
7400747 0.015052 1.27754 down 1.31 up FAM89A 
6980220 0.002714 1.28744 down 2.01 up LOC644322 
1740300 0.002478 1.04621 down 1.58 up TFR2 
6660482 0.018321 1.06965 up 1.07 up LOC643630 
6760441 4.49E-06 1.0399 up 1.26 up C2orf52 
3180315 0.028354 1.11071 down 1.24 up ZNF319 
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4010414 0.033166 1.06445 up 1.33 down PPFIBP1 
3290753 0.008501 1.13463 up 1.01 up CTBP2 
1740209 0.037602 1.20436 up 1.05 up MXRA8 
2810025 0.010405 1.16374 down 1.05 up RCCD1 
20110 0.045853 1.15481 up 1.31 up CREB3L2 
3310632 0.026754 1.47506 down 1.34 up SLC45A4 
4830326 0.019318 1.1347 up 1.05 down MMP27 
520497 0.041275 1.13512 down 1.25 down LOC729786 
7150274 0.026931 1.20551 up 1.06 up SP3 
4570328 0.014995 1.09213 down 1.01 up  
3940215 0.047962 1.08088 down 1.12 down MTFMT 
1030674 9.57E-04 1.21608 up 1.22 down STT3B 
3930279 0.013469 1.00753 down 1.3 up PTPN9 
3180259 0.049047 1.46206 down 1.41 down SULT1A3 
2320292 0.033548 1.13816 up 1.4 up TAF5L 
1400253 0.021217 1.02588 up 1.29 up RAD50 
6280471 0.001936 1.18603 down 1.11 up HSPA1L 
3060010 0.003247 1.27255 up 1.03 down ANKRD36B 
7050414 0.036316 1.12624 down 1.32 up CACNA1H 
3130088 0.011782 1.50064 down 1.21 down  
3420373 0.014264 1.01419 up 1.43 down SOD2 
4250270 0.00162 1.19647 up 1.35 down APOOL 
4050452 0.037624 1.1984 up 1.02 up PPA1 
7200682 0.008922 1.00927 down 1.13 down  
4200441 0.008941 1.03674 up 1.56 down SEC14L1 
20605 0.035997 1.33539 down 1.41 down CDC25C 
3460376 0.021265 1.0761 down 1.31 up RTN2 
1820682 0.019772 1.19837 down 1.08 down RNASEL 
450037 0.020649 1.15776 up 1.04 down POLR2J4 
1090187 0.023714 1.12543 down 1.1 up NAT11 
6220164 0.046939 1.1528 up 1.43 up CENTG3 
5890131 0.033639 1.25881 down 1.1 up PDXK 
6330348 0.041225 1.12282 up 1.22 down NT5DC3 
4010014 0.011276 1.00925 up 1.32 down  
270220 0.034371 1.19587 up 1 up  
1690114 0.029276 1.11925 down 1.14 down U2AF2 
20446 0.047984 1.06128 down 1.48 down CEBPB 
7210300 7.93E-05 1.06423 down 1.59 up C10orf104 
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870524 0.049691 1.34143 down 1.46 up HOXB8 
5130594 0.024815 1.25136 down 1.03 up WDR81 
2070332 0.023102 1.12634 down 1.13 down UEVLD 
4280373 0.033327 1.15006 down 1.13 down MAG 
6980553 0.026364 1.0362 up 1.07 up GALNT9 
6860113 0.017115 1.19775 up 1.23 up COBRA1 
1470332 0.024376 1.14204 down 1.26 up FXYD5 
3780041 0.036325 1.04502 down 1.14 down TIAF1 
870131 0.042828 1.64751 up 1.71 up HSPA5 
620376 0.021675 1.00128 down 1.19 down PPP1R11 
3930347 0.038554 1.15344 up 1.01 up  
4060358 0.014523 1.58714 down 1.97 down ABCA1 
2750647 0.024156 1.08705 up 1.13 down C20orf27 
6450139 0.007983 1.0092 up 1.18 down FTHL3P 
2690477 0.036049 1.00349 down 1.08 up LOC648710 
7150128 0.018042 1.11688 up 1.1 down SGOL1 
1340474 0.001702 1.01287 up 1.05 down LOC647710 
3190255 0.043668 1.16593 down 1.09 up SDF4 
1500687 0.017723 1.18773 up 1.03 up  
7380603 0.00197 1.13215 down 1.45 up WT1 
2360445 5.27E-04 1.11066 up 1.08 down NHP2L1 
1990672 0.036911 1.02525 down 1.14 up PLA2G4C 
1300156 0.015605 1.09863 down 1.09 down ELN 
6900014 0.047873 1.11471 down 1.2 down RNUXA 
4260364 0.015012 1.19276 up 1.29 down RNUXA 
2320674 0.008702 1.02775 down 1.11 up  
2680564 0.010907 1.13935 up 1.14 up C2orf62 
3130674 0.002696 1.23576 down 1.08 down  
4200750 0.04469 1.03777 up 1.08 up  
3370474 0.007114 1.0298 up 1.21 down SERTAD3 
4830477 0.002436 1.31037 down 1.47 down NLGN2 
5310630 0.002671 1.0502 down 1.4 down CSNK1G3 
2480524 0.029008 1.03835 down 1.17 down  
3370438 0.027712 1.18063 down 1.03 up LOC646628 
6770025 0.020826 1.03039 up 1.12 up FAU 
6350148 0.037751 1.07905 up 1.15 down LOC652826 
6510053 0.049524 1.10142 up 1.11 up APEX1 
4850538 0.003721 1.14405 down 1.32 down PAOX 
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5340291 0.010684 1.10721 up 1.01 up KARS 
6200132 0.031475 1.55161 down 1.14 up FZD9 
3370482 0.025783 1.14292 up 1.08 down CYP2B7P1 
730414 0.006398 1.00506 down 1.35 up APOE 
5910349 0.005373 1.41474 down 1 up SPC24 
6100053 0.00245 1.08837 up 1.04 up  
5260600 0.035949 1.19974 down 1.31 down ZNF655 
1090543 0.024497 1.32447 up 1.01 up ABCE1 
3840408 0.025012 1.0917 up 1.06 up OPN1MW 
940672 0.006665 1.21134 down 1.15 up SLC35C1 
2190541 0.011149 1.47969 down 1.15 up GATS 
540020 0.021716 1.07858 down 1.54 down LGALS8 
1170605 0.001727 1.22117 down 1 down EDG4 
3840717 0.007582 1.07066 down 1.01 down ABI3 
6180139 0.032933 1.02159 up 1.1 down LOC647655 
2940243 0.035054 1.23808 up 1.14 up RFWD2 
7570066 0.012404 1.11258 down 1.07 up RFWD2 
2230551 0.035836 1.0764 up 1.17 up  
620403 0.024606 1.07432 down 1.09 down LOC400759 
430678 0.046351 1.07074 down 1.15 down  
4060068 0.004196 1.35529 up 1.67 up PDIA4 
240220 0.006447 1.73863 down 1.07 down M160 
380750 0.030359 1.11902 down 1.51 down LOC644422 
6450070 0.028877 1.09296 up 1.01 down CYLC1 
7650047 0.020976 1.14524 down 1.18 up SLC29A4 
6450056 0.040402 1.15947 up 1.06 down MCOLN1 
2630577 0.006012 1.63835 up 1.02 up CAV2 
6650639 0.04152 1.57348 down 1.59 down VAMP1 
240639 0.047579 1.11177 up 1.03 up  
3290241 0.037988 1.23064 down 1.05 down  
3890750 0.008586 1.1385 up 1.54 down RECQL 
6350048 0.015646 1.14856 up 1.21 up LOC728739 
7050471 0.046021 1.25856 up 1.04 down CCDC41 
5050670 0.006797 1.22262 up 1.07 up NUP160 
5720162 0.012214 1.20892 up 1.17 down ANKRD26 
4760747 0.001562 1.10657 down 1.19 down TPST1 
2350019 0.008429 1.04554 down 1.17 up FEZ1 
3930286 0.045309 1.32924 up 1.09 up SUCLA2 
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5220220 0.036223 1.32765 up 1.12 up SUCLA2 
6220086 0.005176 1.01872 down 1.33 up DYNLL1 
3610615 0.043234 1.11525 up 1.08 up PKIB 
1440452 0.034134 1.14468 up 1.27 up LOC88523 
2470528 0.036577 1.27806 down 1.08 down C9orf116 
580670 0.035935 1.4062 down 1.18 down CCM2 
2260719 0.040888 1.10037 down 1.05 up FLJ42291 
4890181 0.034421 1.08093 up 1.06 down RAP1GAP 
6400037 0.005045 1.10594 up 1.02 up LOC644326 
2190240 0.037455 1.12126 up 1.1 up  
1990491 0.008753 1.18332 up 1.01 down AK2 
6250280 0.005897 1.01987 down 1.57 down PRDX1 
4490397 0.019124 1.00755 down 1.14 up GPR171 
1300398 0.002179 1.07507 down 1.58 down CGGBP1 
6350632 0.024709 1.20192 down 1.41 up TSC22D3 
6280520 0.002443 1.18497 down 1.64 up TMEM45A 
6940551 0.032536 1.08477 down 1.07 down LOC651731 
780500 0.00306 1.46989 up 1.33 down CAB39L 
4920131 0.031384 1.03876 down 1.13 up PUNC 
7400521 0.023316 1.21859 down 1.13 down NEDD9 
6180048 0.024799 1.17801 up 1.08 up NEDD9 
6200309 0.043731 1.03387 up 1.19 down DNALI1 
1430463 0.036835 1.01143 down 1.14 up MICAL2 
4640438 0.008285 1.37175 down 1 up TIGD7 
3990521 0.037167 1.15031 down 1.08 up LOC728635 
450414 2.46E-04 1.31288 up 1.89 up PPM1H 
5090020 0.012106 1.00691 up 1.2 down SMG5 
3360086 0.010067 1.36087 up 1.06 up NCOA6 
5290270 0.012612 1.54746 down 1.2 down S100A4 
1070390 0.027318 1.08453 up 1.03 down  
1430521 0.039631 1.03244 up 1.14 up VIT 
3170093 0.022776 1.00968 down 1.3 up KIAA0247 
5810370 0.022167 1.03644 up 1.11 down ZBTB37 
6450138 0.013692 1.05751 up 1.31 up BCAP31 
5220594 0.007203 1.11653 down 1.13 up C19orf20 
5810634 0.002449 1.51416 up 1.41 up TDO2 
2510445 0.001799 1.63207 down 1.14 up  
6650161 0.014249 1.23445 up 1.2 down GNA13 
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5670241 0.004008 1.38371 up 1.13 up STAU1 
3890543 0.015227 1.38056 up 1.13 down ETNK1 
430050 0.011856 1.00484 up 1.34 up BAMBI 
5490196 0.015432 1.13017 up 1.2 up PC 
2370152 0.026591 1.20327 down 1.02 down  
4670487 0.008936 1.37964 down 1.04 up SIVA 
2970390 0.031965 1.16464 up 1.27 up EXOC2 
5270474 0.037041 1.11652 down 1.01 up ANKRD58 
6620379 0.009625 1.08959 down 1.11 up LRRC20 
6900161 0.020885 1.23987 down 1.53 down RBBP6 
3370468 0.048029 1.04791 up 1.04 down  
7610273 0.013129 1.11276 up 1.01 down PHF1 
5960132 0.001334 1.07826 up 1.42 down NOLC1 
870164 0.002408 1.07033 down 1.17 down ASB6 
4610647 0.033537 1.00293 down 1.1 up  
1990402 0.033517 1.16125 down 1.21 down FCF1 
520521 0.006081 1.12714 up 1.1 up MRPL20 
2190750 0.003352 1.08096 up 1.28 down KLHL15 
4860446 0.006746 1.09271 up 1.05 up DPPA3 
3450338 0.001583 1.11293 down 1.07 down HLA-DOB 
240019 0.013011 1.10111 up 1.3 down TBC1D15 
6180170 0.017038 1.20705 up 1.05 down PFDN1 
7050608 0.020372 1.00539 up 1.08 down LOC642962 
6560484 0.024212 1.11776 up 1 down VPS41 
5550025 0.010728 1.04788 up 1.24 up PACS2 
3450228 0.046818 1.22325 down 1.04 down IL17RC 
6200176 0.01878 1.08359 up 1.08 up DKFZP564J102 
6620600 0.01425 1.14885 down 1.35 up ATMIN 
5290600 0.036935 1.10633 down 1.15 up TTLL1 
2680711 0.041747 1.01166 down 1.12 up LCT 
4760433 0.044382 1.17291 down 1.09 down C16orf7 
5700494 0.015849 1.08893 up 1.4 up HIST1H2AG 
770703 0.001928 1.18234 up 2.11 up ARHGEF6 
4290133 0.005831 1.44121 down 1.09 up PACSIN1 
6020280 0.00327 1.14549 up 1.2 down NRAS 
3780240 0.030463 1.0973 down 1.18 up FLJ39653 
1940167 0.025074 1.22194 down 1.11 up PDPR 
3290398 0.048178 1.02301 down 1.11 down SLC25A3 
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4040224 0.003455 1.2129 up 1.02 up SLC25A3 
7160193 0.01667 1.24076 down 1.05 down AGFG2 
5860369 0.045574 1.47082 up 1.26 up KIAA0564 
3290458 2.83E-05 1.80905 down 1.56 up FEZ1 
5420201 0.041233 1.43869 up 1.19 up BEST1 
870601 0.024915 1.24115 down 1.04 up TOPBP1 
3840402 0.040375 1.31417 up 1.05 up LOC645659 
6480072 0.01457 1.09768 up 1.01 up  
4920095 0.014645 1.00427 up 1.15 up MKL2 
2070039 0.002076 1.14003 down 1.16 up INSIG2 
130433 0.027625 1.00832 up 1.22 up CTTN 
1770343 0.047801 1.01896 down 1.25 down MBD6 
7150692 0.032218 1.08155 up 1.2 down LOC642732 
1070400 7.19E-04 1.62859 down 1.57 down HYAL1 
1510154 0.009541 1.12492 down 1.23 up TCFL5 
3520372 0.023896 1.7524 down 1.01 down CES2 
1050598 0.028917 1.18239 up 1.09 up DUSP4 
3440500 2.59E-04 1.1715 down 1.23 up ELP3 
4220433 0.041645 1.1781 down 1.07 down SEMA3B 
3140646 0.021115 1.20345 up 1.07 down CD2AP 
5820504 0.027587 1.31053 up 1.02 up LOC728944 
580132 0.001257 1.13429 up 1.41 up LAPTM4B 
6650348 0.005873 1.05107 up 1.37 up LAPTM4B 
6560546 0.028477 1.17487 down 1.44 up ITPKA 
3460114 0.028447 1.31879 down 1.15 down  
7560471 0.020789 1.36535 down 1.18 down MOBKL2C 
6560725 0.023298 1.14914 down 1.01 up C16orf59 
3370725 0.024821 1.49707 down 1.14 down RHBDL3 
3800347 0.01893 1.21519 up 1.19 down HIST1H2BJ 
6370020 0.048211 1.14208 up 1.06 up LOC286310 
4760154 0.01332 1.64176 down 1.62 down CCNE2 
6270554 0.030323 1.11351 down 1.58 down LGALS8 
3130228 0.019071 1.16283 up 1.49 up SIL1 
6560603 0.039664 1.05675 up 1.39 up SIL1 
5490707 6.51E-04 1.03532 up 1.41 down FBXO3 
670367 0.011587 1.24146 up 1.03 up RAB5A 
2370064 0.010223 1.23942 down 1.97 down ASGR1 
4120600 0.04149 1.07932 up 1.17 down ZNF654 
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580484 0.011534 1.04623 down 1.22 up HIP1 
5260397 2.78E-04 1.33223 up 1.23 down HIST1H4J 
6040348 0.010708 1.05407 down 1.17 up SMPDL3B 
1660309 0.0011 1.22465 down 1.4 down THOC4 
150538 0.012804 1.09632 down 1.1 down SLIT1 
6380148 0.013463 1.06381 down 1.65 up FAM104B 
580646 0.002242 1.04604 down 1.11 down LOC644012 
3840678 0.019393 1.26603 down 1.07 down CARD10 
6560181 0.007769 1.30473 up 1.04 up MTIF3 
460193 0.012292 1.24725 down 1.65 down MAD2L1BP 
2570369 0.010233 1.11737 down 1.27 up  
4040162 0.00514 1.15121 up 2.12 up MEF2C 
1770170 0.011854 1.19156 down 1.13 up CTDSPL 
1230646 0.02594 1.11937 up 1.23 down THUMPD2 
7200138 0.042007 1.16815 up 1.13 up  
4180008 5.94E-04 1.14751 down 1.09 up TRPC1 
3140068 0.006596 1.0395 down 1.14 down  
6380563 0.021221 1.1274 up 1.34 up UCRC 
2600035 0.049801 1.10259 up 1.05 up NCL 
3440187 0.043936 1.24288 down 1.07 down TAS2R42 
6480037 0.034433 1.21101 down 1.11 up PLA2G15 
5550408 0.005065 1.02023 down 1.31 up TMED3 
2120450 0.001354 1.13112 down 1.04 up  
2070209 0.001518 1.04226 down 1.28 down BTAF1 
6840523 0.00568 1.03228 down 1.23 down RNF8 
5890687 0.048121 1.06051 up 1.18 down FRMD5 
1010053 0.001279 1.17452 up 1.33 up CCNK 
1070358 0.037954 1.1405 down 1.04 up HEXIM2 
70091 0.01742 1.00029 up 1.1 up FGF8 
6400747 0.047953 1.07915 down 1.1 down  
4220491 6.83E-04 1.2872 down 1.74 down LOC440030 
3710594 6.64E-05 1.28002 up 1.09 down PPP2R2A 
4040048 0.002755 1.10244 down 1.91 down LOC653994 
990528 0.002316 1.27988 up 1.33 up DNAJC10 
4780707 0.036876 1.1729 down 1.09 up OTUB1 
290239 0.008235 1.31716 up 1.41 up NAV2 
4230195 0.00817 1.58006 up 1.67 up NAV2 
5130706 0.007267 1.23758 down 1.34 down  
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3850367 0.03454 1.28393 down 1.31 down LOC440160 
2900193 0.005652 1.24102 up 1 up TAF5 
4610403 0.047665 1.04027 down 1.1 down  
5670180 0.001269 1.05255 down 1.12 down TUBG1 
3370014 0.033471 1.03322 up 1.22 up HMGN3 
1170446 0.044928 1.02673 up 1.26 up C9orf10OS 
380070 0.001424 1.13347 up 1.54 up RPS23 
70070 0.002305 1.13664 up 1.3 up GRINA 
1780576 0.016185 1.17846 down 1.14 up MAD2L1 
50414 0.038408 1.24471 up 1.05 down C12orf43 
7560092 0.03282 1.17048 up 1.21 up TMEM126A 
6840392 0.025122 1.15344 down 1.17 up RGS9BP 
6590538 2.48E-04 1.72022 down 1.72 up TF 
3190445 0.047816 1.12926 up 1.32 down UBE2I 
2370632 0.018715 1.01751 up 1.31 up MMP11 
5420326 0.038517 1.22506 up 1.21 up RTCD1 
4480674 0.00677 1.2736 up 1.4 down NHLRC2 
1470315 0.048555 1.03278 down 1.25 down PIAS4 
130192 0.007354 1.1303 up 1.08 up ZCWPW2 
6200669 0.013147 1.29681 up 1.01 down HIST1H2BD 
5270326 1.42E-04 1.25229 up 1.6 down MPDZ 
6420500 0.005179 1.0416 down 1.19 up MGAT3 
6200743 0.045685 1.03267 down 1.22 down CNPY4 
780600 0.047853 1.00979 down 1.15 down HCP5 
830037 0.016252 1.09079 up 1.01 up LOC643043 
1230196 0.044994 1.45904 down 1.33 up AHCTF1 
6040747 0.010015 1.20743 up 1.03 down AHCTF1 
5910379 6.43E-04 1.02418 down 1.19 down LOC645967 
3940475 0.022232 1.06765 up 1.07 down  
7150382 0.004206 1.00506 down 1.33 down NR2C2 
1780446 0.0195 1.13949 up 1.8 up PCK2 
4150564 0.03142 1.13593 up 1.09 down KIAA0776 
870328 0.003326 1.16094 up 1.22 down ECSIT 
5570731 0.001927 1.39543 up 1.03 down C8orf4 
5080364 0.032032 1.06681 up 1.31 down ACTN1 
1440554 0.037218 1.03114 down 1.4 down NFATC2IP 
4050280 0.049092 1.18858 up 1.15 up  
6280048 0.002116 1.23354 down 1.13 up FAM89A 
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2600678 0.00629 1.08676 down 1.04 down  
6450278 0.010452 1.10181 down 1.21 down MKNK1 
110215 0.040682 1.13408 down 1.17 down  
4570670 0.006752 1.05155 up 1.43 down RRAS 
4850682 0.016778 1.11813 up 1.12 up GEMIN8 
510328 0.016362 1.08609 down 1.21 up AMZ2 
4040292 0.001403 1.0218 up 1.25 down GOLGA2 
270091 0.037716 1.0194 up 1.07 down LOC374920 
7570343 0.029616 1.33551 up 1.32 up GTF2H1 
1990577 4.44E-04 1.0261 down 1.72 down GCLM 
6840370 0.004449 1.61103 down 1.35 down C6orf126 
6220368 0.002568 1.19727 up 1.28 up POGK 
3130682 0.002725 1.00561 up 1.59 down RPL23AP7 
7570243 0.011972 1.04695 up 1.56 up SSR4 
780465 0.031109 1.09191 up 1.51 up SLC11A1 
4040279 0.016126 1.15517 up 1.41 up NSF 
5260138 0.027443 1.0471 down 1.16 up NSF 
7610392 0.023814 1.21247 up 1.09 up C2orf63 
7380382 0.039957 1.21479 up 1.01 up ZNF364 
4260554 0.02244 1.08807 down 1.11 down SIM2 
5130139 0.029243 1.00799 up 1.25 up HSBP1 
1850561 0.015294 1.29353 down 1.27 down LMOD3 
5900594 0.015882 1.46093 down 1.57 down CD58 
3610035 0.019156 1.4421 down 1.52 down CD58 
6350392 0.007255 1.03046 up 1.33 up SLC1A4 
650369 0.034914 1.08622 down 1.14 down PSMD8 
1230673 0.028472 1.25848 up 1.01 down PPAN 
6620026 8.07E-05 1.39744 down 1.27 down CD83 
1240661 0.03022 1.04422 up 1.1 up KIAA0528 
4040025 0.007003 1.08942 up 1.11 up ABCC9 
1170653 0.011314 1.01937 up 1.15 up PDGFA 
6770047 0.02148 1.00021 down 1.03 up  
730341 0.049406 1.0947 up 1.12 down  
4830296 0.047988 1.15574 up 1.04 down  
2630315 0.006813 1.07632 up 1.21 up RNGTT 
4810142 0.007972 1.25296 down 1.07 up ESRRB 
730195 9.16E-05 1.19677 up 1.32 up LOC407835 
2940332 0.033399 1.09234 down 1.01 up CYP1A1 
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3060356 0.038598 1.00129 down 1.18 up LOC440456 
5090373 0.023658 1.25848 down 1.15 down LOC647195 
5390440 0.016822 1.10295 down 1.13 down LOC650238 
780097 0.026642 1.05971 down 1.07 up INPP5F 
1780482 0.032557 1.08771 up 1.06 up CACHD1 
4220468 0.034659 1.42282 down 1.24 down ATP1B1 
7330377 0.020165 1.24498 down 1.08 down MLYCD 
1850612 0.004664 1.11115 down 1.21 down PARP2 
4010270 0.010271 1.08156 up 1.38 down LOC440731 
1030370 0.024076 1.0167 up 1.12 up  
20050 0.024999 1.05469 up 1.08 up ATG10 
460528 0.049443 1.20825 down 1.12 down ICMT 
5900575 0.005698 1.05446 up 1.35 down CD276 
2060431 0.01604 1.06699 up 1.09 up LOC650261 
2630717 0.028877 1.04834 down 1 up NOVA1 
6770201 0.011659 1.26065 down 1.12 up GTF2IRD2P 
6110608 0.030244 1.32582 up 1.1 up DHX30 
2320445 0.038596 1.21861 up 1.06 down ARHGEF7 
580280 9.64E-04 1.21691 up 1.11 down TCF20 
3450707 8.10E-04 1.19236 up 1.04 down TCF20 
630358 0.003828 1.06517 up 1.13 down TCF20 
2450142 0.023422 1.01235 up 1.14 up C8orf31 
6350075 0.013753 1.42351 down 1 down LOC728006 
1820092 0.04544 1.08764 down 1.07 up  
6450440 0.03152 1.03435 down 1.26 down PTGR1 
4200259 0.009334 1.12973 up 1.01 down ACLY 
6520619 0.015995 1.05619 down 1.28 down USP53 
1740543 0.031469 1.08426 up 1.08 down JAK1 
6760195 0.033694 1.21829 up 1.1 up RCBTB1 
6620630 7.43E-04 1.15625 up 1.34 up XK 
6040600 0.002057 1.62139 down 1.13 down TMEM98 
5270682 0.047155 1.15843 down 1 up MAP7D3 
6350561 0.031551 1.09952 down 1.13 up TMEM86A 
7550343 0.026693 1.00594 down 1.15 up PRDX6 
7380553 0.019892 1.0486 up 1.21 down ZNF24 
1400735 0.046465 1.04877 up 1.08 down SMC4 
1030678 0.03316 1.20474 down 1.12 down  
4860086 0.019641 1.07188 down 1.12 up TMEM118 
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3140088 0.003987 1.03925 up 1.11 up IL23R 
1230397 0.038449 1.06698 up 1.14 down TMEM69 
630731 0.018406 1.1933 up 1.09 down LOC645649 
1470180 0.005949 1.32256 down 1.02 up GNAT3 
540164 0.023179 1.03879 up 1.19 up KHK 
770170 0.025032 1.08692 down 1.16 down LOC651580 
3450424 0.005478 1.05906 up 1.05 down  
2710563 0.030526 1.23674 down 1.02 down C1orf170 
5820050 0.020893 1.01323 down 1.13 down DCTN2 
2900291 0.018172 1.10628 down 1.27 up ACOT8 
3990743 0.010533 1.14527 down 1.23 down  
4200692 0.006359 1.20264 up 1.16 down NEU1 
7610747 0.014853 1.15245 up 1.17 up MRPL24 
3360259 0.017261 1.08494 down 1.08 down LOC653137 
4010196 0.023719 1.28505 up 1.12 up GATA2 
4490520 0.020706 1.08996 down 1.08 down EBI2 
2760563 0.016978 1.10959 up 1.01 up ANKRD28 
780348 0.027476 1.83309 down 1.18 down LOC338799 
1240373 0.043585 1.10052 up 1.01 down  
7040168 0.013143 1.20749 down 1.01 up TTC19 
5080437 0.035313 1.15591 down 1.08 down LOC644767 
2030600 0.038018 1.05703 up 1.11 up  
4210240 0.03791 1.13424 up 1.19 up  
1980403 0.020281 1.28964 down 1.1 up ZNF395 
4180079 0.007595 1.53933 down 1.24 down CRISPLD2 
4760039 0.045844 1.20649 down 1.04 up ZNF646 
6660661 0.044669 1.1336 down 1.05 down  
3990139 0.019375 1.12574 up 1.08 up LAD1 
2190224 0.002202 1.23091 up 1.08 down KIAA1128 
6660497 0.016914 1.02808 down 1.16 down HSPA14 
4260022 0.024026 1.09955 up 1.11 up PSMG2 
6250189 0.005931 1.18905 down 1.47 up FLJ14712 
7400619 0.004699 1.27048 up 1.2 down SPATA5L1 
6450541 0.035798 1.26319 up 1.08 up PXN 
1780689 0.024162 1.12382 up 1.03 up LOC645177 
7510253 0.002706 2.09749 down 1.87 down ACRBP 
1230278 0.013231 1.04793 up 1.18 up LOC440348 
5900253 0.034607 1.10437 down 1.25 down BATF3 
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2230288 0.025367 1.96378 down 1 down TST 
1070402 0.011002 1.12577 up 1.55 up CANX 
2350670 7.60E-04 1.1243 down 1.13 down  
6330338 0.009645 1.02364 down 1.37 down ITGA5 
4120689 0.032715 1.5221 down 1.14 down FES 
1940040 0.018246 1.14478 up 1.02 down LOC653203 
2120129 0.030445 1.07123 down 1.21 down C20orf175 
1690446 0.004453 1.00257 down 1.32 down PNPLA6 
1430424 0.021387 1.22855 up 1.14 up RFFL 
2450129 0.010204 1.09523 down 1.15 up FLOT2 
5910195 0.006778 1.34435 up 1.1 down RBM18 
5130079 0.047587 1.08715 down 1 down  
1230682 0.001543 1.27727 down 1.6 up BIRC5 
6620626 0.039863 1.35246 up 1.09 up CHCHD3 
3140386 0.013411 1.00934 up 1.5 up NFATC3 
4230632 0.008252 1.34308 up 1.03 up BAG4 
7320347 0.041461 1.07106 up 1.11 down PLEKHG4B 
3060523 0.020374 1.12379 up 1.37 down NAMPT 
2230379 0.015468 1.12841 up 1.46 down NAMPT 
2060286 0.015083 1.1876 up 1.09 down PPP4R1 
6200672 0.01094 1.03535 up 1.25 up NUB1 
5090088 0.006511 1.30937 up 1.42 up EPRS 
3140524 0.00759 1.46383 up 1.03 up NARG1 
730333 0.002915 1.26863 down 1.15 up ZNF623 
150017 0.032365 1.05439 down 1.06 up  
5490086 0.022291 1.21677 up 1.15 up C16orf84 
7380047 0.038948 1.04863 down 1.2 up THRA 
6860612 0.019546 1.10192 up 1.32 up KIAA2026 
450168 0.006839 1.14843 up 1.62 up SFRS7 
460484 0.002824 1.17909 down 2.07 down CCRN4L 
870349 0.021409 1.17681 up 1.23 up ACBD6 
3930356 0.018925 1.01516 up 1.37 down SNX8 
2570523 0.038565 1.0905 down 1.06 up ARL2BP 
1570154 3.98E-04 1.21394 down 1.04 down GPNMB 
4060630 0.040227 1.08434 up 1.06 up  
5860279 0.0228 1.06017 down 1.1 up RAB10 
2470008 0.005646 1.054 down 1.19 up PPARA 
2810280 0.009512 1.4051 down 2.01 down SLC6A6 
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520463 0.009669 1.1913 down 2 down GPER 
580392 0.042125 1.1621 down 1.06 up PTH2 
5290289 0.031489 1.13846 down 1.06 down RPS29 
5870576 0.003307 1.10382 down 1.17 up C21orf33 
4150605 0.010151 1.43728 up 1.08 up ANKRD40 
6900082 0.041231 1.09973 up 1.15 up  
1510543 0.025131 1.43034 down 1.45 down DNASE1L1 
4260482 0.003473 1.07242 up 1.06 down ERBB3 
770240 0.003078 1.04046 down 1.11 down  
510619 0.03333 1.18963 up 1.07 down YWHAE 
780491 0.038287 1.03077 down 1.18 up C10orf4 
1770717 0.035146 1.12082 down 1.07 up HIRIP3 
2640274 0.019168 1.08837 down 1.21 up ALDH5A1 
1450370 0.01106 1.13948 up 1.64 down DCP1A 
3850520 0.010481 1.32685 up 1.02 up PRMT5 
150608 0.011527 1.11821 up 1.08 down LOC646426 
7560041 0.009285 1.18935 up 1.87 down AXUD1 
2030386 0.045058 1.25513 up 1.44 up COPG2 
1010647 0.048538 1.69092 down 1.24 down TP53I13 
3870520 0.008712 1.25901 up 1.07 down VAMP4 
150528 0.004014 1.58165 down 1.41 down MAEA 
20044 0.017496 1.14917 down 1.71 down LOC644743 
3370687 0.001589 1.03512 up 1.55 up CGGBP1 
6580059 0.006791 1.00685 up 1.4 up UCP2 
620725 0.002988 1.21752 up 1.31 down UCK2 
1110435 0.018097 1.08531 up 1.09 down CCDC132 
3710711 0.012055 1.52844 down 1.26 down STAG3L2 
3390091 0.015841 1.02875 down 1.12 down  
2320612 0.01393 1.19932 down 1.28 up LOC654254 
5310255 0.047576 1.11794 down 1 down  
830634 0.004243 1.12679 up 1.66 up USP24 
1570403 0.012012 1.02871 down 1.2 up OPA1 
6270114 6.39E-04 1.18621 down 2.16 up CSF3R 
7160176 0.019315 1.03645 down 1.1 up  
5130440 0.047969 1.61673 down 1.17 down BIN1 
3390452 0.025245 1.02356 down 1.07 up  
7570278 0.005814 1.31358 up 1.05 up EXOC6 
2470609 2.78E-04 1.05257 down 1.41 up SLC39A11 
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3800110 0.030951 1.16942 up 1.06 up ORC5L 
6100630 0.003322 1.00862 down 1.56 up MUM1 
2190377 0.009139 1.23729 up 1.01 up EIF3G 
770470 4.28E-04 1.09668 up 1.03 up  
6040156 0.010466 1.29139 up 1.15 up C6orf52 
3940639 0.032799 1.09998 down 1.15 up PYCR2 
4120619 0.037547 1.45669 up 1.51 up ELP4 
5700424 0.023454 1.3097 up 1.5 up FAM48A 
2480112 0.017931 1.1324 down 1.12 down DSCAM 
3450398 0.023204 1.30653 up 1.12 up POLR1A 
4850341 0.006471 1.22778 down 1.12 up LOC649722 
2940196 0.027209 1.01777 down 1.21 down KIAA0174 
2120537 0.021468 1.41128 down 1.09 down SPOCD1 
7200072 0.033308 1.17425 up 1.11 up  
3710554 0.002701 1.04285 up 1.15 up FGD5 
3440291 0.006691 1.17621 up 1.03 up  
4150070 0.006245 1.11049 down 1.44 up DNAJC19 
4200767 0.034457 1.15719 up 1.05 down CPLX3 
1820154 0.011963 1.44797 up 1.34 up  
5570563 0.049743 1.22013 down 1.34 down HIATL1 
2640463 0.00719 1.25376 down 1.05 down LOC652541 
2340164 0.025903 1.09978 up 1.1 up CEP152 
10184 0.012059 1.20401 up 1.5 up EXTL3 
6040468 0.047847 1.39478 down 1.32 down KEL 
1500376 0.03499 1.05835 down 1.19 down  
3940575 0.022957 1.13316 up 1.09 down DOT1L 
3140669 0.044314 1.15029 up 1.1 down CGI-96 
3940762 0.00284 1.07917 down 1.78 up  
3990241 0.007412 1.36146 down 1.06 down LOC654191 
3780053 0.006976 1.38673 down 1.36 down PALLD 
3610121 0.036556 1.04388 down 1.08 down  
5290408 0.03257 1.04274 up 1.21 down MCEE 
2970475 0.012317 1.15488 up 1.04 down NARFL 
360500 0.007231 1.19424 down 1.06 up SRGN 
3780553 0.048906 1.13587 up 1.08 up DLX2 
3940435 0.042656 1.13685 down 1.52 down EMP1 
5220767 0.003124 1.00397 down 1.32 up FLNB 
1510521 0.043401 1.00811 down 1.05 up PAFAH1B3 
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3840689 0.044905 1.01711 up 1.28 up PIGT 
3190240 0.010635 1.04064 down 1.13 up LRRTM3 
4670707 0.048073 1.21934 up 1.05 up COX18 
3440097 0.037086 1.33669 up 1.19 up YIF1B 
2640273 0.007201 1.22307 down 1.08 up ALDH4A1 
4230373 0.028878 1.23089 up 1.8 up MAP3K1 
2120280 0.016969 1.18164 down 1.15 up LOC400657 
7610341 0.018037 1.29913 up 1.67 up  
3850059 0.025844 1.04855 down 1.56 up LMO2 
2750164 0.048071 1.02415 down 1.14 up  
7650646 0.026622 1.03124 up 1.27 up FRMD6 
3420204 0.045025 1.10183 up 1.06 down  
1110575 0.021006 1.02701 down 1.14 down NDUFC1 
2510289 0.003164 1.00881 down 1.11 down GOLGA6 
1470133 0.020282 1.36675 up 1.09 down ZNF197 
6370528 0.020394 1.19749 down 1.13 up C9orf100 
2690300 0.019214 1.15889 up 1.27 up LOC730432 
2710121 0.045211 1.17536 up 1.26 up LOC442597 
6400300 0.006186 1.00423 down 1.07 down HSCB 
110669 0.04538 1.13387 up 1.12 up USO1 
5390095 0.027545 1.59799 down 1.26 up RASSF2 
5490390 0.00367 1.05468 down 1.42 down ZGPAT 
4900068 0.008829 1.11376 up 1.59 up KIAA1715 
5690382 0.036826 1.11118 up 1.15 down PPP3CC 
4480026 6.00E-05 1.22411 up 1.07 down MAP2K1IP1 
4850343 0.023116 1.04744 down 1.53 down LOC647954 
3190070 0.023879 1.06344 up 1.14 up LOC654244 
2450678 0.023525 1.41986 up 1.46 up DNAJC1 
3800053 0.029923 1.11379 down 1.09 down SHBG 
6940463 0.032111 1.02422 up 1.14 up KCNIP3 
7510259 0.010881 1.25138 up 1.51 up ATP7B 
3990767 0.01895 1.14068 up 1.03 down FBXO28 
2680672 0.026901 1.03781 down 1.03 up TMIGD1 
5420593 0.01038 1.10141 up 1.34 up ZDHHC3 
730044 0.011134 1.26419 down 1.04 down LOC644640 
5820343 0.016169 1.08676 down 1.04 up ERCC5 
4250739 0.016104 1.06037 up 1.39 down CDC2L1 
1050424 0.003579 1.11017 up 1.06 down PUS3 
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4250066 0.033404 1.28465 up 1.01 up NUPL1 
2760484 0.020111 1.06612 down 1.24 up  
5390202 0.011226 1.01237 up 1.34 up TMED9 
4480270 0.048607 1.13408 down 1.1 down  
5810047 0.005202 1.03432 down 1.25 down F2RL1 
6550754 0.008427 1.16883 down 1.21 up EVL 
2060136 0.021436 1.12882 down 1.47 down ATG4B 
1030379 0.02834 1.08851 down 1.16 down TRIM69 
6350187 0.036685 1.01927 down 1.04 down LOC643582 
5560075 0.003569 1.84022 down 1.56 down MFGE8 
2060390 0.018184 1.10651 down 1 up OR52E5 
10324 0.019152 1.24469 up 1.16 up PRR16 
2940491 0.030032 1.01325 up 1.14 up LOC441257 
1820646 0.044293 1.06421 up 1.41 up ZNF462 
1410168 0.007024 1.1245 down 1.23 down ELF4 
2190048 5.31E-04 1.06652 up 1.15 down OPA3 
830176 0.006803 1.10388 up 1.51 up C2orf18 
2710767 0.017601 1.19838 up 1.22 up MLL5 
430091 0.020463 1.02869 up 1.18 down  
2000195 0.021383 1.32702 up 1.09 up VEZT 
1110494 0.015928 1.09541 down 1.17 up TMEM194 
3170110 0.003376 1.15855 up 1.09 down CCNG1 
6400082 0.016419 1.41589 up 1.24 up C12orf11 
730605 5.72E-04 1.09905 down 1.05 up MRPS22 
4780162 0.005595 1.12302 up 1.61 up RELN 
6840064 0.042739 1.17492 up 1.2 down BICD2 
3780609 0.034924 1.44489 down 1.08 down RAD51 
5310360 0.040418 1.02342 down 1.18 up TLE4 
4810390 0.019518 1.07584 up 1.15 down TROVE2 
6200431 0.002891 1.21697 down 1.16 up AKT1 
6040142 0.029264 1.12979 up 1.14 up GRIN2A 
4670725 0.039023 1.1561 down 1.02 up  
1940068 0.007776 1.41517 down 1.42 down ABHD11 
4730408 0.001845 1.05304 down 1.08 up ANAPC5 
7400626 0.033116 1.26236 down 1.81 down NFKB1 
6770187 0.023523 1.19114 down 1.16 down SPRR2A 
7610047 0.045428 1.39832 down 1.02 up LOC644799 
4250678 0.042569 1.57267 down 1.25 down MGC16121 
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4280743 0.016787 1.03205 down 1.35 up RPL37 
870148 0.028356 1.16723 down 1.07 down MSH6 
5490402 0.005794 1.08562 down 1.11 down ZNF580 
270156 0.026917 1.12321 down 1.22 up UBE2N 
2760445 0.006981 1.20803 down 1.08 up LRRC4B 
3840400 0.006428 1.07021 down 1.44 up GMPR 
2060220 0.00885 1.0598 down 1.05 up FAM174A 
3800168 0.001572 1.21386 up 1.02 up SLC2A3 
3780408 0.019593 1.05396 up 1.4 up RAB43 
4880021 0.004231 1.07732 down 1.49 down RBM12 
2810328 0.019183 1.13854 down 1.04 up RBM12 
4260687 0.023357 1.15631 up 1.22 up SLCO4C1 
3930020 0.032019 1.06656 down 1.14 up CTSF 
6180465 0.012585 1.34681 down 1.25 down SLC2A6 
3450463 0.00982 2.65341 down 1.13 down ARRDC4 
6580168 0.008446 1.86534 down 1.03 up ARRDC4 
610470 0.035146 1.26584 down 1.42 up CGB2 
2480288 0.039328 1.20569 down 1.36 up GPAA1 
6560544 0.049837 1.1519 up 1.11 up  
840187 0.043325 1.30597 down 1.19 down ITLN2 
4860301 0.011276 1.11515 down 1.02 down RAPH1 
2710646 0.004808 1.35895 down 1.52 up MSRB2 
1580576 0.038771 1.13707 up 1.42 up ITM2A 
4860204 0.015111 1.09998 up 1.15 down ACIN1 
1820296 0.032514 1.02399 up 1.34 down WTAP 
830377 0.010048 1.14781 up 2.52 down S100A13 
1990563 0.02259 1.10517 up 1.03 down BRP44L 
450554 0.009291 1.09008 up 1.37 down CCNL1 
6220682 0.016744 1.21534 up 1.05 down ZC3H14 
3140092 0.011003 1.13762 down 1.04 up TRAK1 
1660605 0.015729 1.2071 down 1.25 down ZNF436 
7570673 0.005322 1.30726 down 3.55 down UPP1 
5290037 0.012116 1.2989 up 1.28 up HEATR2 
5720767 0.048737 1.09072 down 1.19 down REXO1 
4390348 0.014316 1.13756 down 1.1 down UCP1 
4230403 0.010639 1.00831 down 1.12 down NUMB 
4040386 0.033195 1.09245 up 1.13 up APOL1 
70634 0.026619 1.02026 down 1.45 up RABAC1 
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6450291 0.012159 1.16176 up 1.21 up LEFTY2 
5720408 0.048356 1.12907 up 1.01 down ZNF409 
1450176 0.015707 1.24402 down 1.08 down RGPD5 
5050148 0.008462 1.30764 up 1.23 up CDRT4 
1940521 0.021305 1.07417 down 1.09 down  
2750653 0.04804 1.20953 up 1.02 down ARCN1 
1500136 0.025455 1.325 down 1.01 down MTMR3 
3060500 0.016684 1.0282 down 1.13 down  
6180044 0.034973 1.17261 down 1.11 down  
2340220 0.006767 1.02062 down 1.19 up CD55 
6330132 4.30E-04 1.80996 down 1.95 down ISG20 
1780603 0.028052 1.11838 down 1.24 down IL6R 
5870685 0.025577 1.21858 down 1.59 down IL6R 
6020139 3.47E-04 1.35396 up 1.16 down KLK7 
940487 0.030264 1.07329 down 1.03 up FUT3 
5720538 0.023474 1.45486 up 1.09 up IPO7 
1010465 0.04439 1.31722 up 1.06 up CBARA1 
5890414 0.013224 1.11861 up 1.11 up FYB 
4250309 0.039583 1.13237 down 1.12 up SNAPC1 
3830292 0.021756 1.06753 up 1.01 down  
6420632 0.043386 1.04992 down 1.08 up MCCC1 
5810398 0.034175 1.05095 up 1.21 up SPI1 
1500010 0.003445 1.01533 down 1.4 up CDC20 
1710746 0.01415 1.12472 down 1.3 down PRKRIP1 
3450224 0.005859 1.14967 up 1.04 up  
1090100 0.034408 1.13363 up 1.1 down CMIP 
3310291 0.023236 1.15389 up 1.19 up POU3F2 
7400050 0.002777 1.19004 down 1.15 up CCM2 
3180446 0.003081 1.03907 down 1.23 down MED16 
630048 0.019834 1.11011 down 1.2 down DNCL2A 
1230292 0.005593 1.03895 up 1.32 up MED30 
6420301 1.97E-04 1.08194 down 1.06 down  
580215 0.01375 1.06715 down 1.12 up SFTPA1B 
4560692 0.041194 1.02677 down 1.14 down LOC653380 
450403 0.045765 1.04438 down 1.12 down PSMD2 
2140364 0.015693 1.27174 down 1.1 down ZFYVE20 
3990278 0.028639 1.33708 down 1.43 up SCGN 
3780619 0.026145 1.33182 down 1.04 up TMEM14A 
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2650193 0.043783 1.48705 down 1.66 down SDC4 
4070053 0.012023 1.11092 up 1.54 down BCAR3 
4880370 0.007817 1.2185 up 1.5 up JUP 
4540139 1.81E-04 1.43413 up 1.21 down RSRC2 
4150242 8.17E-05 1.27199 down 1.28 up VPS13D 
4230189 0.002842 1.21424 up 1.25 down TXNL2 
7210288 0.005781 1.11361 down 1.01 down KCNG1 
990730 0.038013 1.00481 up 1.34 up FOXM1 
4610411 0.003748 1.03048 up 1.2 down MTERFD1 
3130541 0.005869 1.24413 down 1.3 up CCNF 
670603 0.012117 1.34665 up 1.45 up PLAGL1 
780424 0.012885 1.07131 up 1.09 down  
2630687 0.037697 1.08628 up 1.25 up CHPT1 
2690603 0.005625 1.07338 up 1.25 up RNF5 
2970669 0.006303 1.15541 up 1.1 down AP4S1 
2850180 0.044307 1.04346 down 1.05 up NUDT16L1 
3310376 0.04492 1.13961 down 1.08 up TIMM10 
4570008 0.049417 1.13681 up 1.02 down ENDOGL1 
4860195 0.019677 1.05473 down 1.29 up SLC35A2 
2100470 0.026453 1.02395 down 1.22 up TIMM17B 
7330392 0.005868 1.21141 down 1.41 up TAP1 
2570477 0.01138 1.2626 up 1.07 down BTN2A1 
2070474 0.004469 1.10403 up 1.21 up TM7SF3 
7320717 0.006899 1.40599 down 1.09 down GALNT4 
6020674 0.022463 1.18057 up 1.03 up FLJ38482 
7380026 0.035403 1.2237 down 1.46 down FAM39E 
6060242 0.015235 1.07142 up 1.5 up ZNF93 
5390653 0.016702 1.19465 up 1.03 down  
6290356 0.008564 1.58995 up 1.91 up SERPINF1 
6350292 0.034421 1.15911 up 1.11 down C1orf50 
6220020 0.007808 1.112 down 1.12 down  
4830372 0.013654 1.15591 down 1.46 up ADSSL1 
6060315 0.035348 1.06851 up 1.28 up FERMT3 
1430544 0.038509 1.2427 up 1.06 up NOB1 
6130753 0.048937 1.11635 down 1.1 down RFX6 
2060088 0.038266 1.12819 down 1.43 down CLCN7 
1990152 0.045016 1.23449 down 1.68 down CSRP2 
2060717 0.00119 1.37446 down 1 up CXorf48 
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5960358 0.002185 1.06718 up 1.33 down PELO 
2450037 0.001335 1.13288 up 1.22 down KIF3B 
5420538 0.003688 1.73311 down 1.07 down TP53INP1 
3940066 0.001709 1.21098 down 1.15 up KLHL30 
5130753 0.04113 1.00012 down 1.12 up LBH 
6400390 0.006036 1.41131 down 1.03 up  
150520 0.004796 1.107 down 1.35 down  
6290523 0.032816 1.4758 down 1.4 down  
2470132 0.018054 1.04993 up 1.03 down CPN2 
5570632 0.001123 2.0163 down 1.49 up  
2630487 0.041264 1.01827 up 1.13 up  
6770181 0.03498 1.83737 up 1.08 up LOC644739 
1450603 0.038087 1.14224 down 1.16 up C14orf106 
3420162 0.011988 1.15844 up 1.3 up CLSTN3 
3800735 0.03162 1.10088 down 1.09 up HVCN1 
4280661 0.014329 1.28571 down 1.12 down TMUB2 
1450102 0.022119 1.06874 up 1.24 up U2AF1 
3120128 0.027592 1.10753 up 1.08 down LOC653238 
2900528 0.04588 1.03435 up 1.11 down TTTY5 
2640377 0.030257 1.13423 up 1.56 up PGCP 
3890593 0.043642 1.06734 up 1.1 down  
3850343 0.04996 1.14512 down 1.42 down SUV420H1 
6450202 0.014886 1.04318 up 1.22 up CDYL 
3930523 0.013115 2.10988 down 1.02 down CLCNKA 
10332 0.035757 1.0276 down 1.22 up HIPK2 
70253 0.008224 1.05596 up 1.57 up UGT2B11 
6980059 0.014814 1.21494 up 1.01 up LOC285359 
3440494 0.01984 1.09866 down 1.11 down FLJ22269 
4060088 0.005647 1.06979 down 1.03 up LOC644677 
4860468 0.04247 1.05222 down 1.16 up ARL1 
5890706 0.001221 1.03278 up 1.17 down SHB 
580044 0.011803 1.17539 up 1.18 up ZNF574 
870056 0.033906 1.02309 down 1.29 up FAM119B 
6350253 0.026451 1.14485 up 1 down  
160239 0.024003 1.17135 down 1.09 down LOC644019 
3460097 0.002379 1.0932 up 1.1 down HOXB2 
6200754 0.040349 1.02881 down 1.09 down  
4570408 0.02641 1.0986 up 1.04 up  
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1940047 0.003213 1.25727 down 1.29 up AIF1 
290692 0.043347 1.09618 down 1.08 up  
1230612 0.012937 1.10195 down 1.22 up CCT6B 
3610278 0.035096 1.18482 down 1.01 up LOC91661 
2650192 0.008251 1.25575 up 1.79 up C6orf105 
7050193 0.016457 1.03356 down 1.1 down RAB40C 
4610632 0.013372 1.00009 down 1.25 up MOCOS 
2900372 0.008133 1.1439 down 1.08 down ARMC10 
7330739 3.80E-04 1.62352 down 2.63 down NDRG4 
6900228 0.044074 1.18127 up 1.15 up  
5570170 0.022773 1.18142 down 1.1 up PNMT 
4290292 0.012482 1.26305 down 1.34 down TATDN3 
3360167 0.008045 1.28819 up 1.59 up CORO7 
7550242 0.003604 1.32324 down 1.21 up HESX1 
1780681 0.045991 1.0869 up 1.41 up HNRPUL1 
730673 0.036026 1.18387 down 1.24 down PCMTD2 
5290148 0.01664 1.04671 up 1.57 up GPT2 
6650575 0.038026 1.02289 down 1.12 down MADD 
4150128 0.002066 1.28847 up 1.42 down LOC340598 
3180189 0.02019 1.00414 up 1.25 up ZNF271 
3850228 0.007062 1.20085 down 1.08 up ZRANB2 
1510382 0.010615 1.07859 down 1.4 up NXPH4 
5310315 0.046987 1.29031 down 1.01 down ZNF813 
1440630 0.041746 1.04674 down 1.22 up CEP110 
290687 0.023849 1.00067 down 1.25 down LOC653884 
580326 0.011287 1.36421 down 1.05 down  
3190561 0.023866 1.36566 up 1.47 down SNORD35B 
6350577 0.012343 1.09835 down 1.13 down  
770504 0.041051 1.12189 down 1.09 down DTNB 
5570176 0.013461 1.12058 up 1.02 down BPY2B 
7570181 0.045425 1.13251 down 1.14 down MCM10 
7040753 6.20E-04 1.13632 down 1.12 down C20orf195 
7040440 0.024043 1.04212 up 1.12 up  
6270315 0.008398 1.21134 down 1.03 down LOC613266 
670703 0.022966 1.09493 down 1.11 up C6orf173 
7650433 0.004356 1.04789 down 1.52 down TIMP1 
4050040 0.00315 1.12913 down 2.01 down TUBB3 
7550538 0.020031 1.2503 down 1.08 down TBX22 
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1230561 0.017652 1.01786 down 1.19 down  
3710440 0.008035 1.16201 down 1.14 up CSDE1 
2760382 0.004083 1.07804 up 1.18 up CLDN14 
10673 0.007142 1.05302 up 1.26 up PLXNB2 
4120398 0.015693 1.12899 up 1.03 down  
2120747 0.040904 1.0951 up 1.07 down  
5090520 0.030293 1.12655 up 1.04 up  
110433 9.20E-05 1.16551 up 2.74 up ASS1 
4900370 0.020738 1.08112 up 1.37 up ASS1 
1500097 0.017989 1.08039 up 1.06 up  
4200068 0.021209 1.16362 down 1.08 down NUP62 
1260575 0.020381 1.22145 down 1.54 up C13orf23 
4050408 0.012572 1.05836 up 1.01 down BNC1 
3420753 0.00258 1.11955 up 1 up GPR109B 
1580224 9.76E-04 1.11103 up 1.47 up SIRT5 
6860367 0.010641 1.02236 up 1.36 down  
3190343 0.035165 1.16804 up 1.13 down  
7100458 0.02384 1.1024 up 1.37 up MECR 
540468 0.029478 1.11825 up 1.07 up  
1510301 5.78E-05 1.35305 up 1.1 down SCYL2 
4670059 0.014811 1.06174 up 1.46 up ZAK 
3780594 0.021598 1.29641 down 1.39 down LOC440345 
6420070 0.021374 1.14397 up 1.02 up PHF1 
2450603 0.024868 1.18461 up 1.14 down SF3B1 
6770541 0.028399 1.02363 down 1.26 up CCDC18 
5550564 0.009063 1.26713 up 1.04 down MTRF1L 
6940397 0.030761 1.16566 down 1.04 down RRAGB 
5090021 0.002531 1.28941 down 1.37 down  
4640079 0.047837 1.04177 down 1.37 up PGLS 
460730 0.00905 1.08137 down 1.41 up BMPR2 
4120070 0.032241 1.07594 up 1.11 up LOC390748 
4010243 0.022853 1.31219 down 1.15 down NAE1 
6510619 0.047636 1.15667 down 1.04 down NAE1 
1230632 0.039709 1.18946 down 1.11 down RNF38 
4830746 0.008071 1.03527 down 1.2 up MGC45491 
1010682 0.015726 1.02799 up 1.15 up ARIH2 
160333 0.007161 1.06977 up 1.32 down C6orf192 
4200551 0.022713 1.72761 down 1.37 down LOC132241 
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2810324 0.044419 1.07245 down 1.13 up LOC641742 
5050369 0.019117 1.16598 up 1.09 up  
610368 0.001515 1.11583 up 1.31 up OR6K2 
4180445 0.012291 1.24193 down 1.12 up C9orf142 
6860681 0.002391 1.05192 up 1.05 down IER3IP1 
60646 7.07E-04 1.10381 down 1.27 down  
2480048 0.003846 1.36734 down 1.54 down CXorf40A 
4010484 0.027394 1.09609 up 1.11 up  
5090288 0.026827 1.08221 up 1.12 down SALL3 
5820494 0.035621 1.0223 down 1.25 up ZNF177 
5670139 0.019898 1.23022 down 1.03 up TMEM149 
1410458 0.028705 1.077 up 1.15 up LOC389316 
2340047 0.013441 1.10732 up 1.32 down CCNL2 
4290014 0.003888 1.11186 down 1.07 down FLAD1 
4060494 0.04585 1.05039 up 1.1 down NFX1 
4290300 0.004545 1.04906 down 1.1 up ATP5H 
5810612 0.041681 1.0059 up 1.18 up ANPEP 
3120121 0.009633 1.13302 up 1.06 up LOC645992 
5360288 0.046132 1.07173 up 1.1 up C16orf78 
3460278 0.021325 1.399 down 1.16 down C22orf13 
6900424 0.014794 1.24434 down 1.31 down TYK2 
2320068 0.043914 1.35761 up 1.07 up GOLPH3 
4490537 0.007841 1.12338 up 1.1 up CCDC88A 
7150553 0.032768 1.0092 up 1.14 down NFATC2 
2900451 0.017183 1.23043 down 1.22 down MR1 
830215 0.018926 1.08571 up 1.22 down MCAT 
1940273 0.01652 1.09955 down 1.36 down SGSM2 
1110022 0.015513 1.00239 up 1.46 up KIF11 
4060176 0.017054 1.09642 up 1.47 up KIF11 
60341 0.015294 1.03476 up 1.48 down LOC653171 
3710025 0.021898 1.27978 up 1.16 up RUFY1 
6650037 0.041232 1.16319 up 1.02 up SPTAN1 
2650743 0.008413 1.07849 down 1.05 up PMP22CD 
4570575 0.030965 1.39515 up 1.06 up ST7 
6860411 0.013382 1.32143 up 1 down ST7 
6330195 0.0192 1.00857 down 1.35 up EP400 
290414 0.049391 1.04376 down 1.13 down  
3440703 0.002512 1.05487 up 1.11 down C17orf58 
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7510554 0.043227 1.21888 up 1.15 up C17orf58 
3450176 0.015173 1.0425 up 1.12 down C17orf58 
3390678 0.005278 1.16521 down 1.16 down LOC647485 
5820521 0.00905 1.1915 up 1.11 down PTBP2 
1740458 0.02503 1.84863 down 1.03 up C7orf41 
4040097 0.00196 1.25603 up 1.85 down KLF6 
3190382 0.042135 1.48115 up 1.52 down SNORD48 
2970128 0.046357 1.0173 up 1.23 up ULBP1 
5340167 0.017281 1.30148 down 1.26 down RFWD3 
5340468 0.002404 1.16065 up 1.29 up ITGA2B 
5890440 0.006676 1.0146 up 1.2 up PKP4 
6520192 0.006703 1.17926 up 1.19 up YIF1B 
1990494 0.038065 1.01043 down 1.2 up FIG4 
270736 0.00716 1.31947 down 1.18 down TRABD 
2120465 0.023867 1.07869 down 1.29 up ZNF313 
7040142 0.012921 1.26061 down 1.38 up KYNU 
6860504 0.033955 1.28711 down 1.09 up  
1570255 0.017572 1.05125 down 1.21 up DEF6 
1980112 0.006234 1.03174 down 1.19 up C9orf90 
1850543 0.032567 1.10155 down 1.02 down TBX21 
2480661 0.017995 1.28997 down 1.51 down SUV420H1 
3370246 0.02583 1.15462 down 1.4 down IHPK2 
840161 0.025244 1.166 up 1.02 up H2BFWT 
6560722 0.041204 1.09426 up 1.34 up RASGRP2 
2650446 0.0053 1.14688 up 1.31 up GANAB 
270110 0.009969 1.0549 up 1.01 down LOC648200 
6020114 0.011907 1.09559 down 1.24 down ONECUT2 
2480431 0.001834 1.07459 up 1.23 up ONECUT2 
6760050 0.035808 1.00786 up 1.41 down CLPX 
1170717 0.006578 1.16608 down 1.21 up BTF3L4 
7160671 0.005844 1.0865 down 1 down PRPF6 
2470215 0.008193 1.05488 down 1.36 up NDST1 
2480603 0.004576 1.06065 up 1.06 up LOC651845 
3890289 0.014597 1.15304 down 1.02 down  
1770730 0.018975 1.20009 down 1.3 down SPAG9 
130164 0.034389 1.04205 down 1.19 down SPAG9 
4920546 0.049598 1.13523 up 1.15 up ARSA 
4490068 0.025023 1.21097 down 1.02 down UPK1B 
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670670 0.011241 1.16055 up 1.09 down LOC388503 
2630747 0.040167 1.02566 down 1.3 down KCTD5 
7550064 0.004226 1.14572 down 1.22 down KCTD5 
2030128 0.003539 1.01833 down 1.08 up  
2490300 0.025534 1.14251 down 1.04 up  
6510441 0.04372 1.16736 up 1.25 up  
2640725 0.035108 1.08175 up 1.09 up ARSJ 
6180300 0.010419 1.04985 down 1.27 up PIGK 
6760364 0.041633 1.11055 down 1.26 down LCOR 
4540722 0.0164 1.16788 down 1.04 up  
2450064 0.02054 1.18699 up 1.23 down NFE2L2 
7330047 0.042417 1.06397 up 1.04 down EIF5B 
3390047 0.01216 1.02707 up 1.1 down FREM2 
4760424 0.008049 1.04552 up 1 down EIF3K 
5490348 0.028487 1.12546 up 1.21 up AZI2 
1710630 0.002611 1.01623 up 1.68 up ST6GAL1 
7320139 0.041946 1.1789 down 1.27 down SOX8 
3930731 0.02436 1.16581 up 1.21 up DHRS7 
2810022 0.03006 1.18199 up 1.18 down C1orf163 
2680343 0.032302 1.13161 down 1.2 up  
3780010 0.03155 1.12985 up 1.07 up  
940010 0.021266 1.17345 up 1.27 up CHCHD10 
3520725 0.011209 1.16277 down 1.11 down LOC645634 
2810121 0.018606 1.16668 up 1.1 down INTS4 
7150670 0.014189 1.15837 down 1.02 up LOC390243 
3780221 0.018728 1.13884 down 1.28 up LOC643911 
1780619 0.010885 1.39656 down 1.52 down EHD1 
1050170 0.042675 1.06966 down 1.16 up IL22RA1 
2970632 0.044023 1.223 up 1.1 up RP9 
1500162 0.007366 1.03845 up 1.77 up PPP1R3F 
770593 0.007193 1.13463 down 1.28 up LSM8 
6450746 0.039273 1.16313 down 1.07 down POU5F1P1 
5910041 0.022425 1.17298 down 1.58 down RPL23AP7 
6220093 0.003844 1.21362 down 1.19 up ATXN7L3 
4060671 0.028837 1.02282 up 1.1 up LOC728089 
5340338 0.008654 1.61503 down 1.36 down E2F2 
4480059 0.001487 1.00622 down 1.22 up  
10201 0.043509 1.05334 down 1.15 down URG4 
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1440187 0.033422 1.07138 up 1.31 up STYXL1 
2000138 0.010979 1.07886 down 1.25 down LOC642197 
5220246 0.018959 1.09773 up 1.05 down C20orf173 
2690110 0.013735 1.12242 up 1.01 down  
5670706 0.017957 1.10891 down 1.75 up FAM171A1 
4760601 0.032934 1.10621 up 1.11 down LOC728014 
110162 0.049328 1.08062 down 1.03 up PACRG 
2760452 0.031075 1.0984 up 1.05 up RPS29 
4540273 0.017721 1.21954 up 1.14 up HERC3 
2600059 0.001423 1.06803 up 1.33 down GNPDA1 
2000669 0.03279 1.19552 up 1.07 down ARHGAP10 
6660411 0.028208 1.09702 up 1.2 down ALG13 
6110561 0.003534 1.38906 up 1.18 up MRPS27 
2600619 0.043383 1.16865 down 1.1 down ARPC4 
3460121 0.019056 1.05983 up 1.31 up TOMM20 
6590768 0.04478 1.09009 down 1.06 up  
4670088 0.012994 1.11897 up 1.04 down NNT 
5960181 0.007699 1.21153 up 2.31 up ASNS 
1780402 0.010878 1.0237 down 1.32 up SEPN1 
6060066 0.049347 1.13492 down 1.05 up ZNF415 
3520167 0.020588 1.27221 down 1.11 down CD63 
620092 0.001779 1.01666 down 1.26 up ATP6V0A2 
3870682 0.032127 1.01983 down 1.22 down PMS2CL 
5550193 0.012038 1.0629 down 1.22 up F8 
380468 0.023274 1.1917 up 1.57 down GMEB1 
4900279 0.018582 1.28388 up 1.46 down GMEB1 
6250402 0.006563 1.01586 up 1.11 up  
4540129 0.018364 1.06107 up 1.06 down KRTAP4-1 
4210050 0.010183 1.35565 down 1.35 down WDR54 
6280768 0.030622 1.25246 up 1.07 up  
150209 0.023775 1.0339 down 1.08 down  
510520 0.032151 1.12368 down 1.29 up ARHGAP22 
4920053 0.003334 1.04347 up 1.36 down BTG3 
6280360 0.012443 1.08036 down 1.14 down SPG7 
1300474 0.012364 1.15306 down 1.01 down  
2060612 0.046753 1.09238 up 1.18 down MRPL27 
7650278 0.032509 1.01994 down 1.21 down TRMT1 
6330601 0.041973 1.29022 up 1.23 up OR51D1 
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10725 0.002209 1.13528 down 1.21 up TMEM59 
7040477 0.003746 1.0269 down 1.12 up PLOD2 
3290639 0.031714 1.21257 down 1.56 down RAB7B 
3060397 0.003674 1.06674 up 1.01 down MAK16 
7050180 0.045623 1.16987 down 1.1 down SLC22A5 
6110286 0.037272 1.22553 up 1.02 down IMPG2 
1710092 0.011178 1.10647 down 1.02 up  
1240730 0.022541 1.15392 down 1.21 up SPINT2 
5960670 0.022871 1.13344 up 1.19 down ARID3B 
5570577 0.001526 1.1398 up 1.1 down C3orf38 
5690068 0.026331 1.24624 up 1.28 up LOC652388 
360341 0.03586 1.01659 up 1.11 up PPP3R2 
3120709 0.01818 1.35172 up 1.01 up CCNT1 
2030037 0.049789 1.01334 down 1.16 up KRTAP19-4 
770543 0.005456 1.33398 up 1.12 up DHPS 
2810605 0.026656 1.29219 down 1.07 down ZNF266 
1030156 0.038377 1.10111 up 1.11 up  
630315 0.001366 1.33547 up 3.84 down DHRS9 
7610180 0.028279 1.11137 down 1.02 up LOC644662 
2470189 0.038608 1.03147 up 1.08 up  
6250484 0.017964 1.01095 up 1.5 up CFH 
4890403 0.037871 1.0091 down 1.16 down MPDU1 
2710528 0.044708 1.03441 up 1.1 up  
6840600 1.58E-04 1.23174 down 3.02 up GLT25D2 
5420561 0.001117 1.1588 up 1.09 down CD276 
70168 0.002832 1.22303 down 1.06 up MED29 
650446 0.041464 1.17795 down 1.21 down SLC16A12 
3460743 0.024676 1.07992 down 1.16 up COL11A1 
2760370 0.012355 1.18626 up 1.66 up CALR 
1770678 0.022596 1.01459 down 1.36 up MRP63 
7000114 0.003236 1.40276 down 1.65 up PPIC 
2970735 2.90E-04 1.39927 down 1.54 up PPIC 
5810068 0.015729 1.12149 down 1.37 down SIPA1 
2690010 0.02653 1.11328 up 1.05 down LOC650620 
2970730 0.024914 1.10284 down 1.31 up MYADM 
4850274 0.044075 1.04851 up 1.11 down FAM123A 
1570484 7.66E-05 1.62343 down 2.04 up ATF5 
6980132 0.045053 1.07065 down 1.08 up LOC727805 
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7050437 0.049632 1.13171 up 1.18 up  
3930360 0.039237 1.09257 down 1.11 down DGKZ 
630706 0.002143 1.15033 up 1.71 down BTBD14A 
4060605 0.002188 1.03747 down 1.33 up MORN4 
6590435 0.046632 1.0325 down 1.14 up PCDHGC3 
2570307 0.013493 1.30771 up 1.01 down TTLL7 
3610372 0.010288 1.18237 up 1.08 up C3orf26 
3890398 0.044681 1.14409 up 1.11 down WBP2 
2490450 7.94E-05 1.22765 up 1.08 down LOC91561 
2710451 0.038835 1.08571 up 1.09 down LOC651894 
3940309 0.015209 1.08086 up 1.21 up CDAN1 
7330646 0.027297 1.27488 down 1.26 down ARS2 
6840164 0.017363 1.51688 down 1.08 down GPNMB 
6200180 0.036945 1.09921 up 1.11 up  
6250605 9.32E-04 1.45088 down 1.23 up RCCD1 
6560452 0.001578 1.06278 up 1 down  
770386 0.048216 1.07957 down 1.01 up  
2000647 0.016385 1.15503 up 1.01 up LOC654118 
2320358 0.016199 1.28367 down 1.14 down SLC39A8 
430639 0.014754 1.0781 down 1.34 up PCF11 
1570189 0.011595 1.17726 up 1.11 down ZNF669 
70451 0.008997 1.32146 down 1.56 up WAS 
3710754 0.04402 1.16072 up 1.09 up EIF3C 
430296 0.008259 1.08193 up 1.41 up HOXB9 
4830044 0.008581 1.05105 up 1.08 down TMED8 
1110095 0.008074 1.02739 down 1.17 down CLTB 
3140750 0.034952 1.17399 down 1.48 up RBM38 
3840753 0.007586 1.70745 up 1.06 up HEY1 
6220201 0.043931 1.96303 up 1 up HEY1 
1340600 0.041631 1.36079 up 1.2 down PPP1R15A 
510687 0.011993 1.0367 up 1.3 down ALDH1A2 
3890102 0.002135 1.03501 down 1.16 down NR4A1 
360187 0.002576 1.05805 up 1.71 down RIOK3 
3130474 0.011811 1.26329 down 1.02 down PANK2 
2340598 0.048593 1.10148 up 1.01 up ANKRD54 
7160228 0.027949 1.09362 down 1.25 down SLC12A4 
610296 0.010997 1.05252 up 1.04 up  
1450280 0.03873 1.15876 down 1.01 down NCAPG 
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6760487 0.002023 1.37224 up 1.17 up CXXC6 
2140114 0.030073 1.09559 up 1.02 up  
2100040 0.006058 1.09181 up 1.07 up  
4040181 0.025051 1.12169 down 1.34 up NUPR1 
6760286 5.08E-04 1.10221 down 1.59 up  
3890292 0.007732 1.27163 up 1.22 down RPS6KC1 
3450280 0.001771 1.19348 down 1.86 down PLEKHO1 
830739 0.008088 1.0551 up 1.18 down RPP21 
7510482 0.01974 1.05321 down 1.01 up RPS4X 
3360220 0.034284 1.19563 up 1.04 down RMND1 
870521 0.021916 1.14343 up 1.04 down DEFB134 
5720445 0.005056 1.30655 up 1.11 down SLC35F2 
5960678 0.006319 1.12006 up 1.15 up NISCH 
6020646 0.024664 1.05708 up 1.02 up CLK2P 
6860719 0.002463 1.23107 down 1.31 down PSCD1 
1230598 0.003855 1.09699 down 1.38 down SORD 
2450725 0.042603 1.27017 up 1.14 down SLC3A2 
6770014 0.007996 1.21901 up 1.32 up TPR 
1980452 0.039894 1.05746 down 1.11 up LOC402573 
240348 0.037161 1.01165 down 1.1 up PPM1F 
6110152 5.22E-04 1.40983 down 1.17 down C21orf62 
1450192 0.049181 1.27454 down 1.03 down CENPM 
2600008 0.04631 1.21095 down 1.07 up ZNF425 
6220451 0.019454 1.15252 up 1.27 down SLC25A4 
520228 0.042728 1.21222 down 1.09 up LOC644390 
7040709 0.031798 1.21606 up 1.11 up IGF2BP2 
4860682 0.005149 1.06249 up 1.04 down  
6900072 0.0443 1.05616 up 1.02 down AR 
6130368 0.039774 1.00737 down 1.36 up LOC729446 
510731 0.010087 1.4881 down 1.97 down RRM2 
2000392 0.001394 1.21618 up 1.18 down RPAP3 
4150278 0.022028 1.04762 up 1.25 down DUSP14 
20619 0.014416 1.11428 down 1.16 down ECAT8 
1500735 0.022985 1.01202 up 1.16 down CTSG 
3170280 0.004284 1.60331 up 1.41 up ZFPM2 
1070025 0.003059 1.28213 down 1.08 up ATPIF1 
6020368 0.010042 1.05118 down 1.38 down TATDN3 
1240356 0.009464 1.13863 up 1.17 up  
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5670037 0.047327 1.21302 down 1.13 up MUTYH 
940138 0.03734 1.13776 down 1.01 down HRCT1 
1090102 0.044465 1.06856 down 1.31 down ZNF274 
3780187 0.004725 1.28242 down 1.65 up GYPB 
3170750 0.011723 1.02822 down 1.11 down  
1260156 9.19E-04 1.35816 down 1.08 down LOC654194 
5810471 0.008974 1.02411 up 1.58 up MYO1F 
6450373 0.035815 1.07432 down 1.07 down DNMT3A 
3310746 0.019712 1.17407 up 1.03 down FAM35A 
1240553 0.020404 1.30843 down 1 up SESN1 
6040037 0.035542 1.14488 up 1.34 up CDC14B 
540113 0.001318 1.16721 up 1.34 up CDC14B 
3940364 0.005051 1.20858 down 1.12 up LOC347376 
7210408 0.014968 1.07392 down 1.07 down LOC652779 
730093 0.001562 1.57984 down 1.25 down SHD 
7050349 0.038151 1.04508 down 1.14 down DDA1 
4220088 0.009109 1.10519 up 1.24 up HSD17B4 
7610170 0.027779 1.25944 down 1.25 down ITLN1 
730725 0.017379 1.11413 down 1.07 down AOF2 
1780301 0.020454 1.09264 down 1.03 down LOC650985 
1660504 0.01701 1.27877 down 1.06 down ZNF181 
7560376 0.042211 1.06866 up 1.15 down LOC146439 
3190367 0.048579 1.14283 down 1.03 down LOC650812 
2510523 0.019088 1.0633 up 1.39 up RBCK1 
4010537 0.042126 1.23054 up 1.1 up  
1450341 0.007719 1.06316 down 1.3 up DLX1 
4810546 0.011852 1.25495 down 1.28 down FASTKD1 
160408 0.002802 1.04088 down 1.2 up FLJ35220 
4220367 0.003436 1.01414 down 1.09 up  
6650327 0.002754 1.17273 down 1.35 up CLGN 
360110 0.01527 1.47234 up 1.76 down KLF6 
2000692 0.021673 1.02939 up 1.03 down OR52R1 
4220619 0.006326 1.35474 down 1.1 down SEC15L2 
3800465 0.032836 1.11241 up 1.02 down FAM174B 
3440356 0.009413 1.04066 up 1.43 up TAF15 
3450722 0.010791 1.44509 down 2.23 down LOC644033 
940133 7.59E-04 1.07563 down 1.13 down  
6960692 0.042512 1.18117 down 1.05 down ZSCAN10 
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7550639 0.00842 1.04153 down 1.14 down GNPDA2 
4120333 0.002216 1.11903 up 1.81 up ERP29 
4780632 0.002932 1.06181 down 1.24 down POMT1 
5870010 0.049512 1.31092 down 1 up MLXIPL 
7160348 0.027382 1.02525 down 1.34 down MAPK6 
2900435 0.021057 1.09408 down 1.31 up SAP18 
1410132 0.031179 1.02465 up 1.08 down ACVR1B 
4570240 0.029981 1.06228 up 1.2 down ACVR1B 
6380021 0.014191 1.15808 up 1.16 down COQ10B 
1070612 0.002462 1.04345 down 1.39 up DVL3 
3830279 0.007876 1.15865 down 1.13 down  
3460477 0.023075 1.28132 down 1.1 up H3F3A 
3780725 0.034651 1.00408 up 1.16 up OSBPL9 
6900653 3.44E-04 1.17692 down 1.58 up  
5910689 0.004559 1.20428 down 1.17 up SMC4 
2120358 0.026955 1.44809 down 1.27 down OR4F21 
3440139 0.024973 1.35892 down 1.25 down OR4F21 
7650524 0.008996 1.34056 up 1.43 up BCAT1 
6590719 0.012344 1.01457 down 1.03 up  
7160343 0.001169 1.29715 down 1.23 down MYLK 
7400669 0.003606 1.15468 up 1.18 up ZC3H5 
4200634 0.04546 1.02665 up 1.22 up LOC441193 
6620601 0.001712 1.32538 up 1.38 down ZBTB40 
6100594 0.04422 1.18699 down 1.01 down PCBD2 
7050612 0.035549 1.12131 down 1.59 down TIAM2 
3940343 7.58E-05 1.19617 up 1.06 down TAF1B 
6280338 0.031121 1.00754 up 1.09 down  
290333 7.87E-04 1.51316 down 1.19 down CDCA4 
1300400 0.034453 1.01684 down 1.49 up SOBP 
3420167 0.046114 1.12426 up 1.09 up SOBP 
3830768 0.009795 1.06053 down 1.84 up SOBP 
7040039 0.00791 1.39326 up 1.07 up ZNF322A 
2480747 0.0109 1.10003 up 1.2 down PPP1R8 
2450528 0.017731 1.17035 up 1.08 up SLC39A12 
6650255 0.042731 1.09902 down 1.08 down  
6420008 0.039599 1.00812 up 1.2 up PROS1 
5260538 0.043994 1.04245 down 1.33 down C9orf30 
4180292 0.045037 1.27886 up 1.95 up ACSM3 
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6100719 0.016033 1.29104 up 1.2 up AP3D1 
4780253 0.010359 1.32618 up 1.1 up POLR3B 
1110092 0.012159 1.12042 up 1.41 up CTSD 
4920458 0.02898 1.09774 down 1.23 up CREB3L4 
4150397 0.042597 1.11758 up 1.17 up HEL308 
4040689 0.04414 1.02237 down 1.04 up  
6110113 0.042047 1.12938 up 1.14 down  
6220520 0.016677 1.07929 down 1.04 up SPAST 
1980674 0.027486 1.07816 down 1.18 up  
20056 0.01684 1.13046 up 1.09 down TPT1 
2450333 0.042784 1.26543 up 1.14 up LOC647797 
160605 0.014404 1.05256 down 1.3 up RASA3 
5390026 0.013087 1.09795 up 1.01 down  
6280092 0.035979 1.01242 down 1.14 up SLC25A23 
6580309 0.044055 1.22663 up 1.19 up  
2470093 0.01808 1.13564 up 1.25 down TJP2 
5910445 0.006578 1.16389 down 1.16 down CDAN1 
2690343 0.0201 1.11669 down 1.14 up TNNC1 
3180113 0.013333 1.06001 down 1.01 up  
3390739 0.009678 1.53825 down 1.07 up FNDC5 
3390437 0.026769 1.11172 up 1.09 down GLE1 
1850279 0.004941 2.11259 down 1.3 down LOC642570 
5860672 0.012519 1.0776 up 1.1 down  
610528 0.036568 1.19589 down 1.11 down MBD3 
6580487 0.036346 1.02773 down 1.06 up HSD17B11 
4570465 0.047968 1.03398 up 1.16 up ZXDA 
3940717 0.017676 1.14508 down 1.03 down LOC652251 
3120019 0.004132 1.06663 down 1.06 up  
2640328 0.03225 1.05158 up 1.1 down LOC727922 
7380167 0.010178 1.34217 down 1.16 up C21orf69 
6350477 0.015132 1.11383 down 1.49 up LOC283683 
1820500 0.040212 1.10983 up 1.14 up  
6450091 0.009132 1.07216 up 1.03 down  
3170072 0.031826 1.16648 down 1.18 up ASCC3L1 
6290437 0.02426 1.38148 up 1.29 up MTHFD1L 
7210402 0.040384 1.03391 up 1.16 down  
3370112 0.006762 1.16153 up 1.45 up RPN2 
110291 0.044209 1.0301 down 1.12 down LDHC 
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7550224 0.028804 1.44434 up 1.25 up TNRC15 
3310670 0.046488 1.06943 down 1.11 down  
3610382 0.009845 1.12646 down 1.08 down ABRA 
2680746 0.04334 1.03522 up 1.1 up CPLX1 
2640471 0.025456 1.15576 up 1.04 up RNF24 
2760102 0.021085 1.21518 down 1.02 down ANKMY1 
130630 0.030432 1.06694 up 1.02 down TMEM151A 
5340220 0.002735 2.05076 down 1.13 up MYBPHL 
6330377 0.006773 1.07477 up 1 up ATP6V0D1 
7380176 0.039747 1.10262 down 1.06 up C1orf126 
2690154 0.028255 1.09803 up 1.13 up  
3400088 0.029127 1.31705 down 1.24 down CXXC1 
4810626 0.001225 1.10783 up 1.11 up  
290403 0.034874 1.10874 up 1.01 down LOC645325 
3890373 0.003863 1.12073 down 2.01 up ITGB2 
1820592 0.002211 1.18018 down 1.9 down HIST2H2AA3 
5690402 0.019144 1.0384 down 1.16 down CLOCK 
270292 0.045239 1.29467 up 1.1 up FKBP1A 
1260017 0.044374 1.03906 down 1.27 down B3GAT1 
1990674 0.003213 1.01931 up 1.73 down NUP50 
6110064 0.039128 1.25549 down 1.06 down  
1010431 0.011211 1.62357 down 1.15 down CRYM 
940543 0.013298 1.00249 up 1.13 up PRTFDC1 
1990438 0.012755 1.15717 down 1.1 up PANK2 
3390228 0.040365 1.10283 up 1.09 down ACBD5 
2070195 0.032078 1.25637 down 1.32 down SNAPC4 
5050441 0.008881 1.26226 up 1.47 up ZEB2 
3190047 0.031121 1.18343 up 1.3 up  
7050300 0.012298 1.01887 up 1.32 down ZFP36L2 
4180553 0.039839 1.03831 down 1.19 down LOC389895 
4810482 0.024192 1.52047 up 1.02 down OPHN1 
6220551 0.01239 1.17539 up 1.06 down DYRK1A 
2680471 0.032652 1.13554 up 1.05 down ESD 
1780538 0.011967 1.11473 down 1.22 up SLC6A8 
4290332 0.028238 1.21114 up 1.05 down KIAA1586 
7550292 0.012344 1.10806 up 1.04 up SELENBP1 
2060400 0.048598 1.03751 up 1.11 down NKTR 
5900397 0.001836 1.05399 down 1.25 down NME2 
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4260411 0.007915 1.1256 up 1.07 down  
610433 0.0213 1.17939 down 1.03 down  
270204 0.014069 1.25453 up 1.18 up RFNG 
6520592 0.006873 1.19516 up 1.42 down SNHG4 
1450082 0.014538 1.09573 up 1.03 down TRAPPC2L 
1470170 0.013416 1.12536 up 1.15 down C18orf8 
4260750 0.046988 1.17757 up 1 down SFRS17A 
4060112 0.037182 1.34106 down 1.06 down FAM53A 
6660092 0.016108 1.04139 up 1.46 down CAMLG 
2060019 0.043161 1.06053 down 1.05 down  
6560433 1.54E-04 1.36696 up 1.2 down ARIH1 
4050746 0.016437 1.67619 up 1.7 up ZFHX3 
4850142 0.042443 1.22292 down 1.13 down KIAA1370 
4920202 0.035537 1.21257 up 1.12 up MAP1A 
6580593 9.70E-06 1.30179 down 1.53 up PPP1R3C 
3990131 0.025734 1.02683 down 1.13 down NUP107 
1510612 3.05E-04 1.59464 down 1.03 down MYL4 
6760091 0.003653 1.0823 down 1.16 up BDNF 
2640246 0.012854 1.10412 down 1.52 down CDC2L2 
460593 0.011103 1.2638 down 1.31 down ABCG1 
3800047 0.004643 1.16211 down 1.26 up AIF1 
5700561 0.028483 1.04596 down 1.2 down FAM118B 
6370500 0.041837 1.10512 down 1.11 up AGRN 
510672 0.027741 1.07244 down 1.46 down LOC731878 
6590309 0.033253 1.15004 down 1.31 down POLE4 
6650414 0.023939 1.13876 up 1.09 up  
4560110 0.007225 1.22836 up 1.41 up ARMET 
4230554 9.63E-04 1.20002 up 1.16 up REXO2 
5720242 0.023425 1.14062 down 1.15 up  
5390703 0.005557 1.11605 down 1.45 up SCARF2 
6040497 0.047615 1.01621 down 1.09 up  
4390162 0.004355 1.29474 down 1.21 down RFC2 
1070138 0.032142 1.11928 down 1.09 up  
7100064 0.004468 1.07202 up 1.29 up FBXO17 
2140047 0.01622 1.10421 up 1.35 up FBXO17 
1660241 0.041168 1.0038 down 1.31 up RYR2 
770221 7.98E-04 1.35062 down 1.05 down C20orf177 
4070167 0.049861 1.06246 down 1.13 up LOC645052 
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2120634 0.006778 1.30436 down 1.07 down CMTM4 
6220403 0.010037 1.48566 up 1.01 up PAK2 
2510100 0.0057 1.64602 up 1.2 up LOC441155 
7000132 0.003713 1.17665 down 1.07 up ST6GALNAC4 
2940541 0.028799 1.27414 down 1.42 down BLZF1 
6110731 0.042346 1.19426 up 1.45 up ITPK1 
5290019 0.004381 1.10608 down 1.21 down ZNF155 
5050368 0.028549 1.42597 down 1.02 down IL10RB 
6040288 0.020158 1.01842 up 1.08 up LOC728005 
6110307 0.033911 1.025 down 1.17 down MRPS34 
4150291 0.0162 1.35836 down 1.1 down LOC643466 
4210605 0.030748 1.03258 down 1.07 up  
450441 0.010728 1.15554 down 1.05 up  
2260010 0.002343 1.05714 up 1.5 down RIT1 
2030470 0.029213 1.07867 down 1.27 down ZNF283 
1240731 0.007306 1.02861 up 1.18 up RFPL3S 
4880379 0.004482 1.37682 up 1.15 up MAFF 
1430138 0.004973 1.1635 up 1.52 down MAFF 
4490500 0.030732 1.70322 down 1.7 down ITGAX 
7320110 8.05E-04 1.29426 up 1.01 down C6orf106 
5900504 0.029447 1.31445 up 1.18 down C6orf106 
840326 0.002552 1.10609 up 1.11 down USP1 
2450228 0.019412 1.12844 down 1.01 down DGKB 
1850348 0.019749 1.05201 down 1.19 down ERCC4 
7610050 0.024787 1.02995 down 1.23 down ABCC5 
450458 0.006853 1.08746 down 1.58 down PNPLA8 
5290465 0.007471 1.30374 down 1 up CASP7 
6200201 0.027211 1.07347 up 1.33 up DEPDC1 
6900019 0.015838 1.11893 down 2.01 up GLOD5 
70646 0.036467 1.12107 up 1.28 down CAPN2 
990121 0.018404 1.08268 down 1.02 up ARHGAP11A 
6200768 0.013024 1.18044 up 1.07 down PPP3R1 
4780541 0.019767 1.20987 down 1.23 down RAE1 
60524 0.02381 1.51785 up 1.01 up DENND1A 
3850021 0.007718 1.19029 down 1.45 up CASP4 
7100546 0.025855 1.05057 down 1.26 down LRWD1 
1430082 0.017063 1.14998 down 1.08 down LOC643693 
7040408 0.037402 1.44813 up 1.19 up LOC653354 
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6180402 0.016471 1.05413 down 1.24 down LOC644330 
5560327 0.027911 1.51889 down 1.01 down  
6370356 0.024621 1.28892 down 1.05 up EEF1A2 
870671 0.017477 1.25757 down 1.1 up BBS2 
1410246 0.011415 1.27301 down 1.1 up BBS2 
3940379 0.015726 1.20914 up 1.16 down DDX47 
940328 0.016679 1.00887 up 1.07 down  
4150195 0.024568 1.03836 up 1.2 down FKBP3 
7210192 0.028224 1.2976 down 1.19 down ADA 
6860551 0.004851 1.10275 up 1.06 down  
1500639 0.020276 1.19289 down 1.69 down  
50427 0.044979 1.00877 up 1.25 up TMEM106B 
1230477 0.047316 1.29828 down 1.13 down IRX5 
4640739 0.040205 1.06323 down 1.15 down  
4070086 0.034309 1.21618 up 1.01 up HAAO 
510689 0.004499 1.05785 up 1.11 down LOC643714 
1010068 3.67E-04 1.04111 down 1.16 up FKBP2 
5810600 0.030483 1.06176 up 1.3 up MAP3K5 
7040079 0.011477 1.21069 down 1.24 down AP1S1 
6040411 0.045902 1.02766 down 1.16 up KIAA1026 
5050603 0.012212 1.22228 down 1.12 up TBC1D10C 
1780647 0.002877 1.19124 down 1.22 up ADCK2 
6290328 0.003616 1.20742 up 1 down MAFG 
4230431 0.006789 1.3742 up 1.66 up CEBPG 
2070131 0.038285 1.52397 down 1.27 down CCNE1 
870497 0.023446 1.54545 down 1.2 down CCNE1 
2000382 0.016894 1.00993 up 1.13 up LOC643461 
3460685 0.007333 1.219 down 1.41 up KYNU 
5260386 0.012549 1.19877 up 1.1 down PCGF1 
2510687 0.0138 1.12232 up 1.14 down WARS2 
3140427 6.38E-04 1.21669 down 1.47 up UNQ2541 
4670609 0.021028 1.21643 down 1.18 down METT11D1 
4890259 0.0127 1.20658 up 1.1 down HIST1H2AD 
160152 0.019284 1.24209 up 1.14 down  
610278 0.003718 1.25889 down 1.03 up ### 
4070168 0.027054 1.17778 up 1.03 down METAP1 
4260050 0.019565 1.12875 up 1.27 down CASC5 
2490452 0.017557 1.09302 down 1.44 up GAA 
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4640242 0.035622 1.14727 down 1.24 up CEP70 
6770576 0.032807 1.07593 up 1.12 down C21orf91 
5290672 0.013685 1.01694 up 1.31 up ACYP2 
3120326 0.005113 1.14838 up 1.45 up ANGPT1 
270601 0.002728 1.3341 up 1 down HIAT1 
5960253 0.030368 1.29775 down 1.14 up TRMT5 
6220270 0.032359 1.08437 up 1.17 up BRD7 
3370270 0.04063 1.01839 up 1.09 down ZFY 
3400626 0.017097 1.2369 down 1.18 down SLC43A3 
770730 0.039201 1.17289 down 1.51 down ANXA2 
4810187 0.021549 1.00837 up 1.22 up STAT1 
5670092 0.021908 1.0968 down 1.07 down ING1 
430754 0.035546 1.01374 down 1.09 up RPLP0 
5420259 0.031307 1.07423 up 1.43 up CDC42EP1 
670376 0.006056 1.33403 down 1.18 down RUSC1 
10612 0.009539 1.35243 down 1.3 up RBM17 
4290110 0.017146 1.05848 down 1.04 up CYP4F3 
1190142 0.008601 1.06651 down 1.5 down EMILIN2 
2640379 0.008667 1.12056 down 1.09 up XPA 
2480408 0.01133 1.09197 down 1.02 up  
3170064 0.019958 1.21514 down 1.3 down MICB 
10255 0.007951 1.10188 down 1.08 up ATP1B2 
6180598 0.006053 1.10343 down 1.52 down NDUFAF1 
5050577 0.036067 1.36869 down 1.03 up PNPLA7 
1990278 0.02192 1.17788 up 1.7 up FCGR2A 
6270020 0.019958 1.02378 down 1.11 up ### 
1820035 0.026495 1.32889 down 1.28 down ZFYVE19 
6250192 0.013292 1.09065 down 1.39 up COL6A3 
460333 0.003689 1.18195 up 1.16 up SPAST 
2320093 0.018067 1.0689 up 1.21 up PIGY 
160189 0.009799 1.21459 up 1.17 up RYR1 
6200086 0.032723 1.03147 down 1.08 up PSAP 
4810180 0.025418 1.20111 up 1.05 up TERT 
2510091 0.032616 1.17865 up 1.18 up COL8A1 
2100082 0.01175 1.2175 up 1.03 down LOC653664 
6330187 0.038764 1.33703 up 1.16 up PLS1 
2570538 0.019151 1.1248 up 1.72 up SOX21 
5360241 0.046685 1.033 down 1.11 up GGCX 
196 
 
4540376 0.044528 1.39611 up 1 up FAM13A1 
6510397 0.006167 1.16225 up 1.49 down WDR19 
4760504 0.003778 1.03178 up 1.69 up  
2710168 0.034329 1.00619 down 1.06 down LOC132203 
3460091 0.030654 1.28138 down 1.18 down SMC6 
840717 0.047773 1.12638 down 1.49 down CTSL1 
4150189 0.02163 1.04996 down 1.45 down CTSL1 
4590128 0.030947 1.27798 up 1.03 up SHOC2 
2490446 0.012148 1.07206 down 1.25 up MAPK1 
620202 0.038387 1.14765 up 1.5 down OSGIN1 
990743 0.0078 1.75155 down 1.25 up DMKN 
20647 0.001904 1.14762 down 1.59 up ANTXR1 
4730341 0.008787 1.12603 up 1.02 up KIF27 
2470482 0.021322 1.12289 up 1.1 up LOC652879 
510484 0.018116 1.56546 down 1.06 up RAB40B 
540243 0.016203 1.24975 down 1.18 up NPL 
4670341 0.031219 1.11103 down 1.04 down  
770672 0.028552 1.05817 down 1.34 down THOP1 
5570132 0.03994 1.10015 up 1.21 up ACTB 
770440 0.021759 1.3522 down 1.27 down ULK1 
3360059 0.01826 1.39747 down 1.06 down CASP2 
6270072 0.012195 1.08381 down 1.1 down  
6380692 0.014173 1.09853 up 1.12 up BMP1 
2030347 0.04859 1.20063 up 1.06 down SPRY4 
730255 0.003239 1.13335 up 1.02 up TFDP3 
6580747 0.044943 1.05965 up 1.08 up  
870368 0.013271 1.0061 up 1.11 down LOC133993 
830661 0.016 1.07721 down 1.75 up DCBLD2 
60132 0.031888 1.16786 down 1.52 up DCBLD2 
6370678 0.044671 1.12953 up 1.31 up ROD1 
4560128 0.024875 1.11366 down 1.23 down HOXD12 
3840750 0.047116 1.07195 up 1.18 down GATC 
1710050 0.020394 1.09781 down 1.81 down CRYM 
7160475 0.01876 1.05924 down 1.28 down C6orf160 
6860010 0.008349 1.19421 up 1.05 up ZPBP2 
1110674 0.0074 1.31138 up 1.22 up ZNF420 
3290202 0.035639 1.06169 down 1.14 down  
2710762 0.036711 1.17713 up 1.1 up  
197 
 
770161 0.029616 1.50223 down 1.14 down C10orf73 
5260047 0.049532 1.06416 up 1.18 down FABP5 
5900746 0.004443 1.24463 up 1.25 down GNL3L 
2100706 0.014425 1.05177 down 1.28 up SORCS1 
5390246 0.022478 2.17184 down 2.96 down CCR7 
7560673 0.004638 1.20431 up 1.02 down NME1 
6510475 0.001873 1.08245 down 1.08 down MTRF1 
1740497 0.018482 1.15649 down 1.1 up RAB8B 
5550497 0.038568 1.0727 up 1.28 up ZNF10 
460711 0.036264 1.24245 up 1.18 up BAT2D1 
6560286 0.004907 2.25695 down 1.19 down LOC649856 
1400017 0.019106 1.10596 up 1.14 down CBX3 
6020468 0.024562 1.06764 up 1.12 up PPP1R14A 
6020543 0.020874 1.05612 up 1.17 up CPD 
1090035 0.024247 1.29672 down 1.03 down UBTF 
3710598 0.025745 1.18072 up 1.03 down PSTK 
270273 0.030227 1.09703 up 1.07 up  
5870309 0.009526 1.26473 down 1.12 down  
2630047 0.01169 1.3729 down 1.27 down  
2190730 0.001579 1.46342 up 1.11 down CEPT1 
2490593 0.010577 1.47943 down 1.01 up COL7A1 
780379 0.020975 1.09991 down 1.04 down  
3610112 0.003848 1.32112 down 1.02 up RAB11FIP3 
3370424 0.017646 1.12064 down 1.12 up ERCC6L 
5050181 0.016472 1.29524 down 1.2 down ERCC6L 
1440398 0.010221 1.09914 up 1.01 up LOC644511 
1470730 0.003554 1.1168 down 1.09 up LOC648362 
1010446 0.045137 1.09375 down 1.1 up C1QTNF6 
6200070 0.039809 1.16897 up 1.13 down LYG1 
160411 5.86E-04 1.05632 up 1.26 up NCOA1 
1510202 0.03037 1.26962 up 1.08 up RWDD1 
3370056 0.00321 1.00133 down 1.61 down KRT8 
3120279 0.007391 1.01903 down 1.28 down PRKAG2 
5900148 0.034615 1.02267 up 1.11 up  
2470746 0.029796 1.01996 down 1.18 down MAK10 
4490541 0.023928 1.17514 down 1.16 down  
110762 0.049348 1.03934 up 1.06 down  
7330594 0.019758 1.07375 down 1.09 up WDR88 
198 
 
5690148 0.015824 1.19088 up 1.01 up REPS2 
5130202 0.00523 1.29684 down 1.22 up CCDC25 
2000288 0.007987 1.18221 down 1.09 up CCDC25 
7320554 0.015583 1.04985 up 1.05 up  
6650451 0.005585 1.30626 up 1.33 up MYCBP2 
4050047 0.049514 1.0735 down 1.12 down  
6040487 0.001759 1.39795 up 1.29 down RAD21 
4220180 0.007242 1.26172 down 1.93 down WDR68 
6250070 0.043837 1.12848 up 1 down  
1850364 0.042412 1.00647 up 1.12 up ZNF550 
110390 0.029152 1.08808 down 1.27 up SLC25A34 
460047 0.021391 1.14038 down 1.08 up HACL1 
6520477 0.026859 1.01036 down 1.17 up LOC642771 
1980692 0.030754 1.16809 up 1.02 up LY6H 
6220487 0.036816 1.10939 up 1.1 up PCMT1 
7000014 0.00682 1.08595 down 1.35 down FAM50A 
460132 0.013978 1.02236 up 1.48 up ZNF75 
4200164 0.014961 1.05774 up 1.14 up LY6G6E 
610400 0.038623 1.01429 down 1.17 up C11orf1 
1300475 0.01428 1.12599 up 1 down FNDC7 
2340577 0.042689 1.23162 down 1.02 up AQP10 
2850192 0.004136 1.31011 down 1.11 down PPCS 
2940398 0.028859 1.02476 down 1.25 up CDCA2 
770762 0.004409 1.16449 up 1.06 up  
2850593 0.011466 1.19962 up 1.05 up TAAR1 
5260152 5.15E-04 1.02332 up 1.1 down LOC646717 
6220673 0.01475 1.26407 down 1.08 up SASH1 
20576 0.037877 1.00409 up 1.09 down HDAC3 
2850382 0.028752 1.09672 down 1.11 up TMTC4 
1820008 0.019821 1.15727 down 1.21 up METTL7A 
7160674 0.001535 1.26188 up 1.19 up UBQLN1 
3140368 0.049253 1.07284 up 1.01 down ADAMTSL1 
3710075 0.016859 1.4317 down 1.41 down SLC12A8 
7560180 0.034911 1.0902 up 1.29 up SUSD1 
630066 0.033501 1.11641 up 1.44 up LRP5 
3130377 0.038348 1.13762 down 1.08 up  
50735 0.00823 1.0108 down 1.19 up ADCY7 
240086 7.33E-04 1.36225 up 1.87 up PHGDH 
199 
 
3290176 0.041326 1.05672 down 1.01 down  
4210364 0.011736 1.24031 up 1.11 down PARG 
6560220 0.020079 1.02664 down 1.16 up PTPN22 
3310445 0.028993 1.11475 up 1.03 up MRPS26 
4200414 0.008888 1.19844 down 1.23 down PSPC1 
2070437 0.007236 1.29543 down 1.41 down LOC653631 
130576 0.001629 1.00567 down 1.47 up UNC5B 
130187 0.006169 1.45147 up 1.37 up PAPSS1 
290634 0.010443 1.09199 down 1.24 down LOC643935 
610086 0.012984 1.04511 down 1.07 up  
3400754 0.014108 1.03899 down 1.32 down LRRFIP1 
7040446 0.013721 1.24699 up 1.13 down RND2 
4050072 0.001376 1.02284 down 1.32 down TMEM189 
6520634 0.049205 1.04846 down 1.03 up  
7330019 0.024488 1.12583 up 1.68 up GYPA 
6510259 0.002117 3.20185 down 1.39 up DLK1 
4830653 0.008394 1.14195 down 1.4 down  
6270041 0.003406 1.1565 down 1.03 up AP2A2 
2260280 0.012175 1.16208 up 1.16 up GPATCH8 
1110112 0.011222 1.06365 down 1.36 down RECQL 
2070494 5.71E-04 1.05818 up 1.43 up PRC1 
3830605 0.032535 1.08068 down 1.29 down DNLZ 
2630017 0.002932 1.0152 up 1.7 up TPST2 
5690347 0.030903 1.04392 up 1.55 up TPST2 
1570014 0.019464 1.01736 up 1.4 up OSBPL2 
4180717 0.02661 1.1074 down 1.28 up OSBPL2 
2030280 0.007914 1.13523 up 1.38 up CAMK1D 
4210022 0.013743 1.02254 down 1.34 up CAMK1D 
5570519 0.016109 1.09039 up 1.23 up LOC401397 
2470079 0.007938 1.15427 down 1.29 down ZNF207 
2630474 0.003015 1.02835 up 1.23 down MLLT11 
4040193 0.016738 1.10196 up 1.04 down KIAA0953 
1710091 0.027254 1.38207 up 1.37 up IRS1 
1690487 0.007171 1.22935 down 1.1 up LOC285382 
5130725 0.021565 1.14484 up 1.02 up ABI1 
3890220 0.034666 1.12317 down 1.26 up TM2D3 
4480520 0.006656 1.13362 down 1.02 up HLTF 
2510280 0.029785 1.00944 up 1.08 down LOC643729 
200 
 
3870435 0.015315 1.16163 down 1.03 up FOXN1 
1010044 0.01686 1.07874 up 1.22 up NEBL 
3940408 0.014734 1.06473 up 1.1 down ACOX1 
3940097 0.017005 1.07585 up 1.19 down LIX1L 
2760255 0.048847 1.22297 up 1.08 down MTF2 
6770259 3.01E-04 1.33509 down 1.25 up FABP6 
3130743 0.022719 1.43103 down 1.23 up FABP6 
1980050 0.035373 1.02434 down 1.3 up MEX3D 
6330368 0.044397 1.03818 up 1.38 up ODF2 
6620403 0.006745 1.16473 up 1.54 up AGBL5 
7650554 0.049097 1.08597 up 1.05 up LOC728095 
270411 0.016539 1.34333 down 1.2 down  
3990682 0.006866 1.22354 up 1.03 down PDPK1 
5910608 0.041073 1.14215 up 1.02 down  
5050689 0.033371 1.01312 down 1.18 up PLD1 
7100300 0.048468 1.11374 up 1.12 up ZNF200 
1980521 0.009779 1.22053 down 1.13 up SLC44A2 
4860079 0.023212 1.00017 down 1.06 up EEFSEC 
1260615 0.010791 1.1948 up 1.2 up SETD2 
1090026 5.11E-04 1.07374 down 1.22 down PMPCA 
3120598 0.001225 1.16689 down 1.62 down AKR1C4 
2320215 0.009867 1.19181 up 1.8 up NUP210 
6590504 0.040371 1.10548 up 1.25 up FIBP 
5130128 0.031519 1.06639 up 1.21 up PLK1 
870020 0.012838 1.47195 down 1.21 down  
4070647 0.035693 1.09016 up 1.03 down ALDH3B2 
2100762 0.006917 1.12233 up 2.05 up INHBE 
130220 0.022029 1.03219 up 1.21 down MRTO4 
4560541 0.026781 1.15808 up 1.03 up MLKL 
4150079 0.019986 1.00459 up 1.2 up PRKAA1 
7040162 0.019577 1.11972 up 1.15 up C21orf59 
1010309 0.004644 1.02334 up 1.46 up SLC4A2 
1430286 0.016335 1.07596 up 1.23 down SLC25A20 
6220161 0.027595 1.03944 down 1.1 down SLC25A20 
6510338 0.005233 1.01123 up 1.1 down MYO19 
7510537 0.04648 1.0995 up 1.21 down SCO2 
6510148 0.008405 1.1223 up 1.22 down FTSJ1 
2650521 0.040409 1.20447 down 1.13 up LRPAP1 
201 
 
6770168 0.016556 1.03444 down 1.19 up CRTAP 
3190025 0.025062 1.033 down 1.15 up  
4860240 0.035764 1.35148 down 1.6 down DERPC 
4260504 0.029918 1.21128 up 1.08 up SNX14 
5670612 0.002949 1.07066 up 1.07 down DUXA 
2900626 0.049508 1.10831 up 1.32 up SRI 
2100400 0.007085 1.35002 down 1.19 up TNFAIP2 
520484 0.01768 1.09894 down 1.3 up USP15 
150280 0.044592 1.00821 down 1.18 down HECTD3 
3400598 0.006003 1.18431 down 1.51 up WIPI1 
5270091 0.013779 1.25142 down 1.07 up FOXL2 
1510241 2.57E-04 1.20453 down 1.26 up FOXL2 
5310209 0.006567 1.59911 down 1.39 down TAC3 
6590156 0.025162 1.15272 down 1.44 down KIAA0363 
4490278 0.023658 1.69439 down 1.52 down C15orf26 
6270273 0.017081 1.01267 up 1.27 up KHDRBS3 
4010603 0.005073 1.06748 down 1.22 down VASP 
5090072 0.047612 1.26555 down 1.17 down C9orf80 
990475 0.002823 1.1651 up 1.03 up C9orf80 
2340187 0.006493 1.16909 down 1.41 up MYO3B 
2750608 0.013683 1.16716 down 1.06 down RABGEF1 
3370360 0.00245 1.0935 down 1.25 up LOC651380 
7050682 0.019056 1.00417 up 1.29 up SEMA6A 
6420288 0.035367 1.38812 down 1.07 down RNF215 
5550402 0.009022 1.09407 down 1.09 up PHF19 
3710544 0.048327 1.11291 up 1.02 up EIF1 
3460707 0.013064 1.30566 down 1.15 down STMN1 
5860201 0.038517 1.03628 down 1.08 up SNRPD2 
3360445 0.045173 1.21512 up 1.41 up USP21 
6110209 0.014932 1.17374 up 1.47 up RSU1 
2510477 0.048688 1.0907 up 1.56 up B3GALT6 
7000154 0.008032 1.15696 down 1.03 down ZNF624 
2760376 0.042145 1.14924 down 1.05 down PSMB1 
20279 6.23E-04 1.12776 down 1.49 up  
2260255 0.044804 1.11084 up 1.4 up NFATC3 
3780435 0.01031 1.10837 down 1.29 down GART 
4780113 0.037481 1.25145 up 1.05 up CALN1 
1470470 0.01569 1.13205 down 1.11 up GPR97 
202 
 
7610739 0.043675 1.19494 down 1.01 up ZNF553 
4670301 0.008307 1.00277 down 1.15 down FNDC3A 
2350440 0.001913 1.04579 down 1.13 up NXF3 
1470093 0.029425 1.17312 down 1.12 down LOC440776 
2810326 0.001278 1.31522 down 1.06 up WBSCR27 
5130093 0.008255 1.14878 down 1.18 down PHLDB1 
4850059 0.012941 1.05036 up 1.34 down LOC643300 
5570754 0.040543 1.17801 down 1.17 down DNPEP 
830682 0.040644 1.14353 up 1.1 down LOC387934 
6580402 0.007798 1.27588 up 1.98 down LOC646463 
7510204 0.038563 1.01088 up 1.13 up CWC15 
1110091 0.001012 1.19345 up 1.08 down TIAL1 
3170543 0.031032 1.24867 up 1.1 down TIAL1 
4730301 0.008848 1.17985 up 1.03 up  
840341 0.003662 1.05724 down 1.11 down  
6590400 0.003795 1.08676 up 1.29 up XPO5 
770575 0.004983 3.0584 down 1.57 down TSPAN32 
3170468 0.040763 1.18155 up 1.07 down CSNK1A1 
6980632 0.012757 1.31131 down 1.38 down LMTK3 
4890670 0.006141 1.44424 down 1.43 down C1orf61 
4220450 0.047538 1.09132 up 1.12 up  
7400719 0.022152 1.08057 up 1.16 up EXOSC1 
1450441 0.021346 1.09855 up 1.23 down ERBB2IP 
1050750 9.16E-04 1.01786 up 1.34 up CLPTM1L 
2690022 0.004495 1.11538 up 1.4 up CIAO1 
6980156 0.010885 1.06818 down 1.49 up CIAO1 
2650102 0.006733 1.09983 down 1.2 up ZNF792 
2810706 0.025833 1.21404 up 1.21 up FERD3L 
3360014 0.029186 1.23665 down 1.07 up TCEAL1 
540075 0.047736 1.12601 down 1.15 up NPC2 
3370349 0.044962 1.11808 down 1.21 down CFB 
1580154 0.015507 1.49907 down 1.13 down LOC650024 
3990239 0.045137 1.14552 down 1.17 down  
3840594 0.006312 1.23761 down 1.02 up LSM4 
1850575 0.009033 1.06039 up 1.29 up CHD6 
6760022 0.023848 1.13788 up 1.25 up MRPL35 
2510392 0.024353 1.0269 down 1.18 up TMEM43 
4070100 0.049661 1.19114 up 1.06 up LOC649044 
203 
 
3290577 0.011918 1.10536 down 1.36 down CCDC74A 
3400397 0.010012 1.01579 down 1.15 down EML3 
1850600 0.033744 1.13769 up 1.02 down  
5690575 0.003232 1.16371 up 1.07 up SLC22A12 
840241 0.016727 1.23366 down 1.67 down 
TMEM189-
UBE2V1 
2320041 0.003476 1.00359 up 1.36 down 
TMEM189-
UBE2V1 
7650592 0.0335 1.39028 down 1.22 down PSMC3IP 
5810541 0.031547 1.2306 up 1.07 up TBRG4 
1580538 0.034876 1.14629 down 1.02 down  
2340414 0.040586 1.18022 up 1.01 up  
3520768 0.04108 1.01739 down 1.21 down TAGLN3 
4230626 0.003971 1.06458 down 1.44 down PRKCD 
4780193 0.01092 1.08871 up 1.15 down POFUT2 
7050138 0.042271 1.00745 down 1.22 down RQCD1 
2680382 0.004368 1.47838 up 1.02 up LEPR 
1170220 0.041056 1.58551 down 1.79 down AHSA2 
4180338 0.005765 1.24985 down 1.45 up LGALS12 
3310403 0.008403 1.07263 down 1.02 down  
5340019 0.028773 1.2406 down 1.01 down  
2690369 0.027788 1.43224 up 1.09 down ACPT 
380553 0.025878 1.01883 down 1.06 down  
2260110 0.005104 1.17607 down 1.1 up GRIK1 
1300703 0.049369 1.02578 down 1.09 up C8orf71 
1430537 0.046074 1.12084 down 1.12 up TMEM106C 
520577 7.44E-04 1.08892 up 1.04 down TIMM23 
5050608 0.048645 1.05647 up 1.09 down TIMM23 
2600138 0.014146 1.07045 up 1.52 down IDS 
6520180 6.87E-04 1.58376 down 1.21 up IL18RAP 
1820037 0.011411 1.02562 down 1.15 down SLC11A2 
2760403 0.007445 1.27081 down 1.07 up GABRE 
5130474 0.005342 1.84296 down 1.09 up GABRE 
6580703 0.001804 2.21944 down 1.15 up  
5270681 0.032341 1.05256 up 1.18 up TMEM110 
6450196 0.010299 1.00272 down 1.08 up GOLGA8E 
5340451 0.002506 1.21795 down 1.41 up FLJ11795 
1980059 0.022325 1.15441 down 1.18 up RASSF2 
1740255 0.012436 1.10016 down 1.13 down KCNAB3 
6060148 0.04186 1.13504 down 1.08 up TRAPPC2 
204 
 
1070575 0.03143 1.22708 up 1.23 down LOC57228 
4050735 0.029599 1.08203 up 1.16 down XPOT 
70136 0.014602 1.23152 down 1.15 down  
4570296 0.034533 1.20189 up 1.02 down USE1 
650630 0.018377 1.10211 down 1.02 up POU2F2 
1580400 0.019113 1.182 up 1.04 down TTC26 
1470475 0.00561 1.19929 up 1.08 up SECISBP2 
3060341 0.043484 1.19545 down 1.06 down LOC440993 
6020474 0.021004 1.1904 up 1.07 up SELS 
5260301 0.024905 1.01262 up 1.11 up  
1580215 0.040578 1.00259 down 1.19 down FBXL6 
1450358 0.001962 1.46327 down 2.06 up HBD 
2450465 0.0049 1.34068 down 1.16 up CYBRD1 
3420270 0.04265 1.0471 down 1.35 up IFT52 
1070451 0.002303 1.09262 up 1.55 down ANXA5 
4760088 0.03437 1.03989 down 1.1 down LOC647041 
7550408 0.008634 1.17502 up 1.09 up CRYBA2 
2000021 0.00567 1.22755 up 1 up TTC7A 
3840072 0.001133 1.98903 down 1.49 up PRG2 
4060333 0.010397 1.02983 down 1.22 up VEGFB 
6040056 0.019793 1.07316 down 1.05 down  
4860364 0.048473 1.0333 down 1.1 down  
2680020 0.002203 1.03147 up 1.45 down DAGLB 
6040279 0.021822 1.28654 up 1.01 up C20orf7 
3610280 0.01376 1.32017 down 1.14 up C9orf127 
2850133 0.016253 1.08125 up 1.11 down SYCE1 
2360646 0.045248 1.00276 down 1.17 up SLC9A11 
4070601 0.012457 1.04215 up 1.11 down ALLC 
4060639 0.006956 1.15163 down 1.04 up ALLC 
20465 0.015341 1.19813 up 1.09 down MRPL36 
6220593 0.03996 1.31724 down 1.25 down MGAT4A 
2640484 0.028219 1.01738 down 1.13 up LOC647310 
1740167 0.005556 1.56472 down 1.37 down PPFIA4 
4290278 0.014746 1.08182 down 1.56 up WT1 
3460564 0.006923 1.03598 up 1.49 up PRKCB1 
4120347 0.017133 1.29534 down 1.75 down DKFZp434N035 
4220195 0.001851 1.2803 down 1.41 down DKFZp434N035 
6270037 0.014761 1.19187 up 1.15 up RAPGEF1 
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5720100 0.045716 1.00947 down 1.24 down ZNF562 
2680128 0.018473 1.01353 up 1.22 up TMBIM4 
1070685 0.046781 1.14426 up 1.08 down LOC606495 
6760605 0.049636 1.08069 up 1.1 down DEDD 
4900072 0.013912 1.05659 down 1.26 down  
5420504 0.049857 1.11905 down 1.05 up TSKS 
2140553 0.027512 1.0089 up 1.33 up RCOR2 
3140193 0.01537 1.14661 down 1.27 up NELF 
4180646 0.007905 1.07604 up 1.03 down LOC399753 
4860543 0.014456 1.37832 down 1.5 down BOLA2 
2470463 0.034379 1.17691 up 1.09 up C11orf54 
1570424 0.007217 1.28805 up 1.2 up WNK1 
5550682 0.02357 1.10027 up 1.36 up WNK1 
4490133 0.003138 1.05177 down 1.35 up SFRS2B 
2600484 0.044323 1.08425 up 1.07 up  
3930168 0.013022 1.08503 down 1.09 up FEZ1 
4490687 0.046041 1.01878 down 1.51 up GBGT1 
20521 0.026955 1.18608 down 1.33 down MASTL 
60215 0.010928 1.32281 up 1.18 down CDCP1 
1010719 0.035278 1.3379 down 1.28 down FEN1 
620603 0.010803 1.22437 up 1.07 down  
3780431 0.026744 1.01744 up 1.24 up CD200R2 
2490411 5.35E-04 1.06383 down 1.09 up ITGB5 
2650114 0.04434 1.1594 down 1.09 up ITGB5 
4590022 0.035381 1.09903 down 1.25 up  
1510139 0.0211 1.07451 down 1.69 up  
2640647 0.040875 1.02033 up 1.04 down NFASC 
510487 0.001138 1.17193 down 1.12 up TFDP1 
270243 0.045103 1.15693 down 1.02 up SLMAP 
3420300 0.008684 1.31433 down 1.13 up EEF2K 
6220475 0.007265 1.05607 up 1.08 up LOC642104 
6250685 0.013603 1.05266 up 1.24 up PAK1 
5420544 0.030088 1.08837 down 1.15 up SFT2D3 
770471 0.014067 1.06571 up 1.15 up LST1 
650315 0.022383 1.04423 up 1.22 up ETF1 
3420403 0.022056 1.16045 down 1.05 up ST7OT1 
3310358 0.018981 1.14357 down 1.26 down PHKG2 
3400450 0.033272 1.11255 down 1.38 down CHKB 
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3060661 0.00135 1.1442 up 1.37 up C10orf97 
4220520 0.011832 1.22073 up 1.09 down TMEM57 
6370241 0.003524 1.0961 down 1.35 down ZBTB44 
5820253 0.015947 1.09563 down 1.01 up  
1850193 8.24E-04 1.27904 down 1.07 down ISCA1 
6620577 0.033138 1.06897 up 1.22 up TTC23 
6980274 0.047005 1.11034 up 1.21 down GLRX2 
6420180 3.41E-04 1.12019 down 1.29 down TJAP1 
5690373 0.002003 1.5339 up 1.31 up GOT1 
130743 0.002633 1.05035 up 1.37 up CLEC4C 
1850593 0.029887 1.07489 down 1.17 up AP1G1 
6480221 0.041575 1.04788 down 1.13 down  
4150670 0.010207 1.15826 down 1.14 down CDC37 
5080523 0.023565 1.4204 up 1.02 down EHD2 
5130475 0.038761 1.07323 down 1.14 down FLJ00312 
870632 0.007203 1.63742 down 1.24 up  
5960682 0.036297 1.15838 down 1.01 up RBPMS2 
3520121 0.023129 1.24561 up 1.74 up RPL28 
2640048 0.014862 1.22227 up 1.07 down GAPDH 
5360382 0.003281 1.06747 up 1.27 up SPTB 
1940239 0.019048 1.19257 down 1.09 down C9orf163 
4210309 0.005154 1.24063 up 1.07 down TMED5 
2970646 0.046302 1.2015 up 1.01 down PLAC2 
6270524 0.022297 1.26079 up 1.18 up ZC3H8 
1430113 0.036907 1.12276 up 1.22 down LOC728505 
4860020 0.036384 1.15063 down 1.09 down  
380338 0.012005 1.01938 up 1.11 down  
1660600 0.047663 1.1449 down 1.18 down LOC728468 
3130113 0.047557 1.09038 up 1.05 up PDE6A 
430546 2.01E-05 1.33106 up 1.73 down HIST1H2BG 
1740026 0.03516 1.16266 down 1.01 up LOC653962 
4860368 5.53E-04 1.00061 up 1.3 down TMEM22 
2640711 0.043162 1.01651 up 1.04 down SMAD5 
1710189 0.012416 1.34802 down 1.91 down RHBDF1 
1300369 0.003218 1.18987 down 1.67 down LOC255783 
4920209 0.046742 1.0582 up 1.03 down LOC644359 
130543 0.015237 1.09891 down 1.01 down  
5080682 0.005373 1.17584 down 1.14 up CTDSP1 
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7160167 0.041838 1.22043 up 1.07 down ALKBH1 
3360056 4.66E-04 1.23881 up 1.08 down ALKBH1 
7320471 0.002282 1.15004 up 1.78 up TFAP2B 
5820646 0.02359 1.0155 up 1.2 up CALCOCO2 
3130634 0.024638 1.15861 down 1.18 down  
3420121 0.031119 1.03737 down 1.24 down ARS2 
1740100 0.003137 1.17737 up 1.56 up PAX6 
7100008 0.017009 1.22925 down 1.18 down C14orf80 
5220750 0.003859 1.18514 down 1.14 down  
4050138 0.005138 1.28517 up 2.05 up GPR98 
5290333 0.014568 1.03491 down 1.07 down ZNF533 
3450142 0.048475 1.1336 up 1 down LOC644266 
4570184 0.033866 1.17488 up 1.21 up PCSK6 
6760730 0.009308 1.36015 up 1.11 up RSRC1 
6960215 0.007002 1.07428 up 1.15 up PITPNM1 
3440739 0.015098 1.80457 down 1.16 down HBB 
360440 0.0303 1.08736 up 1.08 up LOC653461 
5050500 0.001152 1.22284 down 1.03 down ZBTB9 
2190278 0.014239 1.11635 down 1.06 down SCARA3 
6110195 0.020189 1.63537 down 1.25 down ZCCHC24 
1240047 0.041356 1.0696 down 1.37 down DPP7 
3290431 0.013439 1.08426 down 1.17 down UNC45A 
5340327 0.029802 1.19537 up 1.31 up EIF4ENIF1 
3520056 0.00653 1.36279 up 1.37 down ETNK1 
4900689 0.019259 1.31882 down 1.14 up LOC63920 
2320289 0.003015 1.15846 up 1.02 down GLUD1 
2680278 0.026802 1.18814 down 1.14 down FAM111A 
2190241 0.008822 1.13876 down 1.34 down AP1M1 
5550438 0.038877 1.0581 down 1.07 down  
1340192 0.018286 1.44324 down 1.2 down REEP1 
6840390 0.032925 1.13951 down 1.1 up FBXL16 
1090438 0.029539 1.14474 down 1.03 up ZMYND8 
5390333 0.002129 1.85394 down 1.09 down TMEM98 
6650438 8.70E-05 1.15397 down 1.36 up SYNGR1 
1510082 0.032152 1.24987 up 1.3 up LARP2 
6650634 0.009934 1.26138 up 1.39 up KIAA0460 
4560743 0.028312 1.10769 down 1.27 up CD96 
3450598 0.04819 1.45947 down 1.37 down TM4SF19 
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2070451 3.39E-04 1.09191 down 1.5 up PAQR8 
6200437 0.017929 1.37846 up 1.28 up AP3M1 
6580450 0.045661 1.0447 up 1.55 up BCL11A 
1340491 0.014463 1.22526 down 1.09 down SP110 
2640286 0.00839 1.32948 down 1.41 down HBA2 
4040672 0.026673 1.20809 up 1.1 down DDX47 
5700400 0.042691 1.11624 down 1.06 down  
4860343 0.013922 1.03137 up 1.36 up MAP4K4 
2690601 0.043493 1.24595 down 1.02 up ARPC4 
4390450 0.018754 1.16122 up 2.23 down SGK 
7570025 5.94E-04 1.06653 up 1.03 up C11orf45 
2710379 0.002815 1.10388 up 1.18 down SPATA5 
3180154 0.002334 1.36138 down 1.15 down HFE2 
1260129 0.002541 1.01499 down 1.26 up TMED10P 
5910424 0.013234 1.08191 up 1.49 up SLC29A1 
20292 0.018717 1.01279 up 1.15 down MCOLN3 
6760706 0.037861 1.23725 down 1.27 down MCOLN3 
4050451 0.013151 1.14375 up 1.34 up TPP2 
4670097 0.00596 1.08221 up 1.06 down RAB27B 
4560487 0.002664 1.35089 up 1.45 up MAPK8IP2 
6290707 0.009204 1.01196 up 1.11 down SERPINB5 
3780736 0.01502 1.15138 down 1.06 up  
7160379 0.034877 1.08627 down 1.04 up  
830575 0.034491 1.30201 up 1.29 down SNORD38A 
990008 0.014154 1.11325 down 1.09 down SMARCD3 
7330180 0.024515 1.37653 up 1.22 up AUH 
6900725 0.021269 1.45284 up 1.35 up DHX9 
2900379 0.034684 1.18586 down 1.18 down DHX9 
6330537 0.032191 1.21707 down 1.18 down DHX9 
2810392 0.002475 1.05941 down 1.28 up LOC90120 
4150482 0.035379 1.08293 down 1.09 down DOM3Z 
2350711 0.012746 1.02922 down 1.13 up LOC391742 
5290605 0.033904 1.02504 down 1.1 up PFTK2 
3060392 0.010009 1.40756 down 1.04 down  
1030593 0.026509 1.19284 up 1.3 up OS9 
3190672 0.028436 1.09602 up 1.13 down EID3 
1230093 0.004182 1.10192 up 1.17 up EDA 
6370097 6.83E-04 1.26241 up 1.17 up TUFM 
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3940414 0.001015 1.11962 down 1.15 down SFRS2 
7000475 0.01492 1.06594 up 1.12 up HINT1 
6760154 0.003817 1.11396 down 1.26 up SLC25A29 
7210154 0.004529 1.04653 down 1.16 down BIRC3 
5390204 0.042081 1.0126 up 1.11 down SCARF1 
6520537 0.022425 1.01189 down 1.14 up VPS24 
5870487 0.008239 1.02489 up 1.46 up IMMP2L 
5700747 0.018023 1.24099 up 1.02 up DCBLD1 
3120475 0.001943 1.34016 down 1.28 up MAP7 
2000431 0.011407 1.0381 down 1.26 down TMEM159 
4760020 0.043476 1.18537 down 1.06 down UROD 
5050403 0.035612 1.32344 down 1.57 down TDH 
5080037 0.013141 1.20233 down 1.04 down HES2 
360450 0.023702 1.17011 down 1.24 down  
730274 0.008821 1.34176 down 1.86 down MCM7 
4210670 0.004929 1.20547 down 1.11 up PAM 
4070661 0.025914 1.13488 down 1.15 up AZIN1 
6620768 0.003222 1.21459 up 1.01 up MVK 
4200450 0.018839 1.01695 down 1.23 down G6PD 
6650543 3.62E-04 1.04772 down 1.36 down VHL 
4070132 0.037183 1.18318 up 1.08 down PPAT 
7320528 0.044693 1.02901 up 1.14 up MGC46336 
3610735 0.026555 1.22841 down 1.02 down F12 
2120167 0.015507 1.09613 down 1.03 down IL9 
3180528 0.025919 1.37058 down 1.17 down MMP9 
5560110 0.032134 1.42406 up 1.15 up DLG4 
5080709 0.045093 1.45537 down 1.36 down DUSP22 
6520681 0.004564 1.27095 up 1.52 up PYCR1 
2650156 0.002065 1.22754 up 1.34 up TAP2 
3290242 0.012511 1.05364 up 1.31 up PDS5A 
5360112 0.049775 1.07928 down 1.01 up TCF21 
10326 0.015198 1.01373 down 1.1 up  
1470551 0.001307 1.19045 down 1.03 down KIAA0746 
4880703 0.011829 1.4639 up 1.16 down UBQLN1 
4230484 0.023717 1.32496 up 1.31 down UBQLN1 
1430129 0.040068 1.0436 up 1.46 up KIF4A 
3450300 2.07E-04 1.50427 up 1.41 down C18orf19 
360626 0.014562 1.24114 up 1.53 up CMIP 
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1400703 0.002009 1.2002 down 1.32 up CPVL 
3990553 0.018175 1.08349 down 1.57 up  
3170431 0.003733 1.48729 down 1.52 down LRCH4 
7050543 0.014639 1.00217 down 1.4 down TUBB2B 
3850167 0.01333 1.05052 up 1.11 up NUDT3 
6590397 0.048486 1.04389 down 1.15 down C10orf4 
430731 0.034554 1.30208 down 1.1 down WDR53 
4590064 0.006163 1.31402 down 1.26 down CDK2 
1570341 0.020031 1.33679 down 1.17 up C3orf72 
5960133 0.04759 1.12755 up 1.14 up NFIB 
3290224 0.007712 1.05569 up 1.43 up IRF2BP2 
6660768 0.00427 1.49827 up 1.05 up IRF2BP2 
7200431 0.034311 1.30337 up 1.25 down GABPB2 
6040767 0.049944 1.31024 down 1.18 down PIGQ 
2140176 0.047739 1.12492 down 1.15 up THYN1 
5690451 0.002518 1.07051 down 1.08 down NOS2A 
3060692 0.009331 1.09507 down 1.34 up CERK 
3460010 0.019532 1.25577 down 1.07 up MYL5 
6110577 0.006877 1.1839 down 1.15 up MYL5 
2650725 0.020879 1.10494 down 1.14 up  
830735 0.015165 1.09365 down 1.42 up CENTA1 
1230358 0.004603 1.08088 down 1.31 up GRSF1 
1440041 0.031004 1.15691 up 1.09 up LOC400197 
6380193 0.046464 1.12522 down 1.11 down DLX3 
7550608 0.027674 1.43997 down 1.05 up TMEM9B 
4540563 0.015891 1.27248 down 1.26 down OR4F16 
4180204 0.0173 1.23236 up 1.7 up NCOR2 
50398 0.048055 1.0239 down 1.38 up  
2810619 0.047655 1.07216 down 1.08 down  
6980162 0.026276 1.14998 down 1.41 down GALE 
7610435 0.016433 1.11247 down 1.06 down LOC390483 
60095 0.020698 1.04719 down 1.17 up CCPG1 
6220674 0.028929 1.05194 up 1.41 up CCPG1 
5550431 0.045475 1.38638 down 1.02 down MMD 
1710075 0.037597 1.05284 up 1.08 down  
2750376 0.005994 1.24871 up 1.1 up ZNF77 
240156 0.025901 1.01824 up 1.32 down MORC3 
4290142 0.008412 1.12102 down 1.42 down LPCAT1 
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2480332 0.039921 1.11905 down 1.19 up  
1940255 0.017013 1.27429 down 1.05 up TBXA2R 
6660681 0.008153 1.04172 up 1.19 up TBXA2R 
2320079 0.002258 1.06496 down 1.2 up NME4 
1300603 0.001412 1.25339 down 1.22 up SH3GL3 
20487 0.029412 1.08362 up 1.24 up RNF13 
4880551 0.006876 1.06139 up 1.22 up RBM42 
460113 0.006649 1.55597 down 1.11 up MAGED1 
6960288 0.007249 1.09497 up 1.31 up  
6860717 0.015313 1.12229 down 1.59 up HOXC4 
4490767 0.005166 1.19245 down 1.01 up  
3290296 0.026625 1.09886 up 1.17 up MRPS14 
6330474 0.047538 1.02933 up 1.06 down CD151 
5960332 0.040204 1.48404 up 1.19 up SLC39A10 
3610554 0.005635 1.23591 up 1.17 down ARFGEF2 
4920364 0.00113 1.00323 down 1.13 down LOC728654 
2450026 0.008232 1.08395 down 1.1 up  
6560747 0.045462 1.20909 up 1.25 up USP5 
5700370 0.012116 1.19885 up 1.1 up POLDIP3 
3060292 0.001054 1.17258 up 1.66 up LAMP2 
1260274 0.034888 1.10182 up 1.01 down HIP1R 
2940154 0.002555 1.0672 down 1.09 up C1orf182 
520730 0.006712 1.12459 down 1.06 down LOC387756 
2630541 0.039985 1.11877 down 1.04 down  
3520010 0.018359 1.15519 up 1.03 down LOC644429 
5570020 0.009475 1.15204 down 1.66 down RAET1G 
6200010 0.017432 1.06995 up 1.07 down  
5870678 0.020355 1.34032 up 1.6 down LOC441763 
5050681 8.74E-04 1.64178 down 1.22 up TESC 
6350017 0.002589 1.06596 down 1.25 down KIAA1862 
4390382 5.41E-04 1.08584 down 1.5 up KIAA0182 
6200161 0.010263 1.31587 down 1.11 down CECR6 
3840288 8.97E-04 1.16946 down 1.43 up LRFN3 
3290709 0.036383 1.10267 down 1.13 up  
4490475 0.001471 1.50667 down 1.63 down SLC30A3 
3390291 0.016375 1.20315 up 1.07 up MANBAL 
4200575 0.028772 1.1496 down 1.18 up VAMP2 
5290484 5.76E-04 1.17754 up 1.06 down SAR1B 
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150048 0.003182 1.16736 up 1.19 down SEC24B 
2750719 0.004938 1.4035 up 1.11 up DDX21 
5290634 0.019045 1.25508 down 1.05 up BCL2L12 
7550753 0.010495 1.429 down 1.08 up BCL2L12 
7200427 6.94E-04 1.03915 down 1.05 up APLN 
5810452 0.0378 1.10847 up 1.14 up GTF2F1 
3610148 0.007043 1.14799 down 1.34 up EVI5L 
460731 0.045775 1.1946 up 1.09 down ATE1 
6900301 0.036473 1.15053 down 1.25 down C4orf34 
1400435 0.038166 1.11152 up 1.06 up TOMM70A 
6770379 0.00274 1.09826 up 1.53 down ZMYM5 
3450739 0.016024 1.18781 down 1.06 up N6AMT2 
6480605 0.041315 1.13224 up 1.09 down SSSCA1 
4850021 0.029027 1.09186 up 1.04 down  
4280154 0.034965 1.22126 down 1.17 up SULT2A1 
4760300 0.011697 1.01968 down 1.18 up ZMYND8 
7330605 0.007998 1.2503 up 1.03 up OR2W5 
7610187 0.029694 1.18485 up 1.05 up ATF4 
2640390 0.033979 1.01842 down 1.07 up  
4850176 0.048549 1.16656 up 1.08 down RNMT 
3440487 0.018923 1.08527 up 1.06 down DCUN1D5 
2680113 0.019826 1.10358 up 1.03 down DCUN1D5 
7610129 0.016208 1.01631 up 1.25 up RAD51C 
510544 0.003866 1.00762 up 1.18 up RAD51C 
840047 0.04815 1.12101 up 1.05 down LOC196993 
2450020 0.005277 1.14823 up 1.42 down SNORD56 
4280273 0.040887 1.18429 down 1 down GM2A 
3890767 0.04978 1.08934 down 1.15 down LOC284064 
5810273 0.02254 1.27542 down 1.09 up LOC492311 
540411 0.001757 1.56761 down 1.11 down BRCA1 
5050333 0.001329 1.11819 up 1.2 up RHAG 
780719 0.037389 1.1416 down 1.07 down BAIAP3 
780327 0.008568 1.24222 down 1.33 down HPCAL1 
4200019 0.019562 1.31682 up 1.05 down CTNND1 
5820491 0.031155 1.198 down 1.24 up MAP7 
2850551 0.00237 1.1743 up 1.33 up RCAN1 
150082 0.035189 1.10966 up 1.44 up SEC11C 
1500730 0.006541 1.10131 up 1.06 down  
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5960411 0.006533 1.36833 up 1.22 down BCYRN1 
5550356 0.037032 1.02924 down 1.04 up EXOSC8 
2140128 0.005352 1.28098 up 1.36 up SCD 
3830040 0.026474 1.17142 up 1.1 down HERC4 
5570161 0.026609 1.06676 up 1.18 down KCNJ14 
4590301 0.01281 1.31013 up 1.11 up IFNA21 
2490333 0.007653 1.0793 up 1.43 up ZNF467 
7160100 0.005034 1.4943 up 1.05 down PPRC1 
1190653 0.037496 1.11164 up 1.05 down GAPDHS 
2350379 0.010704 1.24774 down 1.15 down TNNT1 
2970577 0.011113 1.09201 down 1.5 down LOC730996 
1410068 0.045427 1.03113 up 1.22 up GSK3A 
5700021 0.0366 1.03176 up 1.06 down  
2850291 0.038548 1.03717 down 1.23 up GARNL4 
6660347 0.022062 1.35884 up 1.06 down ZNF322A 
7150255 0.0071 1.14802 up 1.05 up ARVP6125 
770653 0.019353 1.18808 up 1.02 up  
5270674 0.014432 1.02697 up 1.44 up GPR68 
3890521 0.023665 1.08017 down 1.34 down DEDD2 
3120653 0.04974 1.11472 down 1.19 down NSUN4 
2470689 0.021894 1.11784 up 1.55 down SPHK1 
1260544 0.002175 1.02969 down 1.25 down AKIRIN1 
3460551 0.047852 1.07983 down 1.14 down TMEM20 
5890239 0.009628 1.10769 down 1.26 down SLC43A3 
4480519 9.32E-04 1.16674 up 1.26 up EDEM2 
2710541 0.022406 1.0838 down 1.11 up RNF4 
2260053 0.001455 1.16496 up 1.03 up  
7100577 0.027306 1.25527 up 1.05 up VPS26B 
7570215 0.029684 1.22147 up 1.22 up CPNE3 
6400703 0.007803 1.03956 down 1.37 up KCNMB3 
4490762 0.046186 1.17211 up 1.21 up KCNMB3 
3420747 7.68E-04 1.21443 up 1.06 up ADD3 
4050400 0.01658 1.06377 down 1.64 up HMMR 
5690386 0.005038 1.05848 up 1.04 down  
3450086 0.013788 1.43314 down 1.14 up LOC149134 
7100072 0.016514 1.41294 up 1.03 up PFKM 
6550400 0.005702 1.22343 up 1.06 down  
4150682 0.015079 1.11531 down 1 up IGFL3 
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5420747 0.016659 1.1736 up 1.09 up PPP2R2D 
5960475 0.003168 1.06028 up 1.48 down RHPN2 
5090095 0.011803 1.3101 down 1.06 up KIFC1 
3800477 0.045495 1.06565 down 1.02 up  
1780554 0.001782 1.07159 up 1.07 up TMUB1 
1240414 0.013715 1.20241 up 1.09 down GLRX2 
70414 0.011812 1.23822 down 1.11 down  
3840088 0.009371 1.03238 up 1.11 up LOC652258 
4900095 0.001103 1.26267 up 1.31 down TOR1AIP2 
5820056 0.014526 1.35483 down 1 up RDM1 
6400427 0.005556 1.52783 down 1.77 up CILP 
1440709 2.65E-05 1.5921 down 1.99 up CILP 
1340538 0.002046 1.26952 up 1.62 down SGSH 
1240041 0.019939 1.23273 down 1.02 down GAS2L2 
6220142 0.002867 1.0914 down 1.29 down EXOSC9 
1240575 0.014136 1.09105 down 1.17 up ABO 
70753 0.042967 1.1874 down 1.07 up C9orf123 
1470121 0.044806 1.02089 up 1.15 up FZD3 
6560148 0.013971 1.03437 down 1.26 down TCEB3 
7150634 0.004961 1.48435 down 1.7 down APOD 
5570626 0.043752 1.13766 up 1 down DNAJB14 
4730670 0.021151 1.01274 down 1.16 up GCLC 
5050349 0.012931 1.18357 up 1.36 up VPS13A 
6980546 0.007503 1.19395 down 1.36 up CACNA1I 
3610468 0.018844 1.13599 up 1.04 up  
3290441 0.006717 1.23138 up 1.15 up BMPR1A 
3890563 0.008045 1.21517 up 1.54 up LAMP2 
4890332 0.024305 1.14717 down 1.02 up  
1410241 0.040156 1.07119 down 1 up LOC643529 
830072 0.048624 1.10882 up 1.06 down LYPD5 
6580349 0.017565 1.11263 down 1.08 down LEMD3 
110347 0.038882 1.37996 down 1.19 down PDK3 
6560338 0.033472 1.10794 down 1.47 up ZNF512 
130524 0.007736 1.01788 down 1.11 up EDIL3 
610019 0.001491 1.19017 up 1.04 up POLR3F 
5810424 0.01181 1.03639 down 1.36 up C1RL 
4760692 0.02527 1.0748 down 1.07 down C1orf131 
3390136 0.041524 1.02768 up 1.2 down IPPK 
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3520202 0.013897 1.16823 up 1.53 up DOCK8 
150739 0.032305 1.19278 down 1.14 down C1orf113 
1030477 0.040319 1.03421 down 1.16 up SCARA5 
5560358 0.001683 1.05954 up 1.09 up LOC645504 
1980041 0.003888 1.05132 down 1.14 up LOC441869 
6450685 0.041695 1.23831 down 1.1 down PLXNA1 
870603 0.005189 1.14021 up 1.1 down CCL11 
1990608 0.022559 1.26924 down 1.24 up  
5340435 0.024506 1.11697 down 1.12 up STOML1 
6860386 0.045623 1.08163 down 1.07 down LOC653086 
7570379 0.020314 1.22282 down 1.16 down P4HA2 
5900192 0.01468 1.19987 up 1.02 up CACNA1C 
3890162 0.043443 1.01048 up 1.14 up CACNA1C 
6380438 0.028726 1.07746 down 1.35 up MCM3APAS 
6960338 0.027187 1.09068 down 1 down  
2640008 0.033933 1.08534 down 1.48 down DYRK1A 
7550070 0.003072 1.23556 down 1.14 down LOC730316 
2650082 0.002271 1.06173 down 1.25 up TAPBP 
1400056 0.002391 1.14358 down 1.58 down SNORD30 
540019 0.021916 1.19083 up 1.1 up LOC441179 
7200471 0.031312 1.08149 up 1.14 up PFDN4 
4290327 0.03334 1.04436 down 1.28 down ING5 
1400292 0.03835 1.25816 up 1.07 down VARS 
5670458 0.006831 1.31932 up 1 down PRR3 
4070626 0.024374 1.10227 up 1.53 up VANGL2 
7210634 0.03564 1.37856 down 1.25 down ZBED5 
5390161 0.003736 1.09385 down 2.45 down DUSP5 
2690064 4.14E-04 1.0779 up 1.27 up CEP63 
3360762 0.01636 1.47442 down 1.86 down TMEM191B 
4540382 0.046861 1.09629 up 1.2 down ZC3HAV1 
6940328 0.038689 1.13018 up 1.04 down DDX52 
6290750 0.048717 1.12138 up 1.05 up OR8H2 
4560746 0.029044 1.30833 down 1.09 down FCAR 
4480019 0.021312 1.21861 up 1.2 up HSD11B1L 
1050270 0.010745 1.07017 up 1.11 down  
3190164 0.035282 1.10966 up 1.18 down MUTED 
2650673 0.03395 1.21392 up 1.12 up CLDN18 
430719 0.007808 1.08818 up 1.09 up  
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2470722 0.039658 1.0442 down 1.24 down TDRD1 
4560577 0.003644 1.13078 up 1.06 down KIAA1429 
10291 0.021732 1.20074 down 1.14 down LOC653337 
5670100 4.07E-04 1.26887 down 1.32 up TCN2 
2490719 0.007341 1.43075 up 1.33 down STK17B 
7510731 0.003309 1.04974 up 1.22 down WBP5 
7380465 0.002908 1.17735 up 1.32 down DPH3 
6510279 3.84E-04 1.11853 up 1.35 down DPH3 
1070332 0.005318 1.0739 up 1.3 down SEC22C 
6940025 0.006223 1.00181 down 1.16 down MRPL39 
1300685 0.048465 1.00246 up 1.06 down LOC653249 
1570259 0.026035 1.05833 down 1.05 down LOC652530 
4780192 0.041932 1.18852 up 1.06 up BPTF 
2140528 0.003903 1.11043 down 1.09 up GPR172A 
1450072 9.08E-04 1.35855 up 1.27 up PIGF 
1850176 0.018279 1.39891 up 1.31 down RSC1A1 
6020341 0.039688 1.12165 up 1.19 up MAPT 
3360402 0.03481 1.28076 up 1.24 up CAD 
4180376 0.007176 1.14091 up 1.18 down PI4K2A 
1340768 0.040648 1.00076 up 1.09 down  
2480154 0.022263 1.11604 down 1.09 down SLC26A1 
1990619 0.032824 1.31169 down 1.09 down  
6620736 0.019401 1.02114 up 1.09 down  
6860072 0.034547 1.26571 down 1.4 up TRAPPC6A 
3440593 0.004991 1.10243 up 1.18 down  
3170600 0.027816 1.02341 up 1.12 down  
6420746 0.004534 1.18328 down 1.16 up FGF9 
2450246 0.003189 1.0936 down 1.27 up OSBPL5 
1010048 0.015438 1.16089 down 1.4 up CXXC5 
770102 0.014289 1.18364 down 1.15 down C5orf34 
1780600 0.022229 1.12916 up 1.04 up CD3E 
6420044 8.94E-04 1.63956 up 1.05 down ALKBH8 
2070608 0.019078 1.07308 up 1.17 up LOC652479 
2060110 3.55E-04 1.22453 down 1.47 down TDP1 
3140181 0.04505 1.13813 down 1.1 up TDP1 
5820187 0.002768 1.06264 down 1.28 up SCCPDH 
610273 0.012838 1.19824 up 1.14 up C3orf35 
4540072 8.61E-04 1.42226 down 1 down C16orf75 
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6180088 0.022816 1.09285 down 1.07 up ATP6V0E2 
2900551 0.020695 1.17841 up 1.26 up NVL 
3840091 0.007157 1.09364 up 1.32 down SNORD35A 
3130102 0.034574 1.08159 up 1.18 down TSFM 
4120431 0.030122 1.15541 down 1.1 down TMEM100 
5220491 0.02647 1.1544 down 1.4 up VGLL4 
830242 0.003581 1.41093 up 1.08 up GMPPA 
6370326 0.037663 1.13471 down 1.03 down  
1990546 0.017317 1.09131 up 1.57 up KIAA0152 
630192 0.026516 1.00074 up 1.16 down LOC648974 
780753 0.033244 1.1034 down 1.15 up SUPT16H 
1940438 0.042661 1.11306 down 1.18 down PGF 
4810008 0.012992 1.35188 up 1.33 down PEX13 
2600768 0.010079 1.02649 up 1.14 up AGXT2L1 
3190717 0.016596 1.03681 up 1.24 up MED13L 
4880215 0.007743 1.09732 down 1.32 down GTF2B 
840497 0.04827 1.09276 up 1.02 down LOC650274 
3840131 0.002205 1.25232 up 1.06 up NUP153 
7160653 0.025692 1.14753 up 1.22 down UHRF1BP1L 
5340228 0.01042 1.02884 up 1.39 down GALNT5 
4640376 0.002535 1.10788 up 1.1 down MRLC2 
2190463 0.007925 1.12344 down 1.44 up ADCY6 
6550082 0.039693 1.14288 up 1.08 up LCMT1 
4250437 0.046677 1.04797 down 1.17 up RECQL4 
6760326 0.046147 1.04521 up 1.1 up ZNF658 
3450253 0.022458 1.24549 down 1.02 down ZNHIT3 
7210017 6.35E-04 1.27339 up 1.63 up NOMO2 
6520725 0.031045 1.49771 down 1.24 down TNFRSF14 
2230528 0.033188 1.31739 up 1.03 up MMS19L 
4060192 0.002262 1.29476 up 1.73 up KCNH2 
730035 0.012266 1.19245 up 1.17 down RAP1GDS1 
4260735 2.51E-04 1.25787 up 1.05 up RAP1GDS1 
5560139 0.007988 1.19017 up 1.06 up RAP1GDS1 
3120553 0.03343 1.19942 up 1.07 up  
5080341 0.003194 1.29205 down 1.02 down SLC25A18 
2360402 0.029333 1.04056 up 1.18 up  
620546 0.032545 1.28481 up 1.25 down RRAS2 
4120639 0.001992 1.07942 up 1.12 down PRDM2 
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3460014 0.046966 1.06418 down 1.19 up C4orf18 
2760292 0.030119 1.07624 up 1.02 down PPP1CC 
4010086 3.38E-04 1.18259 down 3.79 down OKL38 
6560608 0.036878 1.0521 down 1.27 down C7orf20 
2900504 0.025113 1.08913 down 1.38 down C7orf20 
630717 0.016137 1.01749 up 1.04 up ZNF33A 
270129 0.049253 1.21637 up 1.44 up TMEM8 
3940411 0.049384 1.33331 up 1.3 up MGC16169 
7000630 7.06E-04 1.25006 up 1.1 down DNAJC3 
4200008 3.40E-04 1.16004 down 1.64 down ATG2A 
1260730 0.007617 1.03635 down 1.33 up EPHB4 
4290082 0.048819 1.15808 up 1.15 down LOC646786 
7330292 0.019386 1.03383 down 1.32 up FBLN2 
2760475 0.017751 1.13361 up 1.03 up LOC731985 
4290376 0.017688 1.14482 down 1.03 down LOC643558 
5340050 0.032136 1.06013 down 1.24 down UBE2V2 
7150292 0.002882 1.01267 down 1.28 up C1orf225 
6860095 0.025305 1.00995 up 1.14 up LSR 
5090056 0.015997 1.31497 up 1.01 up ARFGAP3 
1500164 0.002629 1.29526 up 1 down PCBP1 
7040086 0.049828 1.14324 up 1.06 down C9orf41 
4260086 0.032506 1.06952 down 1.17 up  
7040546 0.028728 1.13315 up 1.18 up LYCAT 
4900039 0.029685 1.07851 down 1.08 up  
3420451 0.010234 1.05435 up 1 down C15orf15 
6060674 0.048311 1.3667 up 1.38 up RPL13 
2940647 0.038635 1.01308 down 1.22 down ZNF559 
3310615 0.001473 1.05002 up 1.28 down NFKB2 
1050162 0.021144 1.12591 down 1.05 down SPG21 
1440379 9.30E-04 1.50998 down 1.6 up FAM178B 
2350458 0.003405 1.18366 up 1.09 down  
7550010 0.011468 1.15607 down 1.14 down  
4860224 0.00808 1.2285 up 1.92 up WARS 
2970678 0.004929 1.29268 down 1.77 down  
1850504 0.010238 1.33793 up 1.1 down FBXW7 
4920047 0.030884 1.24997 down 1.05 up C1QL4 
1940162 8.30E-04 1.39342 down 1.17 down GBP2 
6380102 0.008809 1.16288 down 1.2 up ATP8B3 
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6180128 0.037319 1.09991 down 1.25 down OTUB1 
770044 0.044173 1.11112 down 1.03 down FBXO15 
4490025 0.032335 1.14652 up 1.01 up KIF21B 
6520630 0.01602 1.1402 down 1 up PIK3R1 
460204 0.002516 1.11538 up 1.55 down ADFP 
1110615 0.030423 1.07611 down 1.14 up BEX4 
5080228 0.043085 1.13535 down 1.1 down ATP2C1 
3120360 0.009861 1.12308 down 1.04 down LOC646730 
2190100 0.013389 1.08486 up 1.1 up KLHDC1 
1440364 0.011415 1.02507 up 1.74 down AGPAT4 
2350364 0.04094 1.15093 up 1.02 up GPR135 
7560653 0.008718 1.10832 up 1.8 up LOC731992 
5290608 0.033932 1.08894 down 1.1 down RARRES2 
5340433 0.023817 1.2915 up 1.08 up PPARGC1B 
5810201 0.014932 1.12462 up 1.2 down ZNF593 
5080156 0.002762 1.10501 down 1.31 down CLP1 
6580164 0.007115 1.20289 up 1.04 up PHF21A 
1470598 0.004576 1.36943 down 1.21 up PARP3 
1510458 6.02E-04 1.16484 down 1.26 up MYH9 
4480291 0.006697 1.34288 down 1 up OR2B6 
110719 1.90E-04 1.04179 up 1.85 up SLC16A3 
5270239 0.039083 1.13482 down 1.07 up TUBD1 
7650026 0.006927 1.86143 down 1.12 down MUC1 
5900682 0.011235 1.10951 down 1.14 up SUMO3 
6860678 0.005898 1.25519 up 1.24 down HNRPDL 
7100681 0.011768 1.09078 up 1.47 down CCDC137 
5890600 0.043573 1.00043 down 1.21 down WDHD1 
4900010 0.008851 1.15991 up 1.03 down HIF1A 
540195 0.013505 1.07698 down 1.01 down ADAM5P 
10044 0.005184 1.06522 up 1.25 down BCAP29 
5820195 0.015117 2.28454 down 1.08 down CLCNKA 
3610092 0.019099 1.02089 up 1.18 down RBM23 
5570678 0.037528 1.17546 down 1.03 down RPS27L 
780767 0.004907 1.042 up 1.44 down ProSAPiP1 
7160132 0.013915 1.01456 up 1.14 down  
3420100 0.049154 1.13778 up 1.12 down DSC2 
5490376 0.003521 1.14299 up 1.8 up NCOR2 
2360184 0.001004 1.31202 up 1.02 down GTF2F2 
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6590521 0.013339 1.05315 down 1.18 down LOC388578 
1710044 0.036794 1.18148 up 1.07 up ZNF695 
6130554 0.040162 1.13902 down 1.09 down  
6330646 0.046129 1.12048 down 1.3 down ZNF672 
7570408 0.00311 1.2664 down 1.21 down CCL5 
540427 0.008598 1.13006 down 1.04 down UTY 
1580392 0.036537 1.11863 up 1.1 up ERN2 
4070600 0.037757 1.20339 up 1.04 up ZNF654 
2100209 0.005567 1.00575 down 1.17 down FAM24B 
7610162 0.013859 1.09107 up 1.23 down PPFIA1 
430019 0.026006 1.56713 up 1.26 down LOC391045 
2850465 0.006962 1.39553 down 1.25 down  
4010735 4.93E-04 1.22623 up 1.03 up MRPL9 
6290735 0.007886 1.11201 up 1.29 up EPHB3 
4180195 0.00711 1.06152 up 1.2 down SP6 
5720398 0.028185 1.39471 up 1.08 down NDUFAF2 
3520541 0.038646 1.15909 up 1.09 down CHUK 
1070519 7.31E-04 1.12918 down 1.26 down LOC654126 
4850600 0.034175 1.12158 up 1.1 up ZNF17 
1740161 0.010798 1.15993 down 1.1 up ENAH 
520358 0.014129 1.29009 down 1.39 down IKBKG 
2000372 0.024756 1.2134 down 1.16 down  
610519 0.031624 1.02947 down 1.24 up TPM1 
840064 0.025638 1.08225 down 1.38 up LOC645489 
1580411 0.044871 1.2506 down 1.35 down CD3D 
730228 0.023306 1.18668 down 1.01 down VDAC3 
60360 0.031146 1.15611 up 1.04 up PSMD3 
70288 0.019139 1.25757 down 1.28 up  
7610427 0.002538 1.06014 up 1.11 down  
5290193 0.048513 1.09117 down 1.19 down KCTD6 
5130168 0.041923 1.07016 down 1.24 down KCTD6 
5900286 0.026922 1.18905 down 1.08 up ZFP90 
4830066 0.01477 1.06642 up 1.12 down OR4K13 
840053 0.008465 1.12245 up 1.15 down SNTB2 
4860068 0.007125 1.06555 up 1.53 down STX1A 
3990731 0.004221 1.14973 up 1.26 down PTPN2 
2000553 0.032423 1.20025 down 1.01 up LOC221442 
1940632 0.019312 1.13973 down 1.04 up NCAPG2 
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1430435 0.037684 1.30872 down 1.34 up C3orf34 
4010184 0.001976 1.16435 down 1.09 up C8orf13 
4290097 0.015845 1.06568 up 1.37 up CD99 
6370167 0.024091 1.12579 up 1.2 up  
3400553 0.024934 1.22042 up 1.03 up OPRK1 
5960095 0.029707 1.23587 down 1.44 down  
4760474 0.044988 1.4518 down 1.52 down TUBA4A 
2070189 0.018953 1.28486 up 1.04 up ZNF451 
770356 0.027286 1.21254 down 1.25 down PPA2 
1710113 0.00577 1.594 down 1.25 down PPP1R3E 
2000064 0.02228 1.07255 up 1.4 up CTPS2 
5910187 0.006345 1.11205 down 1.73 down SDHALP1 
2450332 0.01459 1.06871 down 1.35 down SDHALP1 
7100035 0.027482 1.21459 down 1.17 down IL28RA 
1230524 0.010085 1.15425 up 1.02 down ST6GALNAC3 
7160592 0.003295 1.04551 down 1.4 down ACOT9 
6330647 0.045247 1.23606 up 1.11 up RPS7 
5340719 0.049949 1.33464 up 1.19 down  
730020 0.005586 1.05269 up 1.27 up ARMC7 
1820681 0.004458 1.37637 down 1.22 up DPEP2 
2140274 0.007179 1.03261 down 1.07 down SPPL2B 
2480373 0.002795 1.13391 down 1.28 down ELMOD2 
1090382 0.033245 1.01507 up 1.07 down  
6860372 0.032592 1.05192 up 1.06 down LY6G5C 
2810494 0.014471 1.24467 up 1.05 up  
4880348 0.032222 1.27416 up 1.1 down YME1L1 
5360184 0.025183 1.04585 down 1.32 down RNF6 
5050544 1.12E-04 2.01796 down 1.58 up MS4A3 
3870411 0.036167 1.06683 down 1.23 up ZNF782 
3990026 6.93E-04 1.66288 down 1.27 down CCNE1 
6590093 0.049531 1.2391 down 1.13 down CCNE1 
7380767 0.00479 1.00873 down 1.14 down CHST4 
830470 0.005094 1.02641 down 1.3 up psiTPTE22 
870154 0.020468 1.16452 down 1.17 up C11orf57 
2710523 0.030751 1.25362 down 1.06 down REM2 
1570193 0.010749 1.067 down 1.46 up ARHGDIB 
6960437 0.004267 1.18087 down 1.04 up C11orf41 
3520164 0.015953 1.41018 up 1.14 up C6orf65 
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4730132 0.018016 1.01647 up 1.27 down NSUN5 
5340458 0.027017 1.19987 down 1.17 down NSUN5 
2900246 0.046984 1.33483 down 1.59 down TRIOBP 
7330010 0.009645 1.38737 down 1.41 down OR4F3 
270754 0.032673 1.13373 up 1.19 up PTGER3 
6220088 0.024537 1.00923 up 1.18 up MED13 
4730632 0.033334 1.13998 up 1.16 up  
4120369 0.004205 1.52449 down 1.05 down APOBEC3G 
1190026 0.01463 1.40234 down 1.01 up APOBEC3G 
2970121 0.006262 1.20674 down 1.16 up MXD3 
7550364 0.005892 1.14778 down 1.16 up APH1A 
6510162 0.037372 1.05574 down 1.14 up DBF4B 
7040040 0.041432 1.16332 down 1.09 down  
4210356 0.04523 1.14686 down 1.05 up  
6200243 0.045512 1.13421 down 1.27 up PGP 
5360553 0.006138 1.08332 down 1.25 up ECH1 
1770661 0.024434 1.13027 up 1.2 up RAB21 
2470619 0.014568 1.3164 down 1 up AKT1 
2120524 0.002656 1.65958 down 1.85 up IGFBP5 
2190674 8.11E-05 1.50352 down 2.2 up IGFBP5 
3190615 0.00423 1.08058 down 1.2 down LOC283682 
7650128 0.046257 1.16615 down 1.07 up ECGF1 
5290575 0.033904 1.20918 up 1.22 up  
2810615 9.30E-04 1.10548 down 1.67 up GRB10 
4010021 0.041461 1.18652 down 1.02 down FN3KRP 
840468 0.001649 1.11148 down 1.09 down  
780594 0.034485 1.06034 up 1 down  
4290475 0.039151 1.15428 up 1.25 up PPP3CA 
4670719 0.004594 1.44335 up 1.05 down ZFP91 
2060468 0.047515 1.09354 up 1.02 down PRKACB 
770682 0.014488 1.04471 up 1.05 down MGC29506 
3990273 0.020697 1.23369 up 1.18 down PGAM4 
3400431 0.004268 1.06111 down 1.32 up CLDN11 
6040110 0.044236 1.14201 down 1.01 up  
6860026 0.009737 1.04342 down 1.3 up ZNF358 
7550709 0.029406 1.11039 up 1.22 up LOC649509 
3830369 0.039595 1.00327 down 1.27 up LOC389000 
6040538 0.037302 1.06091 down 1.04 up  
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1940470 0.038632 1.10766 down 1.26 up LOC728734 
6760300 0.011795 1.15919 down 1.26 down KRTAP26-1 
4810154 0.040681 1.16134 down 1.05 down STK31 
3800025 0.022805 1.07634 down 1.33 up C2orf28 
2680438 0.008312 1.12907 down 1.28 up C2orf28 
1710674 0.020116 1.1595 down 1.18 up DUSP23 
4390195 0.042115 1.15458 down 1.07 up HMGN1 
6220300 0.045571 1.07078 down 1.12 up HMGN1 
7040600 0.012661 1.08649 down 1.02 up ARSB 
3850577 0.01237 1.04041 up 1.3 down HK1 
5220035 0.04942 1.17073 down 1.35 down TUFT1 
4280162 0.011077 1.02269 down 1.3 down SCNM1 
6130725 0.019092 1.37115 down 1.49 down ARHGEF18 
3390092 0.019908 1.1123 up 1.17 down PLEKHM2 
7400333 0.018953 1.09704 down 1.06 up AGAP1 
5090739 0.009568 1.12358 down 1.34 up NPAL3 
1260341 0.047933 1.00974 up 1.1 up IL13RA1 
6250435 0.007886 1.13888 up 1.32 down ARHGEF3 
1940397 0.016114 1.08151 down 1.02 up  
5690632 0.026298 1.0832 up 1.05 up  
2070041 0.018025 1.03477 up 1.11 down  
1660673 0.022146 1.03409 down 1.3 down OSAP 
7000682 0.004729 1.81168 up 1.36 up CARS 
1430468 0.00883 1.09335 up 1.05 down  
1410138 0.001483 1.22744 down 1.26 up  
5560079 0.007772 1.0629 up 1.27 down GPBAR1 
7570753 0.024787 1.16959 down 1.02 up PCDHB2 
6450367 0.00704 1.12269 up 1.05 up KRT26 
4590608 0.038147 1.21168 down 1.28 down POLD3 
3850224 0.015191 1.19478 up 1.06 down TMEM167A 
7330056 0.026432 1.10223 up 1.14 up DKFZp686K1684 
4280193 0.028019 1.14475 up 1.28 up C19orf6 
4220072 0.014345 1.20294 up 1.03 up  
3190706 0.04354 1.23392 down 1.01 up LOC650095 
4890240 0.018084 1.10556 up 1.2 down WDR4 
7610471 0.011701 1.0818 down 1.11 down COMMD6 
6980300 4.18E-04 1.29167 down 1.06 up MGC4172 
5810474 0.024556 1.19875 up 1.15 up PTPRS 
224 
 
770474 0.019313 1.01703 down 1.44 up LPHN1 
430176 0.015596 1.17432 down 1.13 up ZNF717 
3930382 0.030722 1.23357 down 1.14 up NMT2 
1710731 0.025056 1.05859 up 1.37 down MATR3 
5310088 0.038689 1.20089 down 1.1 down GPR137 
2650348 0.03079 1.17139 down 1.38 down C15orf44 
6590594 0.023121 1.1152 up 1.23 down HIST1H2AC 
1300576 0.034593 1.09865 down 1.22 up TMEM107 
6620072 0.00703 1.0483 up 1.19 up CAPZB 
3930367 0.003562 1.95571 up 1.14 up DAB2 
110279 0.00938 1.09652 up 1.2 down RUFY3 
3460521 0.034255 1.19452 down 1.46 down LOC653310 
3370307 0.009968 1.01347 down 1.12 up  
4250463 0.014794 1.09419 up 1.66 up OCA2 
870553 0.041863 1.33579 up 1.05 up ZNF775 
2350441 0.002647 1.1404 down 2.06 up COL23A1 
2100639 0.018629 1.10559 up 1 up LOC645004 
5910164 0.002066 1.01061 down 1.47 down LARP2 
5890136 0.008527 1.05466 up 1.25 down KIAA0913 
1780019 0.032925 1.1728 up 1.06 down PLEKHH2 
4860408 7.48E-04 1.04059 down 1.19 down RAPH1 
2100241 0.038349 1.08572 down 1.34 down RAPH1 
1510019 0.011998 1.33661 down 1.25 up MGST2 
7150253 0.007995 1.09024 down 1.07 up PPM1M 
4610026 0.037414 1.07538 down 1.16 up LOC727735 
5080091 0.02329 1.0155 down 1.03 up  
6380360 0.004602 1.01248 up 1.09 up  
990725 0.005179 1.14992 down 1.23 down DONSON 
6270739 0.008712 1.03652 up 1.03 down NPPA 
4760458 0.025585 1.07052 up 1.54 down UBTD2 
2340379 0.031869 1.13908 up 1.19 up LOC645620 
5700017 0.014359 1.23583 up 1.05 down KBTBD4 
3890138 0.003402 1.58974 down 1.8 down MTMR11 
2480026 0.030975 1.04838 up 1.14 up FLJ22222 
7160630 0.010886 1.25954 down 1.15 down LOC440396 
1010475 0.001726 1.01001 up 1.13 up CAMK2G 
3130433 0.002193 1.01108 up 1.19 down ING1 
2370301 0.02145 1.06198 down 1.17 up PELI3 
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610113 0.018899 1.08561 down 1.84 down TNFSF14 
1770541 0.007958 1.04821 up 1.38 up SERP1 
1170246 0.01517 1.0062 down 1.47 down GEM 
1440605 0.012858 1.13821 down 1.13 down ZNF101 
4200022 0.04543 1.7269 down 1.85 down C13orf25 
1940754 0.045433 1.16511 up 1.13 down LOC648931 
5050025 0.029797 1.05624 down 1.12 up KBTBD7 
4560324 0.027723 1.10794 up 1.2 up  
2970592 0.005646 1.60767 down 1.28 down  
2450056 0.04138 1.19283 up 1.05 up  
6100382 0.016605 1.05995 down 1.31 down RTKN 
5050470 0.005847 1.32193 down 1.22 up GHR 
2370110 0.025527 1.13071 up 1.05 down MATR3 
2370138 0.001557 1.27355 down 1.41 down TRIM26 
4230608 0.044448 1.172 down 1.24 up IGSF3 
6480082 0.001131 1.22699 down 1.05 down ARHGAP1 
730750 0.02621 1.1128 up 1.05 up LOC654252 
2630220 0.012044 1.26257 up 1.04 up SEPSECS 
5900451 0.015419 1.23467 up 1 down SPTBN2 
1010315 0.003396 1.35189 up 1.29 down LINS1 
2490544 0.023258 1.0867 up 1.06 up SNX14 
5340328 0.002613 1.05337 down 1.17 up JMJD2C 
1980138 0.022628 1.45647 up 1.17 down MRRF 
4150711 0.043151 1.03463 up 1.09 down USP37 
5910609 0.001297 1.03968 up 1.6 down IL4R 
630221 0.001445 1.07658 down 1.01 down  
7320468 0.022446 1.13845 down 1.3 down NCKIPSD 
1660685 8.14E-05 1.09529 down 1.69 up ARHGAP15 
1240360 0.037151 1.10965 down 1.23 up MRPL52 
2970609 0.048895 1.12554 up 1.12 down TMF1 
4880639 0.019273 1.12681 up 1.03 up LOC646804 
4280619 0.00546 1.09854 down 1.14 down  
1070386 0.049394 1.46794 up 1.58 up CBX1 
7040241 0.027422 1.08311 down 1.16 up OAT 
3990382 0.017516 1.30792 down 1.78 down INO80C 
1430068 0.030037 1.56907 down 1.62 down USF1 
6580050 0.023647 1.04667 down 1.06 down C14orf144 
6450438 0.024803 1.00404 up 1.29 up DMXL1 
226 
 
1110433 0.017713 1.19146 up 1.13 up  
6760576 0.038785 1.23512 up 1.08 up SUPT5H 
6250397 0.012297 1.15311 up 1.26 down DPH3 
1090594 0.043646 1.19466 up 1.07 up RNF146 
3450097 0.014761 1.14099 down 1.03 down Rg9mtd1 
840554 0.003103 1.13599 up 1.16 down RYBP 
5910202 0.033323 1.00227 up 1.13 up PIH1D1 
7560647 0.039404 1.27398 up 1.22 down CPT1C 
6290168 0.036983 1.00173 up 1.14 down C10orf116 
4060056 0.001561 1.2815 down 1.25 up POLQ 
2640544 0.007846 1.19812 up 2.3 up ASS1 
2970379 0.034362 1.19972 up 1.26 down NET1 
6110279 0.003537 1.51563 up 1.27 down NET1 
7610504 0.006912 1.2613 down 1 down ZNF519 
4780608 0.01209 1.23524 up 1.03 up LOC653338 
4670390 0.032135 1.06912 down 1.05 up CXCL2 
620615 0.049248 1.21752 up 1.18 up NDUFA7 
3610008 0.037984 1.08721 up 1.04 down  
1820279 0.035266 1.22175 up 1.34 up TSPAN18 
7550441 4.52E-04 1.10642 up 1.2 down NKRF 
2340474 0.02914 1.07384 down 1.26 down SERF1B 
2490537 0.046417 1.44167 down 1.19 down TNFRSF1B 
2320133 0.005339 1.21572 down 2.26 down TXNRD1 
2100072 0.002508 1.21198 down 1.14 down  
130670 0.039768 1.29001 down 1.16 down ZDHHC5 
5570300 0.035892 1.17536 down 1.33 down C10orf78 
3400497 0.044871 1.2198 down 1.61 up C21orf122 
6980129 0.029583 1.97444 down 2.24 down PI16 
6130377 0.012786 1.12867 up 1.03 up LOC653206 
1570520 0.020397 1.14289 up 1.17 down DHX16 
6280326 0.040277 1.34267 down 1.05 down HDC 
70463 0.01505 1.36053 down 1.28 down NOL3 
5700348 0.043501 1.14585 up 1.13 up VPS28 
110041 0.008965 1.09064 down 1.03 up RABEP2 
10546 0.033209 1.10126 up 1.4 down RPS24 
3710053 0.00702 1.07228 down 1.34 up APBA2 
7550181 0.035254 1.00349 up 1.27 up IFNAR1 
7380626 0.031138 1.19512 down 1.08 up FLJ20273 
227 
 
6020736 0.002232 1.19344 up 1.4 down UBE2H 
3180014 0.012393 1.19826 up 1.04 up NFKBIB 
540131 0.012655 1.37142 down 1.27 up PXMP2 
5820324 0.005729 1.20837 down 1.22 up PXMP2 
270414 0.021378 1.12351 down 1.32 down FAM156A 
6560300 0.031649 1.04057 down 1.52 down SLC31A2 
60463 0.00663 1.29572 down 1.07 up OTUD5 
1240678 0.041858 1.12378 up 1.06 up SPATA17 
4570170 0.049686 1.14933 up 1.11 up KIAA0947 
6770242 0.004752 1.27781 down 1.47 down MARCKSL1 
5810609 0.032936 1.1575 down 1.24 down KIAA1143 
1340689 0.038772 1.05332 up 1.21 up RPN1 
5270138 0.014107 1.25783 down 1.19 down PPP2R3C 
840025 0.028036 1.48282 down 1.07 up FYN 
5340593 0.015755 1.25616 up 1.06 up AKAP8L 
1980209 0.013016 1.15676 up 1.07 down SEC23B 
6370133 0.038362 1.31276 up 1.03 up SEC23B 
5050376 0.00857 1.14287 down 1.26 up C21orf33 
4560762 0.044523 1.13804 up 1.35 up ST13 
3170520 0.027301 1.18023 up 1.06 down ARHGAP17 
3130703 0.010415 1.0037 down 1.29 down CA13 
2680689 0.016252 1.19748 up 1.09 up  
7400608 0.041656 1.01685 up 1.38 down UXT 
7160037 0.047928 1.03211 up 1.22 up USP13 
2470066 0.03121 1.47573 down 1.4 down LOC653346 
1110241 0.029856 1.14073 down 1.07 up ALG10B 
2140653 0.017865 1.02119 up 1.07 up TPM1 
4180369 1.23E-05 1.16953 down 1.31 down ATP2B4 
5490612 0.012144 1.08149 down 1.24 up ARHGAP12 
780608 0.002979 1.03314 down 1.33 down RNFT1 
2350168 6.78E-05 1.60092 up 1.15 up SCN9A 
2140398 0.038954 1.2062 down 1.11 down CALCOCO1 
290632 0.017351 1.1722 up 1.01 down  
2510088 0.008309 1.14095 down 1.06 down GPR64 
1170600 0.022917 1.10717 down 1.21 down UQCRC1 
730731 0.037481 1.07512 up 1.05 down  
6020634 0.013048 1.02651 down 1.05 up  
1580202 0.019057 1.22368 up 1.17 up ZNF598 
228 
 
3420112 0.032559 1.07591 down 1.04 up LOC440226 
3800537 0.0112 1.04744 down 1.45 down PLEKHB2 
6290161 0.042313 1.31367 down 1.09 up SLC16A9 
4540241 0.014662 1.21241 up 1.19 down C5orf32 
1850309 0.027091 1.21733 down 1.48 down CDK10 
940753 0.004582 1.13501 down 1.64 down RALB 
4780612 0.006566 1.21172 down 1.1 up UNC93B1 
5220397 7.84E-04 1.05034 up 1.27 up RREB1 
4060187 0.010569 1.16705 up 1.38 up RREB1 
1710114 0.004706 1.08668 down 1.46 down LYPLA2P1 
2260189 0.045825 1.23793 up 1.34 down FLJ14166 
1710612 0.044067 1.07056 down 1.11 up CLIP2 
3190059 0.009976 1.17711 up 1.03 down IMMT 
6860273 0.001881 1.3002 up 1.1 up C2orf43 
5690181 0.022804 1.11703 down 1.11 up KIAA1712 
7610767 0.044133 1.04788 down 1.14 up F5 
1710037 0.025871 1.18819 down 1.05 down SHF 
840253 0.019226 1.17065 up 1.2 up ALDH2 
3290315 0.005503 1.26237 up 1.27 up NRD1 
430309 0.004191 1.31467 up 1.15 down C6orf66 
2340524 0.002331 1.13517 up 1.06 down ALG14 
7560093 0.00182 1.10007 up 1.25 down UBL7 
6860377 0.03808 1.50911 up 2.39 down DUSP1 
6590520 0.014539 1.15852 down 1.08 down C14orf131 
6110767 0.040353 1.10509 down 1.14 down C17orf90 
3390133 0.032993 1.06036 down 1.18 down  
2680110 0.001467 1.1236 down 1.23 down TM4SF1 
50286 0.028137 1.33997 down 1.01 up EEPD1 
2360471 0.043199 1.06872 up 1.24 up H2AFY 
3930154 0.00191 1.0507 up 1.86 up H2AFY 
4670703 0.022452 1.07243 up 1.68 down LOC221710 
6770392 0.031787 1.06276 down 1.17 up SRI 
990386 0.002146 1.19436 up 1.05 up LOC728760 
6100408 0.045198 1.12696 down 1.12 down NLRC5 
990372 0.019671 1.01797 up 1.11 up COL17A1 
5890435 0.037861 1.22467 up 1.11 up PC 
990487 0.043763 1.00458 down 1.51 up GYPE 
4260192 0.046139 1.04718 up 1.15 up FUNDC1 
229 
 
6590541 0.021598 1.30567 down 1.05 up PAQR9 
5670685 0.039815 1.10095 down 1.07 up  
4210039 0.021433 1.12794 down 1.14 up ABCB1 
5550435 0.025189 1.1207 up 1.01 down  
4200360 0.00957 1.06427 down 1.1 down  
6110674 0.045787 1.23174 up 1.07 up ATP5A1 
940711 0.029802 1.15054 up 1.06 up ATP5A1 
730286 0.004223 1.16969 down 2.04 down TXNRD1 
4480338 0.030156 1.21414 down 1.03 down AKTIP 
5490270 0.036968 1.13041 down 1.45 up LOC92270 
1710053 0.007148 1.17685 down 1.12 up SERP2 
10170 0.02118 1.04909 up 1.1 down GNG5 
2490121 0.024393 1.02409 up 1.1 up FAM90A2P 
5820647 0.005431 1.18726 up 1.2 down ZNF668 
4390484 0.007764 1.14901 down 1.39 up TACC3 
70300 0.004756 1.26479 up 1.34 down LYPLA1 
520609 0.017012 1.51365 down 1.58 down KIAA1324 
3360113 0.015595 2.0685 down 2.51 down MEG3 
6980544 0.031224 1.06801 up 1.33 down SLMO1 
6220671 0.003299 1.15572 down 1.74 down PLAUR 
3120682 0.027153 1.07807 down 1.18 down FLJ32810 
3310477 0.013509 1.09136 up 1.11 up TPI1 
6350047 0.022643 1.1653 down 1.04 down  
6450220 0.048815 1.33779 down 1.03 down  
780554 0.007394 1.49277 up 1.52 down MBNL2 
4830220 0.024366 1.16428 up 1.27 down ZNF193 
5720059 0.031082 1.2361 down 1.1 up GFOD1 
6560687 0.029801 1.06134 down 1.02 up GLT6D1 
1780156 0.015351 1.0705 down 1.14 up SAMD4B 
630564 0.034554 1.16934 up 1.08 up  
2970019 0.031408 1.22328 up 1.44 down HIST1H4H 
3840164 0.00999 1.28342 up 1.11 up FAF1 
1030102 0.026419 1.09029 down 1.15 up RGS16 
1990750 0.044721 1.00874 down 1.18 down LOC255326 
1300750 0.02286 1.15471 down 1.03 down GOLGA7 
3610064 0.009886 1.0235 up 1.02 up NACA 
3400593 0.019253 1.21281 up 1.09 up SMARCD1 
6110133 0.011356 1.22383 up 1.43 up COLEC11 
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4760301 0.003402 1.10034 up 1.34 up DDX54 
1740600 0.029547 1.08454 up 1.05 down NR1D2 
6550209 0.021362 1.52115 up 1.07 up KIF2A 
4920253 0.017869 1.00155 down 1.08 up LOC644319 
2480768 0.022799 1.28151 down 1.1 up DHFRL1 
3400072 0.044685 1.05578 down 1.07 up ZNF544 
3420332 0.007001 1.00508 down 1.16 down SLC37A3 
1410289 0.009347 1.19208 up 1.3 up PTCH1 
2490470 0.003191 1.06086 up 1.21 down MPZL1 
6180397 0.024128 1.18018 up 1.05 up OR6C75 
610224 0.026704 1.0141 down 1.12 down LOC401180 
6110592 0.016833 1.23 down 1.26 down ABHD11 
6100180 0.03623 1.68817 down 1.34 down EFEMP2 
1740435 0.003303 1.19025 down 1.65 down HSPC159 
5560639 0.007358 1.15333 up 1.05 down MB 
3370671 0.010343 1.08652 down 1.3 up MED20 
1300286 0.023664 1.28429 down 1.35 down MYLK 
5670327 0.010551 1.06138 down 1 up GOT1L1 
2060458 0.020929 1.09421 up 1.03 up C1orf2 
1050044 0.012069 1.27095 up 1.11 down HCFC2 
6510487 0.02241 1.13968 down 1.17 down FAM96B 
1090491 0.019827 1.10994 down 1.1 up IFT81 
4560538 0.013184 1.30896 up 1.52 up MAPK1 
2570026 0.018059 1.26797 up 1.51 up MAPK1 
6110451 0.046136 1.29973 up 1.12 up SNX25 
670427 0.031511 1.01223 down 1.05 up LOC642340 
7320307 0.02027 1.27822 down 1.01 down PDCD7 
4760373 0.007173 1.00227 down 1.16 down CEBPZ 
2190411 0.013428 1.03673 up 1.36 up PRKCB1 
7160292 0.012179 1.18215 down 1.47 down ST3GAL2 
6760358 0.009794 1.19639 up 1.05 up LOC648245 
4760047 0.007373 1.14504 up 1.33 up UBE2D2 
6860082 0.01208 1.0869 down 1.25 up SLC16A5 
5260537 0.020905 1.2466 up 1.25 up YEATS2 
1660438 0.035022 1.18403 up 1.06 up PDLIM4 
4880544 0.012242 1.27762 down 1.13 up GALNT12 
650328 0.030287 1.01211 up 1.22 down TNFRSF4 
990020 0.028525 1.21794 down 1.1 down PFAAP5 
231 
 
6520215 0.03747 1.203 up 1.11 down ANXA1 
2630008 0.016033 1.16372 down 1.06 down COQ10A 
2710386 0.002035 1.22797 up 1.02 down SRP72 
2900438 0.017051 1.06036 up 1.02 down ANO8 
2190139 0.004524 2.13296 down 1.49 down CA1 
3710156 0.026319 1.00922 up 1.3 up ROBO1 
4760296 0.012778 1.02253 down 1.05 down SLC34A2 
380528 9.38E-04 1.50807 up 1.08 up CHORDC1 
2060445 0.002372 1.10416 down 1.14 down TXNDC2 
4040398 0.018265 1.11065 up 1.4 up MAL 
4070392 0.006682 1.1018 down 1.21 up CYBA 
1410113 0.013683 1.2302 up 1.17 down ARL4A 
5690463 0.034882 1.1003 down 1.36 down C11orf80 
7510414 0.019071 1.05462 up 1.79 up IGFBP4 
5550450 0.023241 1.05325 down 1.29 down NPPC 
2690082 0.02646 1.03483 down 1.24 up  
780440 0.007191 1.06463 up 1.09 up C11orf73 
1260435 0.009551 1.09286 up 1.22 down ZNF511 
1190228 0.015288 1.04192 up 1.22 up LYCAT 
3360646 0.001096 1.18964 up 1.07 up MVP 
6560093 0.009828 1.05809 up 1.18 up SLC15A2 
3800468 0.038931 1.06614 down 1.08 up  
2030044 0.006308 1.10466 up 1.1 down C1orf144 
870681 0.018003 1.1781 down 1.03 down GLIPR1L1 
6590615 0.018887 1.47949 down 1.05 down STAR 
1170332 0.016656 1.36359 up 1.16 down AAK1 
6400392 0.001512 1.34987 down 1.04 up GSTM1 
5130497 0.001108 1.4315 down 2.75 down S100A13 
5860148 0.012166 1.47957 down 2.72 down S100A13 
5220541 0.011917 1.23109 up 1.11 up SDCCAG1 
4560154 0.013179 1.0973 up 1.35 down KIAA0831 
780240 0.005868 1.22498 up 1.19 up C12orf24 
1430360 9.73E-04 1.09681 down 1.29 up ABHD14A 
870731 0.016534 1.33387 up 1.31 down C2orf49 
2640671 0.014749 1.25399 down 1.08 up LOC642342 
4210626 0.011573 1.14164 up 1.3 down SLC25A22 
4050681 0.004072 1.05249 up 1.06 up NDUFV2 
2360414 0.046986 1.05062 up 1.28 down PI4KAP1 
232 
 
2940730 0.012312 1.2448 up 1.33 down ADAM9 
3170593 0.007682 1.18278 up 1.1 down PTPRA 
1660451 0.007599 1.34018 up 1.03 up PAPD1 
6510189 0.005436 1.04186 up 1.11 down VKORC1L1 
5960114 3.56E-04 1.09005 up 1.03 down MRPL34 
3710296 0.041746 1.04183 up 1.03 down SERPINF2 
2260731 0.014359 1.00867 down 1.08 up ERAP2 
3310703 0.001233 1.77534 down 1.11 down FLJ25404 
5390433 0.008453 1.1766 down 1.14 up DICER1 
1240379 0.022264 1.26218 up 1.1 up ALDH1B1 
2750327 0.028429 1.25214 down 1.13 up  
2340500 0.019869 1.18018 down 1.32 down KLC3 
4070014 0.00477 1.07284 down 1.27 down APBA3 
6560193 0.042319 1.06373 down 1.21 down PHLPPL 
5490008 0.01051 1.18147 up 1.14 down RSL1D1 
4890544 0.021862 1.24265 down 1.12 up SPATA22 
2190544 0.021448 1.12893 down 1.02 down DPY19L4 
5130162 0.003244 1.38322 down 1.05 down AK1 
1470750 0.043305 1.19671 down 1.01 up CDC23 
7570240 0.006491 1.06713 up 1.38 down GLMN 
6520270 0.030827 1.16361 up 1.01 up GALT 
6020647 0.014787 1.06434 down 1.16 down  
2060246 0.004759 1.06043 down 1.16 up TTC30A 
5900092 0.042529 1.07368 up 1 down  
7210296 0.042963 1.03351 up 1.07 up LOC643363 
5490403 0.03739 1.01393 up 1.12 up CD1E 
7160468 0.004329 1.40523 up 3.22 down DHRS9 
6270367 0.009384 1.13233 up 1.24 down LOC654174 
4260289 0.04979 1.10257 up 1.06 up IL4 
2060064 0.027649 1.16902 down 1.32 down NOL12 
3800470 0.010919 1.07046 up 1.2 up MBOAT7 
3890349 0.048543 1.10559 up 1.17 up HIST1H4C 
2450192 0.00405 1.19493 up 1.02 down MIZF 
5960068 0.041642 1.14744 down 1.01 down PDGFRB 
1090400 0.004796 1.2411 up 1.17 up ATXN2 
4010041 0.010445 1.12723 up 1.04 up MPI 
1430131 0.004257 1.14345 down 1.11 down  
2490328 0.022657 1.06345 down 1.06 up LOC731486 
233 
 
1940021 0.008887 1.04728 down 1.32 up GRN 
6840184 0.003442 1.17801 down 1.19 up GRN 
2650601 0.047986 1.13988 down 1.05 down GPBP1L1 
2640601 0.021526 1.12438 up 1.28 up GIT1 
3140731 0.039259 1.46172 up 1.1 up MDN1 
60475 0.008045 1.10008 up 1.01 down  
6770377 0.041275 1.07647 up 1.09 down TMEM135 
4640719 0.025013 1.09806 up 1.28 up DIS3 
990315 0.042293 1.09184 up 1 down TCP1 
5260609 0.048054 1.13802 up 1 down SGCZ 
6940433 0.038955 1.12516 up 1.3 up STAT5B 
6110187 0.007273 1.00698 up 1.32 up CSNK2A2 
1440369 0.04514 1.15842 up 1.05 up RNF128 
4070424 0.008026 1.25715 down 1.48 down LOC90835 
3290689 0.046386 1.14555 up 1.17 up C14orf166 
50626 0.038578 1.28111 down 1.27 down PLA2G3 
4850411 0.035363 1.07665 up 1.21 up LOC646046 
6280025 0.028803 1.01547 down 1.09 up LOC283755 
6110184 0.013242 1.15979 up 1.04 up BPIL3 
1300376 0.042168 1.02072 up 1.08 down  
4180091 0.045385 1.18531 down 1.04 down LOC652377 
1170347 3.81E-04 1.03176 down 1.17 down CXorf26 
7150373 0.040117 1.01925 up 1.11 up LOC649198 
6250053 0.0389 1.0443 down 1.33 up PTTG1IP 
4880619 0.008291 1.15925 up 1.16 up ARMC9 
1570148 0.018604 1.06836 up 1.04 down LECT2 
5570279 0.009596 1.22265 up 1.58 down HIST1H1C 
1470035 0.038654 1.07575 up 1.26 up ADH5 
7100619 0.001776 1.21177 down 1.33 down  
7200670 0.009393 1.3376 up 1.04 down MRPS30 
3390563 0.006117 1.05567 down 1.46 up FOXD4L1 
630687 0.037424 1.14624 up 1.02 down LOC653464 
7150725 0.021823 1.09296 down 1.12 up TEX9 
6560327 0.006577 1.19022 down 1.01 up ACAD10 
1300719 0.006551 1.06172 down 1.36 down C14orf149 
3990639 0.027118 1.05759 up 1.34 up POLN 
3710504 2.77E-04 1.94463 down 1.4 up LYZ 
1110154 0.003794 1.49506 down 1.07 down PIB5PA 
234 
 
4220102 0.01904 1.10642 up 1.28 up SOX6 
3840484 0.012424 1.08941 up 1.16 down LOC652287 
5870543 0.038424 1.09983 up 1.19 down DSCR4 
4810433 6.57E-04 1.22338 down 1.09 down MTMR10 
5420709 0.006334 1.03336 down 1.19 down BTN2A2 
160079 0.003388 1.16885 down 1.22 down MGC10997 
160215 0.035275 1.12237 down 1.02 down SAC 
1110296 0.003422 1.22095 down 1.28 down PXMP4 
6650594 0.007225 1.01072 down 1.89 up ATP11B 
6060706 0.015552 1.03217 up 1.56 up ATP11B 
1820343 0.013078 1.07737 down 1.15 up WNT5A 
2450280 0.033727 1.16908 down 1.03 down ZCCHC17 
3180736 0.01543 1.22818 up 1.52 up ARHGEF1 
1780070 0.045516 1.15266 up 1.07 up RUVBL1 
5090347 0.019887 1.30662 up 1.11 down CD24 
5700112 0.029007 1.30759 up 1.4 down KIAA0241 
6220402 0.048151 1.12755 up 1.11 up C21orf93 
4830592 0.006359 1.06477 down 1.19 up MGC34761 
290520 0.046052 1.21153 up 1.19 up TMPRSS7 
1440707 0.04551 1.01094 down 1.13 up APPBP2 
3710202 0.045392 1.13115 down 1.17 down MST1 






Gene Fold Change Standard 
deviation 
p-value 
HuADE DDX21 4.10 0.33 p<0.01 
DDX31v2 8.45 0.23 p<0.01 
DDX47v1 1.73 0.75 p<0.01 
DDX47v2 6.01 0.84 p<0.01 
DDX49 -2.86 0.41 p>0.05, not 
significant 
DDX52v1 1.51 0.83 p>0.05, not 
significant 
DDX54v2 1.07 0.19 p>0.05, not 
significant 
MoADE DDX21 5.48 1.61 p<0.01 
DDX31v2 11.42 2.21 p<0.01 
DDX47v1 1.92 0.25 p<0.01 
DDX47v2 15.78 0.08 p<0.01 
DDX49 -5.21 0.14 p<0.01 
DDX52v1 1.86 0.13 p>0.05, not 
significant 
DDX54v2 1.38 0.04 p>0.05, not 
significant 
Equivalent DDX21 1 0 - 
DDX31v2 1 0 - 
DDX47v1 1 0 - 
DDX47v2 1 0 - 
DDX49 1 0 - 
DDX52v1 1 0 - 
DDX54v2 1 0 - 






Appendix 1.9: Graphical representation of Table 3.1.  Control group was untransfected HL-CZ. 
 
 Type of siRNA 
treatment 




Condition compared with for p-value calculation p-value 
DDX21 Negative control 3.08 0.46 - - 
Equivalent 34.5 0.75 DDX21HuADE p>0.05, not significant 
Control Equivalent p>0.05, not significant 
HuADE 32.8 1.63 Control HuADE p>0.05, not significant 
DDX31 Negative control 2.99 0.58 - - 
Equivalent 29.8 1.48 DDX31 HuADE p<0.01 
Control Equivalent p>0.05, not significant 
HuADE 18.5 1.04 Control HuADE p<0.01 
DDX47 Negative control 2.45 0.44 - - 
Equivalent 27.9 0.57 DDX47 HuADE p<0.01 
Control Equivalent 0.01<p<0.05, slightly 
significant 
HuADE 17.9 1.49 Control HuADE p<0.01 
GAPDH Negative control 3.06 0.57 - - 
Equivalent 32.4 0.85 GAPDH HuADE p>0.05, not significant 
Control Equivalent p>0.05, not significant 
HuADE 32.5 0.80 Control HuADE p>0.05, not significant 
Non-targeting Negative control 4.33 0.74 - - 
Equivalent 33.9 0.92 Non-targeting HuADE p>0.05, not significant 
Control Equivalent p>0.05, not significant 
HuADE 30.3 1.16 Control HuADE p>0.05, not significant 
Control Negative control 3.21 0.41 - - 
Equivalent 31.4 1.56 Control HuADE p>0.05, not significant 
HuADE 28.7 1.30 - - 




Appendix 1.10B: Supernatants of samples from Figure 3.11 were harvested, freeze-thawed for 1 
cycle and subjected to plaque assay to determine virus yield in the infected HL-CZ. 
 
 
 
